3 Robotics Stocks That Could Be Multibaggers in the Making: July Edition
- As the field of robotics progresses and enters more and more industries, robotics stocks are becoming increasingly promising investments. AI machine learning (ML) are some of the critical aspects that have formed the basis of robotics today.
- 07/18/2024
|
7 ‘Death Cross' Stocks That Could Be Contrarian Buys
- Death cross stocks – on the surface, the title sounds incredibly menacing. However, it may be one of the more misunderstood concepts.
- 07/17/2024
|
Medtronic: Lock In This Dividend Aristocrat While It's Still Cheap
- Investing in stocks carries risks, but not investing can also be risky, especially with potential declines in savings account yields. Medtronic is a strong dividend aristocrat with top-line growth, profitability, and new product opportunities in the healthcare tech sector. MDT remains a good value stock with strong financials, dividend growth, and potential for market-beating returns.
- 07/17/2024
|
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
- Medtronic (MDT) closed the most recent trading day at $78.10, moving +1.32% from the previous trading session.
- 07/16/2024
|
7 High-Yield Dividend Stocks Beating Inflation
- At this writing, current inflation rate is 3% over the past 12 months. That's the reading as of the end of June.
- 07/16/2024
|
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research
- Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032 Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032
- 07/16/2024
|
How Much Will Medtronic Pay Out in Dividends This Year?
- The medical-device specialist habitually declares dividend raises. This year's model is quite modest, though, so buyer beware.
- 07/16/2024
|
Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
- Medtronic is a global leader in medical therapies, with portfolios in cardiovascular, neuroscience, medical surgical, and diabetes segments. My investment thesis is based on market leadership, a robust pipeline, and a strong balance sheet for M&A, with a bullish outlook on future growth. MDT has underperformed in recent years, but with earnings growth and a strong pipeline, I consider shares to be cheap.
- 07/16/2024
|
3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade
- Medtronic is a giant medical technology company that has raised its dividend payout for 47 years consecutive years. As a successful net lease REIT, Agree Realty has raised its dividend payout by 34% over the past five years.
- 07/15/2024
|
2 Healthcare Stocks to Buy Hand Over Fist This Month
- Johnson & Johnson and Medtronic are healthcare leaders that have faced their share of issues in recent years. Still, both companies have the innovative capabilities and expertise to succeed in the industry in the long run.
- 07/14/2024
|
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
- Over the years, especially the past three, I have become more cautious about the technology sector's blatant overvaluation. Nevertheless, it is difficult to ignore the capabilities of companies such as Nvidia (NASDAQ: NVDA ) and their innovative solutions for AI.
- 07/13/2024
|
3 Healthcare Stocks Injecting AI for Big Gains
- While the pairing of artificial intelligence and healthcare may sound like something straight out of a science fiction movie, there are several avenues through which the high-speed data processing offered by AI can improve patient outcomes. From more precise diagnosis to pandemic modeling, the large-scale algorithmic models we call AI can help the world of medicine immensely.
- 07/13/2024
|
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- The latest trading day saw Medtronic (MDT) settling at $77.06, representing a +0.23% change from its previous close.
- 07/10/2024
|
3 Undervalued Stocks Ready for a Breakout This Summer
- As the second half of 2024 unfolds, main Wall Street indices are reaching new highs. The Nasdaq 100 index soared more than 20% year-to-date, and the S&P 500 saw an all-time high with a 16% surge.
- 07/10/2024
|
4 Cheap Stocks to Buy Ahead of Earnings
- Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.
- 07/09/2024
|
Nasal Packing Devices: Global Market Forecasts from 2024 to 2029 Featuring Strategic Analysis of Meril Life, Anthony Products, Medtronic, Entsho, and Innovia Medical Among Others
- Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "Nasal Packing Devices Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.
- 07/09/2024
|
7 ‘Buy and Hold Forever' Stocks for Lasting Riches
- Buy-and-hold stocks don't have to be boring. Often, investors looking for buy-and-hold stocks see recommendations centered around what can be called charitably value traps.
- 07/09/2024
|
4 Dividend Aristocrats To Buy In July And 4 To Watch
- "Dividend Aristocrats
- 07/09/2024
|
I'm Buying Dividend Aristocrats With Up To 8.5% Yield
- A Lower-risk portfolio can be created by buying durable companies with long track records of rewarding shareholders at attractively low prices. Overpaying for a stock can lead to outsized risks, so it's important to separate price from value and company from stock. Medtronic and Altria are dividend aristocrat value stocks trading far below historical norms, offering income and potential for capital gains.
- 07/08/2024
|
3 Robotics Stocks to Sell in July Before They Crash & Burn
- Robotics is the core of automation in a variety of business sectors. In this day and age, with the demand for and proliferation of artificial intelligence- and machine learning-based technologies, the robotics sector could experience a real boom.
- 07/05/2024
|
3 Robotics Stocks to Buy on the Dip: Summer 2024
- The remarkable advancements in automation, powered by robotics, have put several robotics stocks to buy on investors' radar. In recent years, the mushrooming power, utility and functionality of artificial intelligence have accelerated the use of robotics across several industries.
- 07/05/2024
|
Yielding An Average Of 4%, My Top 3 Buys For July
- The highlighted companies are currently out of favor with the market, offering an opportunity to invest in undervalued stocks with high yields. Medtronic is a leader in medical devices, U.S. Bancorp is the largest regional bank, and Comcast is a dominant player in broadband and entertainment. Each stock has investment grade credit ratings, growing dividends, and projected 5-year PEG ratios below historical averages, making them attractive buys.
- 07/05/2024
|
Blue-Chip Fire Sale: 3 Stocks the Market is Dead Wrong About
- If this year's market volatility has you feeling uneasy, you're not alone. The overvaluation of many tech stocks has created a challenging environment, but plenty of affordable, undervalued blue-chip stocks can provide the stability your portfolio needs.
- 07/03/2024
|
Medtronic Loses 5% in a Month: What's Next for MDT Investors?
- Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
- 07/02/2024
|
Going Beyond Morningstar's 10 Best Value Stocks List
- Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P 500, Bristol-Myers has the highest potential rate of return. In comparison to Morningstar's 10 Best Value Stocks with 10 Best Dividend Stocks, Bristol-Myers stands out as undervalued with a high potential return.
- 07/01/2024
|
My Best Dividend Aristocrats For July 2024
- The ProShares S&P 500 Dividend Aristocrats ETF continues its positive run in 2024, posting a gain of 1.45% in May. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 35 months of tracking these strategies, two strategies are outperforming NOBL, while 1 remain relatively close.
- 07/01/2024
|
Medtronic Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Other Innovation Programs
- Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Medtronic Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehensive information and insights into Medtronic's technology activities, focusing on its digital transformation strategies and innovation programs. It offers an overview of Medtronic's technology initiatives, covering partnerships, product launches, and acquisitions. Each technology initiative is detailed with insights into the technology theme, objectives, and benefits, giving a clear understanding of the strategic intent behind each move.
- 07/01/2024
|
If I Had To Retire With 10 Dividend Aristocrats, It Would Be These
- If you want a massive dividend snowball: Get the right combination of dividend yield and growth for maximum compounding effect. Dividend Aristocrats may not always be the best choice due to high valuations and low yields. I refine a list of Dividend Aristocrats from 60+ to 10 based on yield and growth rates if I had to pick just 10.
- 06/30/2024
|
Medtronic (MDT) Shares Positive Data for MiniMed 780G System
- Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.
- 06/25/2024
|
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
- With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep DUBLIN and ORLANDO, Fla. , June 21, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that showcases the benefits of the MiniMed™ 780G system.
- 06/21/2024
|
Sempra Appoints Jennifer M. Kirk to Board of Directors
- SAN DIEGO , June 20, 2024 /PRNewswire/ -- Sempra (NYSE: SRE) (BMV: SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024.
- 06/20/2024
|
Rags to Riches: 3 Robotics Stocks That Could Make Early Investors Rich
- The robots aren't coming. They're already here.
- 06/20/2024
|
10 Upcoming Dividend Increases
- I highlight ten companies with a history of raising dividends this week. The list will complete not only June, but the first half of 2024. Dividend King National Fuel Gas Company extends its streak with a 4% increase.
- 06/20/2024
|
3 Generative AI-Based MedTech Stocks to Keep an Eye On
- With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.
- 06/20/2024
|
3 Healthcare Stocks to Buy Now: June 2024
- Healthcare stocks offer a haven for investors amidst the uncertainty. The Fed elected to hold interest rates at a 23-year high between 5.25% and 5.5% to combat persistent inflation.
- 06/20/2024
|
3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition
- Building a portfolio today can be both easy and difficult. It's easy because every bit of data you need to make your choices is available 24/7 with a few taps on the screen.
- 06/20/2024
|
BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC
- TROY, Mich. , June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its "Stock to Study" and Medtronic PLC (NYSE: MDT) as its "Undervalued Stock" in the September 2024 issue for investors' informational and educational use.
- 06/14/2024
|
Medtronic: Now Is The Time To Buy This Deep Value Dividend Aristocrat
- When done right, pairing quality and value can be an especially potent investing strategy. Medtronic's revenue edged higher as currency-neutral non-GAAP EPS dipped a bit in the fiscal fourth quarter. Relative to its size, the company's $17 billion in net debt is quite manageable.
- 06/14/2024
|
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
- Novo Nordisk and Medtronic are longtime leaders in the healthcare industry. Both are proven innovators with attractive prospects in the years ahead.
- 06/14/2024
|
Medtronic: Why I Disagree With The Crowd
- MDT stock enjoys a bullish rating from analysts and Seeking Alpha writers. But insider transactions are completely dominated by selling - for good reasons in my view. The valuation is not as attractive as on the surface once growth is factored in.
- 06/14/2024
|
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
- During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 06/12/2024
|
Medtronic plc (MDT) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Medtronic plc (NYSE:MDT ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024 10:40 AM ET Company Participants Geoff Martha - Chairman & Chief Executive Officer Conference Call Participants David Roman - Goldman Sachs David Roman Good morning, everybody. I want to welcome everyone here to the 45th Annual Global Healthcare Conference.
- 06/11/2024
|
Medtronic (MDT) Cardiovascular Business Expands Amid Macro Woes
- For Hugo surgical robot, Medtronic (MDT) is scaling manufacturing production, expanding regulatory approvals and ramping up installations to see continued progress internationally.
- 06/07/2024
|
4 Dividend Aristocrats To Buy In June And 4 To Watch
- "Dividend Aristocrats
- 06/07/2024
|
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
- DUBLIN , June 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 45th annual Goldman Sachs global healthcare conference on Tuesday, June 11, 2024. Geoff Martha, Medtronic chairman and chief executive officer, will answer questions on the company beginning at 10:40 a.m.
- 06/06/2024
|
Medtronic Raised Its Dividend for a 47th Straight Year, But Here's Why It Isn't a Great Dividend Growth Stock
- Medtronic has been increasing its dividend for decades. But the rate of its increases has slowed drastically in recent years.
- 06/06/2024
|
With Less Than 10% Contribution To Sales How Important Is The Diabetes Segment For Medtronic Stock?
- Medtronic's (NYSE: MDT) diabetes segment, which sells insulin pumps, continuous glucose monitoring systems, and consumables has seen its revenue rise at a slower pace of 1.4% annually from $2.4 billion in fiscal 2020 (fiscal ends in April) to $2.5 billion in fiscal 2024. The slower growth can be attributed to unfavorable currency translation, given that over 60% of the segment sales are derived from markets outside the U.S. However, we think the company will see a pickup in diabetes sales going forward.
- 06/06/2024
|
The 2 Most Important Charts I Want (Dividend) Investors To See
- Recent data indicates a heightened risk of stagflation, with slowing economic growth and persistent inflation. This poses challenges for the economy and portfolios, but also presents opportunities to buy beaten-down stocks with strong pricing power and growth potential. My focus remains on resilient dividend growth stocks and sectors like energy and healthcare, which are well-positioned for these conditions.
- 06/05/2024
|
Dividend Delights: 3 Stocks That Will Sweeten Your Investment Returns
- Dividend stocks are the best way to play a market potentially on the cusp of a massive rebound, thanks to the Federal Reserve potentially cutting rates three times if inflation stays low, which has made the market more optimistic. The latest Bureau of Economic Analysis report shows that inflation cooled slightly in April.
- 06/05/2024
|
I'm Buying Dividend Aristocrats With Up To 8.5% Yield
- Medtronic and Altria are two value stocks with long track records of raising dividends for over 25 consecutive years. Medtronic is a healthcare technology company with strong revenue growth and a safe dividend yield of 3.4%. Altria, despite challenges in the tobacco industry, offers an 8.5% dividend yield and potential upside from its e-vapor business and strategic investments.
- 06/04/2024
|
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
- Finding overlooked stocks (worth investing in) is tough in today's market. While you can screen for micro-caps, pink sheet stocks, and similar speculative investments, most of the best blue-chip and long-term stocks are well-known and heavily invested in.
- 06/03/2024
|
Medtronic announces closing of public offering of €3.0 billion of senior notes
- DUBLIN , June 3, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and €700,000,000 principal amount of 4.150% senior notes due 2053 (collectively, the "Notes"). All of Medtronic, Inc.'s obligations under the Notes are fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.A.
- 06/03/2024
|
Beat the Heat: 3 Stocks to Buy Before the Summer Slowdown Sets In
- The summer doldrums are almost upon us. June is absolutely the worst month in which to invest, no matter the market index.
- 06/03/2024
|
Is Medtronic Stock a Buy?
- Medtronic's growth rate has been showing signs of improvement. The company recently announced it would be raising its dividend for the 47th consecutive year.
- 06/01/2024
|
Watch These 5 Stocks That Recently Hiked Dividends
- Investors may keep a tab on stocks like HLNE, RL, SPTN, EQH and MDT, which have lately hiked their dividend payments.
- 05/31/2024
|
Medtronic Stock Is a Sell, According to 1 Wall Street Analyst
- Medtronic exceeded quarterly forecasts last week, but its stock got punished anyway. Shares cost nearly 30x earnings, but those earnings are growing painfully slowly.
- 05/30/2024
|
Medtronic announces pricing of €3.0 billion of senior notes
- DUBLIN , May 29, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and €700,000,000 principal amount of 4.150% senior notes due 2053 (collectively, the "Notes"). All of Medtronic, Inc.'s obligations under the Notes will be fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.A.
- 05/29/2024
|
The 3 Best MedTech Stocks to Buy Now: May 2024
- In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity to save an estimated $200 billion to $300 billion annually through enhanced workflow management. Inspired by these findings, this article explores the three best MedTech stocks to buy now, each poised to capitalize on AI-driven advancements.
- 05/29/2024
|
My Best Dividend Aristocrats For June 2024
- The ProShares S&P 500 Dividend Aristocrats ETF hits its first speed bump in April, dropping by 4.69%. Some of this loss has been recovered in May. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 34 months of tracking these strategies, one strategy is outperforming NOBL, while 2 remain relatively close.
- 05/28/2024
|
If You Can Only Buy One Dividend Stock in May, It Better Be One of These 3 Names
- Dividend stocks are making a comeback in portfolios after a period where higher interest rates made fixed-income options more attractive to income investors. As these investors return to dividend stocks, the criteria for selecting the best options have evolved — a trend that applies to most stock segments today.
- 05/28/2024
|
Going Beyond Morningstar's 10 Best Dividend Stocks List
- Morningstar published their 10 Best Dividend Stocks, which are undervalued blue-chip stocks with reliable dividends. The article analyzes the valuation and estimated future total return of each stock, comparing them to the S&P 500. Comcast has the highest potential rate of return among the 10 stocks, while Sempra has the lowest.
- 05/27/2024
|
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
- Earlier, the Federal Reserve stood poised to cut the benchmark interest rate, which boded well for reliable dividend stocks. Essentially, Uncle Sam's high yields wouldn't compete with the passive income stemming from private enterprises.
- 05/27/2024
|
Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
- Medtronic's fair price estimate is $142.20, indicating a 73.3% upside from $82.07, with potential annual returns of 28.8% through 2029. FQ4 2024 earnings exceeded expectations with an EPS of $1.46 and revenue of $8.59 billion. Medtronic focuses on innovation through AI, data analytics, and new partnerships, enhancing competitiveness and product offerings.
- 05/27/2024
|
Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?
- Medtronic stock reacted negatively to an earnings report that many Wall Street analysts found encouraging. Wells Fargo raised its price target for Medtronic to $105 per share.
- 05/26/2024
|
Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial
- Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.
- 05/24/2024
|
Medtronic Dips: Is Now the Time to Buy?
- Shares of Medtronic NYSE: MDT are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow are enough to keep investors interested and if they should be.
- 05/24/2024
|
Medtronic's Mixed Q4 Earnings Report
- Medtronic's top line saw growth in Q4 and full-year, but that growth disappeared in the bottom-line figures. Medtronic management was positive in its outlook for fiscal 25 with projected organic revenue growth of 4%-5%.
- 05/23/2024
|
Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
- Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.
- 05/23/2024
|
Medtronic plc (MDT) Q4 2024 Earnings Call Transcript
- Medtronic plc (NYSE:MDT ) Q4 2024 Earnings Conference Call May 23, 2024 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head, Investor Relations Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Executive Vice President and Chief Financial Officer Brad Welnick - Vice President, Investor Relations Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Brett Wall - Executive Vice President and President, Neuroscience Portfolio Mike Marinaro - Executive Vice President and President, Medical Surgical Portfolio and Surgical Operating Unit Que Dallara - Executive Vice President and President, Diabetes Operating Unit Conference Call Participants Travis Steed - Bank of America Securities Robert Marcus - JPMorgan Vijay Kumar - Evercore ISI Lawrence Biegelsen - Wells Fargo Pito Chickering - Deutsche Bank Joshua Jennings - Cowen and Company Richard Newitter - Truist Securities Matt Miksic - Barclays Ryan Weispfenning Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and I appreciate that you're joining us this morning for our Fiscal '24 Fourth Quarter Video Earnings Webcast.
- 05/23/2024
|
Why Medtronic Stock Slumped Today
- Medtronic beat on sales and earnings and gave exactly the guidance that Wall Street expected. Its stock dropped today anyway.
- 05/23/2024
|
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/23/2024
|
Medtronic Q4 earnings: ‘we're optimistic about fiscal 2025'
- Medtronic PLC (NYSE: MDT) is in focus on Thursday after reporting market-beating financial results for its fourth quarter. Medtronic issues in-line guidance The stock is flat at writing because $MDT issued roughly in-line guidance for the full year.
- 05/23/2024
|
Medtronic (MDT) Q4 Earnings and Revenues Surpass Estimates
- Medtronic (MDT) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.57 per share a year ago.
- 05/23/2024
|
Medtronic's stock rises after earnings beat expectations and the dividend was raised
- Shares of Medtronic PLC MDT, +0.69% rallied 1.3% in premarket trading Thursday, after the medical device and therapies company reported fiscal fourth-quarter profit and revenue that rose above expectations, and lifted its dividend. Net income for the quarter to April 26 fell to $654 million, or 49 cents a share, from $1.19 billion, or 88 cents a share, in the same period a year ago.
- 05/23/2024
|
Medtronic beats quarterly profit estimates on medical devices strength
- Health tech firm Medtronic beat Wall Street estimates for quarterly profit on Thursday, aided by a post-pandemic pickup in surgical volumes at hospitals that boosted demand for its medical devices.
- 05/23/2024
|
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase
- Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles across many high-growth markets DUBLIN , May 23, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter (Q4) and fiscal year 2024 (FY24), which ended April 26, 2024. Key Highlights Q4 revenue of $8.6 billion increased 0.5% as reported and 5.4% organic Q4 GAAP diluted earnings per share (EPS) of $0.49; non-GAAP diluted EPS of $1.46 FY24 revenue of $32.4 billion increased 3.6% as reported and 5.2% organic FY24 GAAP diluted EPS of $2.76; non-GAAP diluted EPS of $5.20 FY24 cash from operations of $6.8 billion increased 12%; FY24 free cash flow of $5.2 billion increased 14% Company returned $5.5 billion to shareholders in FY24, including $1.6 billion through net share repurchases in Q4 Company issues FY25 guidance Dividend increased to $0.70 per share quarterly, annual $2.80 per share; 47th consecutive year of dividend increases Received U.S. FDA approval for Evolut™ FX+ TAVR system and Inceptiv™ closed-loop spinal cord stimulator; received China National Medical Products Administration (NMPA) approval for Symplicity Spyral™ renal denervation system; submitted Affera Sphere-9™ ablation catheter and Simplera Sync™ CGM to U.S. FDA seeking approval Q4 Financial Results Medtronic reported Q4 worldwide revenue of $8.589 billion, an increase of 0.5% as reported and 5.4% on an organic basis.
- 05/23/2024
|
7 Blue-Chip Stocks to Buy Now: May 2024
- If the market's dramatic shifts this year have left you feeling unsettled, you're not alone. Despite widespread overvaluation in many tech stocks, plenty of blue-chip stocks to buy can provide the portfolio stability we all need.
- 05/23/2024
|
Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade
- Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.
- 05/22/2024
|
3 Healthcare Stocks to Buy Now: May 2024
- It's a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the overall stock market by an average of 10% over the past seven recessions.
- 05/21/2024
|
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
- Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 fourth-quarter results on Thursday, May 23 (fiscal ends in April). We expect Medtronic Medtronic stock to trade sideways post-Q4 results announcement, with its revenues and earnings expected to meet the street estimates.
- 05/21/2024
|
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
- Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.
- 05/20/2024
|
Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
- Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
- 05/20/2024
|
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
- Internationally known clinical and translational researcher also co-leads the GI oncology team DETROIT, May 20, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team (MDT). Dr. Saif is a world-renowned hematologist and oncologist specializing in GI cancers, experimental therapeutics and pharmacogenetics. He joined Karmanos on March 1, 2024. "Karmanos Cancer Institute is a trailblazer in cancer research and has been a major contributor to significant strides in new drug and therapy development," said Dr. Saif. "I am most excited about continuing translational research at this NCI-Designated Comprehensive Cancer Center with access to a diverse cancer population. This cancer center's rich data from clinical trials, studies, and investigations largely shapes the understanding of cancer and treatment for multiple populations. The avenues the physicians, scientists, and researchers have open to them are endless, and I am honored to be part of this significant work in Detroit." Dr. Saif has an extensive background in translational research and developing and managing clinical trials. As the Phase 1 Clinical Trials MDT leader, he will lead a team of physician co-investigators, non-physician providers, clinical personnel, and Clinical Trials Office staff to oversee Phase 1 solid tumor investigations. Karmanos' Phase 1 team oversees over 70 clinical trials at various stages of the protocol lifecycle. Members of this MDT include medical oncologists specializing in many different cancers, who research, study, and develop therapies, bringing them from lab to bedside. Having a Phase 1 team in Detroit gives cancer patients access to promising new treatments not offered elsewhere. Dr. Saif will also work alongside Najeeb Al Hallak, M.D., MS, medical oncologist, in leading the GI and Neuroendocrine Oncology MDT, a team made up of cardiothoracic surgeons, endocrinologists, gastroenterologists, hematologists, medical oncologists, pathologists, radiologists, radiation oncologists, and surgical oncologists that dedicate their research and treatment to GI and neuroendocrine cancers. He specializes in treating anal, biliary, colon, carcinoid, esophagus, GIST, liver, pancreas, rectum, and stomach cancers. His research interests include anticancer drug development with an emphasis on analysis of pharmacokinetics and pharmacodynamics, biomarker discovery, pharmacogenetics, epidemiology and disparity studies in GI cancers, and developing complementary and alternative medicines to treat cancer. "Dr. Saif's philosophy and leadership in novel therapeutics fits our vision of continuing to grow our Phase 1 Clinical Trials Program at Karmanos. His research interests in GI cancers will complement our GI team. I am confident we will see more breakthrough discoveries from these MDTs with Dr. Saif's leadership and vision," said Boris Pasche, M.D. Ph.D., FACP, president and CEO at Karmanos. In addition to his leadership roles, Dr. Saif sees patients at Karmanos Cancer Center in Detroit. He is also a professor in the Department of Oncology at Wayne State University School of Medicine. Before joining Karmanos, Dr. Saif served on the faculty at the University of Alabama at Birmingham, Yale University School of Medicine in New Haven, Connecticut, Columbia University in New York City, and Tufts University School of Medicine in Boston, Massachusetts. He has served as the leader of the GI oncology division at Yale, Columbia, and Tufts and as the program leader in experimental therapeutics at Tufts. He has also served in executive roles at Northwell Health in New Hyde Park, New York and Orlando Health. Dr. Saif is a member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society of Medical Oncology (ESMO), Carcinoid Foundation, and American Society of Pharmacology and Experimental Therapeutics (ASPET). He has served as the principal investigator on over 75 clinical trials and has published over 650 scientific papers in addition to textbook chapters, abstracts, and proceedings of meetings. Dr. Saif earned his medical degree from King Edward Medical College in Lahore, Pakistan, and completed his internal medicine residency at the University of Connecticut School of Medicine in Farmington, Connecticut. He completed medical oncology and hematology fellowships at the National Cancer Institute, National Heart, Lung and Blood Institute, National Institutes of Health, and National Naval Medical Center in Bethesda, Maryland. View Dr. Saif's physician profile here. To learn more about Phase 1 Clinical Trials or to request an appointment, visit karmanos.org or call 1-800-KARMANOS. About the Barbara Ann Karmanos Cancer InstituteKarmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org.
- 05/20/2024
|
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
- Medtronic plc (MDT Quick QuoteMDT - Free Report) recently announced positive results demonstrating the safety and efficacy of the Affera Mapping and Ablation System with the Sphere-9 Catheter. The SPHERE Per-AF study, an FDA Investigational Device Exemption (“IDE”) pivotal trial, compared Sphere-9 to the conventional Thermocool SmartTouch SF radiofrequency ablation catheter with the Carto 3 System.The late-breaking clinical data was presented at the Heart Rhythm Society 2024 Annual Meeting and simultaneously published in Nature Medicine. The latest development comes as a significant boost for the Cardiac Ablations Solutions business, part of Medtronic’s Cardiovascular portfolio.Importance of the Study and FindingsMedtronic’s Sphere-9 Catheter is an all-in-one pulsed field (PF) and radiofrequency (RF) ablation and high-density mapping catheter for the treatment of persistent atrial fibrillation (AFib). As one of the most common and undertreated heart rhythm disorders, AFib often begins as paroxsymal AFib (presents intermittently) and progresses to persistent (lasts for more than seven days without stopping), increasing the risk of serious complications, including heart failure, stroke and death. The prospective, multicenter SPHERE Per-AF clinical trial evaluated the Sphere-9 Catheter with the Affera Mapping and Ablation System for the treatment of persistent AFib. The subjects were randomized 1:1 to receive treatment with either the Sphere-9 Catheter with the Affera Mapping and Ablation System or the Thermocool SmartTouch SF RF ablation catheter with the Carto 3 System. For the primary analysis, a total of 420 patients were enrolled across 23 sites in the United States, Czech Republic and Israel. All patients in both arms of the trial received pulmonary vein isolation and linear lesions based on their needs.Image Source: Zacks Investment ResearchThe Sphere-9 Catheter demonstrated a positive safety profile with a primary safety endpoint rate of 1.4%. No safety events, including pulmonary vein stenosis, esophageal events or cardiac tamponade, were reported. More than 95% of Sphere-9 procedures used a single transeptal puncture compared to 62% in the control arm.Additionally, Sphere-9 demonstrated 73.8% freedom from AFib compared with 65.8% observed in the control arm. Following 100% acute isolation of pulmonary veins and linear lesions, Sphere-9 Catheter-treated patients also observed less recurrence of atrial arrhythmias throughout the 12-month follow-up period.Moreover, treatment with the Sphere-9 Catheter demonstrated superior efficiency over the control arm for procedural characteristics, including skin-to-skin procedural time, time between the first and last ablation and energy application time. The patients treated with the Sphere-9 Catheter are reported to have experienced improvements in the quality of life in both mental and physical well-being.More on the NewsAs pioneers in cardiac ablation treatment, including cryoablation and PFA, the company is thrilled to share these results, which provide compelling evidence for the use of an all-in-one catheter that can be used without any need for a second catheter. The Affera Mapping and Ablation system with Sphere-9 Catheter demonstrates a positive safety, efficacy and efficiency profile, which can potentially amplify Medtronic’s innovative and trusted portfolio. The results bring them closer to introducing this technology to the United States and beyond. The investigational Affera Sphere-9 Catheter was recently filed for the FDA’s approval by the company and is not presently approved for sale or distribution. In March last year, the Affera Mapping and Ablation System, which includes the Sphere-9 Catheter, received CE Mark approval.Industry ProspectsPer a Research report, the global AFib device market was valued at $2.04 billion in 2021 and is expected to witness a CAGR of 12% by 2029. A growing prevalence of AFib among the adult population is likely to push the demand for the devices in the global market. Other Developments in the Cardiovascular PortfolioIn a separate release, Medtronic announced late-breaking data from the global Lead Evaluation for Defibrillation and Reliability Pivotal Trial, which demonstrated that its investigational OmniaSecure defibrillation lead achieved the primary safety and effectiveness endpoints and exceeded prespecified performance goals. The design of the OmniaSecure defibrillation lead is based on the Medtronic SelectSecure Model 3830 pacing lead, which has offered safe and effective treatment to patients for more than 20 years.Price PerformanceIn the past year, MDT shares have dropped 4% compared with the industry’s decline of 0.6%.Zacks Rank and Key PicksMedtronic currently carries a Zacks Rank #4 (Sell).Some better-ranked stocks in the broader medical space are Hims & Hers Health (HIMS Quick QuoteHIMS - Free Report) , High Tide (HITI Quick QuoteHITI - Free Report) and Medpace (MEDP Quick QuoteMEDP - Free Report) . Each of them sports a Zacks Rank #1 (Strong Buy) at present. Hims & Hers Heath stock has rallied 53.3% in the past year. Earnings estimates for the company have risen from 10 cents to 18 cents in 2024 and from 23 cents to 32 cents in 2025 in the past 30 days.HIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. In the last reported quarter, it posted an earnings surprise of a staggering 150%.Estimates for High Tide’s 2024 earnings per share have remained breakeven in the past 30 days. Shares of the company have surged 57.9% upward in the past year against the industry’s fall of 0.6%.HITI’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 91.7%. In the last reported quarter, it delivered an earnings surprise of 100%.Estimates for Medpace’s 2024 earnings per share have moved up to $11.29 from $10.53 in the past 30 days. Shares of the company have surged 87.6% in the past year compared with the industry’s 5% growth.MEDP’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 12.8%. In the last reported quarter, it delivered an average earnings surprise of 30.6%. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
- 05/20/2024
|
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment
- HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON, May 17, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive results demonstrating excellent safety and efficacy of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, an all-in-one pulsed field (PF) and radiofrequency (RF) ablation and high density (HD) mapping catheter for the treatment of persistent atrial fibrillation (AFib). The SPHERE Per-AF study, a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal trial, compared Sphere-9 to the conventional Thermocool SmartTouch® SF radiofrequency ablation catheter with the Carto™ 3 System.
- 05/17/2024
|
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™
- Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm DUBLIN and BOSTON , May 17, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its investigational OmniaSecure™ defibrillation lead met its primary safety and effectiveness endpoints, exceeding prespecified performance goals, in the global Lead Evaluation for Defibrillation and Reliability (LEADR) Pivotal Trial. Late breaking results were presented at Heart Rhythm 2024 and simultaneously published in the journal Heart Rhythm.
- 05/17/2024
|
Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know
- Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 05/17/2024
|
These Dividend Stocks Are an Investor's Best Friend
- Fund managers have historically pivoted to top dividend stocks in low-interest-rate environments. With the Fed poised to start cutting interest rates within the next eight to 12 months, these two blue chip dividend stocks could be compelling buys.
- 05/16/2024
|
Medtronic (MDT) Advances While Market Declines: Some Information for Investors
- In the closing of the recent trading day, Medtronic (MDT) stood at $83.52, denoting a +0.82% change from the preceding trading day.
- 05/13/2024
|
Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings
- Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
- 05/10/2024
|
Arecor shares higher after Medtronic deal; broker remains upbeat
- Shares in Arecor Therapeutics PLC (AIM:AREC) rose in the wake of news it is teaming with US med-tech giant Medtronic to develop a new, high-concentration, thermostable insulin designed specifically for use in the latter's next-generation implantable insulin pumps. Arecor believes there is the potential for 'significant advancements' in treatment for a group of diabetes patients who find limited benefits from conventional therapies.
- 05/09/2024
|
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
- DUBLIN , May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m.
- 05/09/2024
|
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
- Arecor Therapeutics plc (“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund Arecor's development of Arestat™ enabled novel, high concentration, thermostable insulin, specifically tailored for use in combination with a next-generation implantable pump Cambridge, UK, 9 May 2024: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, today announced a research collaboration with Medtronic plc (NYSE: MDT), a global leader in healthcare technology, to develop a novel, high concentration, thermostable insulin for use by Medtronic's Diabetes business in a next-generation implantable pump. This new insulin has the potential to bring significant advancements in the current insulin treatment options for a small population of patients who have limited options for controlling their diabetes with traditional therapy.
- 05/09/2024
|
Arecor Therapeutics agrees insulin tie-up with US med-tech giant Medtronic
- Arecor Therapeutics PLC (AIM:AREC) said it is teaming with US med-tech giant Medtronic to develop a new, high-concentration, thermostable insulin designed specifically for use in the latter's next-generation implantable insulin pumps. Arecor believes there is the potential for 'significant advancements' in treatment for a group of diabetes patients who find limited benefits from conventional therapies.
- 05/09/2024
|
4 Dividend Aristocrats To Buy In May Plus 4 To Watch
- "Dividend Aristocrats in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years."--Kiplinger.com/Investing.
- 05/08/2024
|
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- The latest trading day saw Medtronic (MDT) settling at $81.76, representing a +0.09% change from its previous close.
- 05/06/2024
|
Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know
- Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
- 05/06/2024
|
5 Expected Dividend Increases In May 2024
- 5 Expected Dividend Increases In May 2024
- 05/03/2024
|
Medtronic (MDT) Rises Higher Than Market: Key Facts
- Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.
- 04/29/2024
|
My Best Dividend Aristocrats For May 2024
- The ProShares S&P 500 Dividend Aristocrats ETF performed well in March, finishing up 4.60%. Some of these gains have been erased in April, though. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.
- 04/29/2024
|
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
- Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN , April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
- 04/26/2024
|
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
- Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 04/24/2024
|
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
- While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks. When conducted in a controlled environment, AI can help accelerate productivity.
- 04/23/2024
|
Medtronic (MDT) Laps the Stock Market: Here's Why
- Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.
- 04/22/2024
|
Here's Why You Should Retain Medtronic (MDT) Stock for Now
- Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
- 04/18/2024
|
Medtronic Stock: Buy, Sell, or Hold?
- The medical device maker's growth rate has averaged less than 2% in the past five years. However, it's still innovating and recently launched an AI-assisted endoscopy system.
- 04/18/2024
|
Cash Burn: 3 Dividend Aristocrats to Dump for Buyback Plays
- Although dividend investing has plenty of research backing its efficacy, it's a slow burn. Further, it may incur high opportunity costs during broad-market rallies, such as what we saw during the bull in the Nasdaq last year.
- 04/16/2024
|
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
- AI could solve one of the biggest problems in drug development: the lengthy time it takes to bring a product to market. The AI in healthcare market is set to expand at a compound annual growth rate of nearly 50%.
- 04/16/2024
|
Medtronic: Dividend Aristocrat Value In Plain Sight
- Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year. The company has maintained pricing power and has a strong balance sheet, with an A+ grade for profitability. Medtronic is well-positioned for future opportunities, including diabetes care, and is undervalued compared to historical norms with a decent starting dividend yield.
- 04/13/2024
|
35% Undervalued? Medtronic's Future Looks Very Bright
- Medtronic is undervalued compared to its long-term P/E ratio and has potential for strong returns. The company's focus on innovation and product diversification positions it well for future growth.
- 04/12/2024
|
Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know
- Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 04/12/2024
|
Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable
- Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.
- 04/11/2024
|
7 Dividend Stocks to Buy Now for Decades of Consistent Returns
- Dividend stocks are finally cycling back into portfolios after a few years' worth of higher interest rates put fixed-income options ahead of dividend distribution yield for income investors. As those investors circle back toward dividend stocks, a few things have changed about how to best look at the many available offerings – but that's true for most stock segments today.
- 04/11/2024
|
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
- Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.
- 04/10/2024
|
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
- A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
- 04/10/2024
|
Medtronic (MDT) Registers a Bigger Fall Than the Market: Important Facts to Note
- In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.
- 04/04/2024
|
Disney will 'eke out a narrow victory' over Nelson Peltz, former Medtronic CEO says on proxy fight
- Disney's (DIS) annual shareholder meeting, which will decide Disney's board membership, will take place on April 3. The vote has attracted media attention as activist Nelson Peltz has questioned Disney's current leadership and seeks to embed his views in the company.
- 04/01/2024
|
Medtronic's (MDT) Newest Evolut TAVR System Gets FDA Approval
- Medtronic (MDT) announces the FDA approval of the newest-generation Evolut TAVR system for the treatment of symptomatic severe aortic stenosis.
- 04/01/2024
|
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
- Healthcare expenses tend to rise year after year regardless of what's happening to the overall economy. Medtronic has a 46-year history of consecutive annual dividend raises.
- 03/31/2024
|
My Best Dividend Aristocrats For April 2024
- My Best Dividend Aristocrats For April 2024
- 03/30/2024
|
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
- Now that it's focused on just medical technology and pharmaceuticals, Johnson & Johnson's pace of annual dividend raises could accelerate. Medtronic is the largest publicly traded medical device manufacturer, and it offers a 3.3% yield at recent prices.
- 03/30/2024
|
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks
- The AI-in-healthcare market is expanding in the double digits and could reach more than $148 billion by the end of the decade. Nvidia CEO Jensen Huang says AI may have the most impact in the healthcare industry.
- 03/23/2024
|
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
- Medtronic and Merck are innovative healthcare leaders. Both are developing new products to keep sales growing.
- 03/21/2024
|
3 Companies With Strong Irish Operations
- One of Diageo's biggest brands shares a very special symbol with the country of Ireland. Medtronic acquired an Irish company and then found the island a great place to settle.
- 03/17/2024
|
3 Stocks to Buy if the Fed Keeps Rates High for the Rest of 2024
- “Higher for longer” may prove true as sticky inflation indicates the higher-rate environment might be here to stay. As interest rates stay steady, risk-averse investors gravitate towards short-term Treasuries for safety.
- 03/14/2024
|
The 3 Most Undervalued Healthcare Stocks to Buy in March 2024
- Undervalued healthcare stocks are primed for a comeback this year, proving themselves as lucrative investments amidst a revitalized market. With a significant uptick in performance, the S&P 500 Health Care index soared roughly 7% year-to-date (YTD), marking a robust recovery from last year's challenges.
- 03/14/2024
|
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
- There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.
- 03/13/2024
|
Medtronic plc (MDT) Management presents at 2024 Barclays 26th Annual Healthcare Conference (Transcript)
- Medtronic plc (MDT) Management presents at 2024 Barclays 26th Annual Healthcare Conference (Transcript)
- 03/12/2024
|
Here's Why You Should Retain Medtronic (MDT) Stock for Now
- Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.
- 03/12/2024
|
Active Rebound: 2 Discrete Semiconductor Stocks Making Moves
- Semiconductor stocks are surging thanks to the artificial intelligence (AI) boom driven by Nvidia Co. NASDAQ: NVDA and Advanced Micro Devices Inc. NASDAQ: AMD. The VanEck Semiconductor ETF is up 28.66% year-to-date (YTD).
- 03/12/2024
|
Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
- Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its dividend for 46 consecutive years, which qualifies Medtronic for its status as a vaunted Dividend Aristocrat. The 10-year dividend growth rate is a strong 9.8%, although more recent dividend raises have been in mid-single digits.
- 03/11/2024
|
Medtronic's (MDT) MiniMed 780G System Study Data Favorable
- Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
- 03/11/2024
|
Medtronic is a Dividend Aristocrat That Keeps Gaining
- Medical device maker Medtronic PLC NYSE: MDT is a Dividend Aristocrat in the medical and healthcare sectors. The medical device maker has raised its dividend payout for 46 consecutive years through bull and bear markets.
- 03/11/2024
|
2 Medical Device Stocks to Buy Hand Over Fist in March
- Medtronic is a leading medical device maker that continues to get bigger and more diversified. DexCom's continuous glucose monitoring devices are crucial for diabetics, enabling strong growth.
- 03/08/2024
|
The Top 3 Healthcare Stocks to Buy in March 2024
- Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.
- 03/07/2024
|
3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade
- Medtronic is the world's largest medical device company, and it has a 46-year streak of consecutive annual dividend raises. Cigarette sales are steadily declining, but Altria Group's bottom line keeps on climbing.
- 03/05/2024
|
What's Next For Medtronic Stock After An Upbeat Q3?
- Medtronic MDT (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and adjusted earnings of $1.30 per share compared to the consensus estimates of $7.9 billion and $1.26, respectively.
- 03/01/2024
|
Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
- Thesis & Performance: Previous analysis suggested a fair price of $137.6; Q3 2024 earnings beat estimates, affirming my "strong buy" recommendation. Financial Overview: Q3 2024 earnings reported revenue of $8.1B and EPS of $1.30, surpassing estimates, with steady growth in net income despite segment year-to-date underperformance. Two valuation models presented: analyst estimates suggests a $178.12 fair price (107.5% upside), meanwhile the conservative model projects a $126.09 fair price (46.9% upside).
- 02/25/2024
|
Medtronic Nixes Spinoff Plans For Monitoring And Respiratory Units
- Medtronic's choice to retain its PMRI Business is mainly driven by the improved performance of its Patient Monitoring segment in recent times, is a result of a comprehensive evaluation of its portfolio.
- 02/22/2024
|
Where Will Medtronic Stock Be in 3 Years?
- Medtronic's business showed signs of promise in Q3, with revenue growth of around 5%. The company is exiting its ventilator product line, which should improve profitability.
- 02/22/2024
|
MDT vs. LMAT: Which Stock Should Value Investors Buy Now?
- Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?
- 02/21/2024
|
Is Medtronic Stock a Buy Now?
- Medtronic boasts nearly five decades of dividend growth. Currency exchange rates and inflation have been hurting its profits.
- 02/21/2024
|
Why Medtronic Stock Jumped Today
- Medtronic beat revenue and earnings estimates for its fiscal third quarter. Growth was broad-based across product portfolios.
- 02/20/2024
|
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up
- Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
- 02/20/2024
|
Medtronic Beats Estimates and Boosts Outlook on Heart, Diabetes Device Sales
- Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology firm posted better-than-expected results and raised its guidance on increased demand for its heart and diabetes devices.
- 02/20/2024
|
Medtronic CEO on earnings: Back to growth in China after challenging few years
- Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.
- 02/20/2024
|
4 Ultra-Safe Passive Income Vehicles to Buy and Hold Forever
- Dividend stocks are an excellent source of passive income. Some dividend payers are markedly safer investments than their peers, however.
- 02/20/2024
|
Medtronic (MDT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended January 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/20/2024
|
Medtronic (MDT) Q3 Earnings and Revenues Beat Estimates
- Medtronic (MDT) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.30 per share a year ago.
- 02/20/2024
|
Medtronic Stock Jumps. Medical Device Maker Tops Earnings and Raises Forecast.
- Medtronic reported adjusted per-share earnings of $1.30, beating Wall Street's call for $1.26, according to FactSet.
- 02/20/2024
|
Medtronic Is A Healthy Portfolio Boost
- Medtronic's revenue soars 88%, leading healthcare innovation, while Non-GAAP EPS up 40%, showcasing steady growth. Medtronic has decent growth opportunities and limited risks. With Medtronic's P/E ratio below average, I believe it's a buy.
- 02/18/2024
|
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
- Not every stock has been swept up in the stock market's euphoria. Shares of Medtronic and Sanofi have been more muted lately.
- 02/16/2024
|
Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
- Medtronic has a history of dividend increases and is well-positioned for long-term growth in the healthcare industry. The company's financial performance has been solid, with stable margins and consistent free cash flow. Medtronic has a strong balance sheet and is focused on implementing operating efficiencies to improve profitability.
- 02/16/2024
|
Medtronic (MDT) Advances But Underperforms Market: Key Facts
- In the latest trading session, Medtronic (MDT) closed at $83.68, marking a +0.11% move from the previous day.
- 02/14/2024
|
ChatGPT Stock Predictions: 3 Robotics & Automation Companies the AI Bot Thinks Have 10X Potential
- In the bustling realm of forward-looking investments, robotics stocks stand out for their tremendous potential and relevance. These dynamic assets offer around-the-clock productivity, virtually uninterrupted by the mundane constraints of human labor.
- 02/14/2024
|
What Analyst Projections for Key Metrics Reveal About Medtronic (MDT) Q3 Earnings
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Medtronic (MDT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2024.
- 02/14/2024
|
What's in the Cards for Medtronic (MDT) in Q3 Earnings?
- Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal third-quarter performance.
- 02/12/2024
|
February's Smart Buys: 7 Value Stocks You Can't Afford to Miss
- Investors are back to looking at value stocks as many see high-flying growth as a bubble poised to burst. Even index investors focused on benchmarks like the S&P 500 are increasingly wary of the risks associated with a handful of stocks carrying the rest.
- 02/09/2024
|
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
- In the closing of the recent trading day, Medtronic (MDT) stood at $86.18, denoting a -1.12% change from the preceding trading day.
- 02/08/2024
|
7 Dividend Stocks Worth Holding for the Long Haul
- Investing in dividend stocks is generally reserved for those who prefer steady returns and low volatility over the thrill of rapid potential gains. Investors saw tech stocks explode in 2023 as artificial intelligence emerged.
- 02/06/2024
|
Medtronic to announce financial results for its third quarter of fiscal year 2024
- DUBLIN , Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2024 on Tuesday, February 20, 2024. A news release will be issued at approximately 5:45 a.m.
- 02/06/2024
|
Medtronic (MDT) Suffers a Larger Drop Than the General Market: Key Insights
- Medtronic (MDT) concluded the recent trading session at $86.75, signifying a -1% move from its prior day's close.
- 02/05/2024
|
Could Medtronic Stock Help You Become a Millionaire?
- Medtronic expects its business to generate around 5% organic growth for fiscal 2024. A return to normalcy in the healthcare industry should benefit the medical device company.
- 02/03/2024
|
Buy, Hold, Profit: 3 Dividend Stocks to Own Forever at Bargain Prices
- Today's dividend stocks are increasingly popular in a wild reversal as top tech stocks take center stage and push market indices back to all-time highs. But that presents a prime opportunity for income investors and long-term “buy and hold” strategists.
- 01/31/2024
|
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
- The latest trading day saw Medtronic (MDT) settling at $86.97, representing a -0.54% change from its previous close.
- 01/30/2024
|
My Best Dividend Aristocrats For February 2024
- My Best Dividend Aristocrats For February 2024
- 01/30/2024
|
Up Just 6% In 2023 Is Medtronic Stock A Better Pick Over Abbott?
- Given its better prospects, we believe Medtronic stock (NYSE: MDT) is a better pick than its peer, Abbott stock (NYSE: ABT). Abbott trades at a higher valuation multiple of 4.9x revenues vs.
- 01/29/2024
|
2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now
- Medtronic's global medical device business has supported annual dividend raises since 1978, and it's well positioned for more growth. AbbVie's lead drug fell off a patent cliff last year, but soaring sales of recently launched treatments make the stock a buy right now.
- 01/28/2024
|
Top 7 Value Stocks to Outperform Growth in 2024
- 2024 could easily turn into the year that value stocks come out on top. Though “official” numbers say differently, there's a clear sense of unease as tech-heavy indices soar to all-time highs despite wide-ranging layoffs pointing to troubled economic conditions.
- 01/24/2024
|
Medtronic (MDT) Stock Slides as Market Rises: Facts to Know Before You Trade
- Medtronic (MDT) concluded the recent trading session at $84.72, signifying a -1.88% move from its prior day's close.
- 01/24/2024
|
3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom
- Aging stocks (or longevity stocks) are drawing attention from investors for obvious reasons. The Baby Boomer generation is now almost fully retired, and Gen X is right on its heels.
- 01/24/2024
|
3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024
- Blue-chip healthcare stocks tend to be among the top portfolio picks for long-term investors today. Though their blue-chip status implies maturity, which they have, it also implies that the companies have limited growth prospects.
- 01/23/2024
|
Is Medtronic Stock a Buy Now?
- Medtronic is implementing important changes to its business. The company is also investing in high-growth areas.
- 01/23/2024
|
Value Vault: 3 Forgotten Dividend Aristocrats Offering Steady Income
- When we imagine dividend aristocrats, a handful of big names take the spotlight. AT&T (NYSE: T ), Realty Income (NYSE: O ), Exxon Mobile (NYSE: XOM ) — these are some of the common names investors flock to when finding income-generating options for their portfolio.
- 01/17/2024
|
Medtronic receives FDA approval for deep brain stimulation system
- Medtronic PLC NYSE: MDT, a member of the medical sector and the healthcare industry, received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation (DBS) system on January 8. This system includes the PC neurostimulator, BrainSense technology and SenSight directional leads.
- 01/17/2024
|
How To Invest $1 Million In Retirement For Life-Long Income
- We outline an Income Strategy for creating a self-sufficient portfolio for retirees and income-focused investors with $1 million to generate a life-long income stream. We explain the benefits of generating income through dividends and distributions rather than selling shares for capital gains. We compare the results of backtesting an income strategy with index investing for the past 24 years, starting from the year 2000.
- 01/13/2024
|
Medtronic: Positive FDA News, Remains Undervalued With Shares Near Resistance
- Medical device stocks have made a strong comeback in the past three months, becoming market leaders. Medtronic is a medical technology firm with a below-market valuation and a high forward dividend yield. MDT has seen strong earnings growth and received FDA approval for a new device, with a positive outlook for future growth.
- 01/13/2024
|
3 Dividend Stocks to Bank On for Consistent Income
- While capital appreciation is vital, dividends are also important to total returns. Dividend stocks for consistent income provide both and are often more stable.
- 01/11/2024
|
Medtronic (MDT) Rises As Market Takes a Dip: Key Facts
- Medtronic (MDT) concluded the recent trading session at $87.09, signifying a +0.01% move from its prior day's close.
- 01/11/2024
|
Medtronic's (MDT) Percept RC DBS System Secures FDA Approval
- Medtronic's (MDT) latest innovation joins the Percept family, the first and only DBS system with sensing, directionality and advanced programming.
- 01/11/2024
|
2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade
- After underperforming the broad market over the past year, shares of Medtronic offer a 3.4% dividend yield. AbbVie shares offer a juicy 3.8% dividend yield even though the payout has grown 287% over the past 10 years.
- 01/11/2024
|
Medtronic Stock's Rally Is Set To Continue
- Medtronic's stock has increased by 27.61% since my previous 'Buy' rated article, outperforming the S&P 500. But what's coming next? Medtronic continues to develop and expand its range of products, with strong revenue growth and increased EBIT margin in Q2 FY2024. MDT has a clear plan on how to lower its COGS and stop the ongoing decline in gross profit margin ASAP. I think we can expect GP expansion shortly.
- 01/10/2024
|
Medtronic (MDT) Wins CE Mark for MiniMed 780G With Simplera Sync
- Medtronic (MDT) secures the CE Mark for the MiniMed 780G system with the disposable, all-in-one Simplera Sync CGM.
- 01/10/2024
|
International Wide-Moat Stocks On Sale - The January 2024 Heat Map
- International Wide-Moat Stocks On Sale - The January 2024 Heat Map
- 01/09/2024
|
Medtronic plc (MDT) JPMorgan 42nd Annual Global Healthcare Conference (Transcript)
- Medtronic plc (MDT) JPMorgan 42nd Annual Global Healthcare Conference (Transcript)
- 01/09/2024
|
Why Medtronic Stock Got Off to a Roaring Start This Week
- The medical device manufacturer won approval for a neurological product. Its latest Percept neurostimulator has been greenlighted by the U.S. FDA.
- 01/08/2024
|
Medtronic CEO: The amount of data you have is going to be your currency for innovation
- Medtronic CEO Geoffrey Martha, with CNBC's Jim Cramer, joins 'The Exchange' to discuss the impact of weight-loss drugs, AI-driven care, and more.
- 01/08/2024
|
Wearable Technology Market Gains Ground, 3 Stocks in Focus
- In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.
- 01/08/2024
|
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
- Medtronic (MDT) concluded the recent trading session at $84.57, signifying a +0.76% move from its prior day's close.
- 01/05/2024
|
Generative AI Reshapes Healthcare: 3 Stocks in Limelight
- Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.
- 01/05/2024
|
Inflation and Interest Rates: 3 Stocks Set to Thrive in a Changing Economic Climate
- At this point, investors are back to looking for inflation-proof stocks to shield their portfolios. After closing 2023 on a bullish note, as an early Santa Claus rally sent markets back to all-time highs, we're entering 2024 on a muted note.
- 01/04/2024
|
Here's Why You Should Retain Medtronic (MDT) Stock for Now
- Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.
- 01/02/2024
|
6 Top Long-Term Stocks On My 2024 Wishlist
- The market is flying as we enter 2024, but some sectors offer compelling values. Other stocks will be terrific buys when they return to Earth.
- 01/01/2024
|
Is Medtronic's High-Yielding Dividend in Danger?
- The medical device maker's payout ratio is alarmingly high at close to 90% of earnings. Plus, its quarterly free cash flow recently fell well short of what it pays out in dividends.
- 12/30/2023
|
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
- Medtronic (MDT) concluded the recent trading session at $82.38, signifying a -0.42% move from its prior day's close.
- 12/29/2023
|
AI Predictions: Meta's Llama Says These Will Be the 3 Best-Performing Stocks in 2024
- Artificial intelligence (AI) holds promise for many industries, sparking public imagination about the capabilities it may one day attain. However, we must temper expectations when it comes to AI predictions for the stock market.
- 12/28/2023
|
3 Deep Value Stocks for Hidden Gems in 2024
- Finding deep value stocks involves pinning down and investing in significantly undervalued companies based on their material worth. In effect, to find deep value stocks, you do research to find something – anything – the market missed and capitalized on the mispricing.
- 12/28/2023
|
My Best Dividend Aristocrats For January 2024
- The ProShares S&P 500 Dividend Aristocrats ETF continues its recent good run in December, through the 22nd, the ETF is up 3.91%. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.
- 12/26/2023
|
Final Trade: ETH, BABA, MDT, ET
- The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
- 12/22/2023
|
Medtronic (MDT) Up 2.9% Since Last Earnings Report: Can It Continue?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 12/21/2023
|
3 MedTech Stocks With Potential to Benefit From AI Boom in 2024
- Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).
- 12/21/2023
|
3 Aging Population Stocks to Profit from the Boomer Generation
- As the Baby Boomers age, the number of elderly Americans has risen quickly. Specifically, the number of those 65 and older in the U.S. jumped 38.6% between 2010 and 2020 to 55.8 million.
- 12/21/2023
|
7 Undervalued Dividend Stocks to Buy for a Bargain
- Dividend stocks are about to enjoy a renaissance. Just look what happened with Costco (NASDAQ: COST ) last week – the warehouse giant announced a special $15 cash dividend and shares soared to new all-time highs.
- 12/18/2023
|
US Politician makes suspicious health stock purchase
- In a recent disclosure, United States Representative for Michigan's 6th congressional district Debbie Dingell has come under scrutiny for her stock purchase in Medtronic (NYSE: MDT), a prominent medical devices company.
- 12/16/2023
|
Why Medtronic Stock Topped the Market on Thursday
- The medical-device giant won approval for a device that combats irregular heartbeats. The FDA gave the green light to the PulseSelect PFA System.
- 12/14/2023
|
5 Dividend Aristocrats Signal Buy In December, With 6 To Watch
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 66 Aristocrats, screened as of December 12, 2023, represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 13.71%-31.37% topped-by XOM & CVX. By yield, WBA topped-all Aristocrats. Top-ten Yields from ABBV, ESS, CVX, FRT, BEN, TROW, AMCR, O, MMM, & WBA, averaged 5.13%.
- 12/14/2023
|
Medtronic receives FDA approval for heart condition treatment; shares rise
- Medtronic PLC (NYSE:MDT) late Wednesday announced that the US Food and Drug Administration (FDA) has approved its PulseSelect Pulsed Field Ablation (PFA) system for the treatment of two heart conditions, paroxysmal and persistent atrial fibrillation, which can cause stroke or heart failure. The medical technology company said its PFA is used for ablation procedures that treat atrial fibrillation using small burns or freezes to cause some scarring on the inside of the heart to help break up the electrical signals that cause irregular heartbeats.
- 12/14/2023
|
Medtronic gets FDA approval for new heart-condition treatment
- Medtronic said the U.S. Food and Drug Administration has approved its PulseSelect Pulsed Field Ablation System for the treatment of two heart conditions.
- 12/13/2023
|
Medtronic (MDT) Expands AI-Driven Care With New Partnership
- Medtronic's (MDT) expanded collaboration with Cosmo Pharmaceuticals is a strategic step forward in its quest to use AI to improve patient care.
- 12/13/2023
|
3 of the Best Stocks for Value Investors to Buy Now
- #Morningstar #ComcastStock #StockInvesting These cheap stocks from companies with wide economic moats look attractive for 2024. 00:00 Introduction 00:46 Medtronic MDT 01:21 Comcast CMCSA 02:00 RTX RTX Susan Dziubinski: Hi I'm Susan Dziubinski with Morningstar.
- 12/12/2023
|
Medtronic: The GLP-1 Drug Headwinds Are Overblown
- Mr. Market has overemphasized the potential negative impacts of GLP-1 drugs on conventional diabetes care since there is no miracle one-time drug. Medtronic's bottom lines have also been impacted by the elevated inflationary pressure and FX headwinds, naturally depressing its profitability metrics compared to pre-pandemic levels. However, we are not overly concerned since the diabetes segment only accounts for a small portion of its sales, with the PPI inflation already cooling.
- 12/10/2023
|
Investing in the Aging Population: 3 Healthcare Stocks to Watch
- In 2016, there were 49 million Americans aged 65 or older. Analysts forecast that will grow to 73 million retirement-age Americans in 2030 and an eye-opening 95 million in the year 2060.
- 12/07/2023
|
Solid as a Rock: 3 Blue-Chip Stocks for a Stable Portfolio
- It's understandable if you have whiplash from market moves this year. We've seen stocks surge, fall and surge again on the heels of the current Santa rally.
- 12/07/2023
|
Got $5,000? These 3 Stocks Are Deep-Value Buys Right Now
- Medical device maker Medtronic should benefit from a return to normality in the healthcare industry. United Parcel Service ought to experience better growth as macroeconomic conditions improve.
- 12/07/2023
|
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.
- These companies all have solid histories of dividend increases and are making future dividend payments a priority. You can likely count on them to grow your passive income from year to year.
- 12/07/2023
|
A Bull Market Is Coming: 2 Top Stocks to Buy Hand Over Fist
- The market's recovery could continue into 2024 -- and these stocks should benefit. Medtronic boasts a steady business and an incredible dividend track record.
- 12/05/2023
|
Medtronic: On The Verge Of A Massive Turnaround
- Medtronic's recent earnings report has boosted investor confidence, suggesting the worst may be over for the company. The impact of the weight loss drugs on Medtronic's long-term growth prospects is expected to be limited and could be overstated. MDT's valuation isn't cheap relative to its sector peers, but its best-in-class profitability grade likely justifies the premium.
- 11/30/2023
|
Medtronic Stock: Bull vs. Bear
- Medtronic has revamped its business to favor growth. There are other stocks out there offering higher growth rates and longer streaks of payout hikes.
- 11/29/2023
|
If You Can Only Buy One Tech Stock in December, It Better Be One of These 3 Names
- The top tech stocks are always a point of contention among investors. Some prefer sticking with reliable companies like the Magnificent 7, while others decry the same for being grossly overvalued.
- 11/29/2023
|
3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
- Medtronic is a well-diversified healthcare company with strong secular growth and pricing power. The company has four major business segments, each contributing over $2 billion in annual revenue. Medtronic's recent financial results have exceeded expectations, and the company has adjusted its full-year guidance upward.
- 11/28/2023
|
10 Dividend Growth Stocks For November 2023
- In my monthly series of 10 Dividend Growth Stocks, I rank a selection of Dividend Radar stocks and present the 10 top-ranked stocks for further research and possible investment. This month, I'm presenting high-quality stocks with the highest defensiveness scores based on a scoring system developed by David Van Knapp. I ranked candidates by considering, in turn, their Dividend Safety Scores and their Beta measure of volatility.
- 11/28/2023
|
3 Top-Rated Value Stocks That Analysts Are Loving Now
- The stock market is enjoying some holiday cheer. Amid signs that inflation is letting up and the Federal Reserve may finally put an end to its rate hikes, traders are piling into all sorts of investments right now.
- 11/27/2023
|
Is Medtronic a Good Dividend Stock to Buy Now?
- Medtronic has a history of raising its dividend rapidly, but its pace has slowed down. Fiscal second-quarter sales earnings fell slightly, and the company's predictions for the next six months aren't exciting anyone.
- 11/25/2023
|
Should You Pick Medtronic Stock At $80 After An Upbeat Q2?
- Medtronic (NYSE: MDT) recently reported its Q2 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating our estimates, and we believe that MDT st
- 11/24/2023
|
$1,000 Invested in These 3 Dividend Stocks Could Make You Rich
- Chevron's growing dividend has enabled it to produce enriching returns. Coca-Cola's ability to grow hasn't fizzled out.
- 11/24/2023
|
If I Could Only Buy 1 Stock Right Now, This Would Be It
- Medtronic has been working to get key products across the finish line. The company is jettisoning slower-growing divisions so it can focus on growth.
- 11/24/2023
|
Medtronic: oversold, overextended high yield reversal in play
- After two years of correction and downtrend, providing ample incentive to buyers all along the way, medical device maker Medtronic NYSE: MDT has finally reached its bottom, and the reversal is on. The Q2 results confirm normalization in the wake of the COVID bubble and a solid trajectory for growth that is nearly irresistible for value-minded income investors.
- 11/22/2023
|
Why Medtronic Stock Trounced the Market on Tuesday
- The medical-devices specialist published its latest set of quarterly results. Happily for its shareholders, the company managed to grow on both the top and bottom lines and beat analyst estimates.
- 11/21/2023
|
The impact of wight-loss drugs to our business 'is negligable', says Medtronic CEO
- Geoff Martha, Medtronic CEO, joins 'Closing Bell Overtime' to talk quarterly results, the impact of weight-loss drugs, and more.
- 11/21/2023
|
Medtronic (MDT) Q2 Earnings Beat Estimates, 2024 View Up
- Medtronic (MDT) Q2 results reflect broad strength across businesses and geographies, benefiting from durable fundamentals.
- 11/21/2023
|
Medtronic delivers beat and raise for 2Q sending shares higher
- Medtronic PLC (NYSE:MDT) shares moved higher in early trade on Tuesday as the medical devices company raised its fiscal 2024 sales and profit guidance. For the full year ending in April 2024, it expects organic revenue growth of 4.75% over fiscal 2023, up from its prior guidance of 4.5%.
- 11/21/2023
|
Medtronic's second-quarter earnings top estimates as medical device maker raises guidance
- Medtronic PLC's stock MDT rose 0.8% premarket Tuesday, after the medical device maker posted better-than-expected earnings for its fiscal second quarter and raised guidance. Dublin-based Medtronic posted net income of $909 million, or 68 cents a share, for the quarter to Oct. 27, up from $435 million, or 32 cents a share, in the year-earlier period.
- 11/21/2023
|
Medical device maker Medtronic raises fiscal 2024 profit view
- Medtronic on Tuesday raised its annual profit forecast for the second time this year, banking on higher demand for its medical devices as surgery volumes pick up pace.
- 11/21/2023
|
Earnings Exchange: Medtronic, Agilent Technologies & Trip.com
- Ari Wald, managing director and head of technical analysis at Oppenheimer, joins 'The Exchange' to discuss Medtronic, Agilent Technologies, and Trip.com.
- 11/20/2023
|
Medtronic's (MDT) Symplicity Spyral RDN System Gets FDA Boost
- Medtronic (MDT) receives the FDA approval for Symplicity blood pressure procedure for the treatment of hypertension.
- 11/20/2023
|
US FDA approves Medtronic's blood pressure treatment device for use
- The U.S. Food and Drug Administration on Friday approved the use of Medtronic's treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by drugs, the company said.
- 11/17/2023
|
Why Medtronic (MDT) Could Beat Earnings Estimates Again
- Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 11/17/2023
|
What's in the Cards for Medtronic (MDT) in Q2 Earnings?
- Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal second-quarter performance.
- 11/17/2023
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- 11/17/2023
|
Unlocking Q2 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
- Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2023.
- 11/16/2023
|
3 Long-Term Stocks You'll Regret Not Buying Soon: November 2023
- Amidst the uncertainty, savvy investors recognize that market downturns potentially pave the way for future prosperity. However, the quest for long-term stocks to buy soon remains fraught with challenges.
- 11/16/2023
|
7 Large-Cap Stocks to Buy for the Long Haul
- While sometimes overshadowed by stocks in the mega-cap ($200 billion market cap and higher) stocks category, large-cap stocks (or stocks with a market cap between $10 billion and $200 billion) can often offer investors the best of both worlds. Large-caps are typically shares in established, profitable enterprises.
- 11/16/2023
|
Where Will Medtronic Stock Be in 5 Years?
- Medtronic's growth rate has been underwhelming in recent years. Growth is a priority now and Medtronic is selling off majority stake in slower-growing areas of its business.
- 11/16/2023
|
Invest in the Future With These 7 Forever Stocks
- One of my favorite investment strategies when seeking forever stocks is to look to past trends that turned stale. Think of some of the hottest sectors in the past five years that saw massive investor interest before falling back to Earth.
- 11/15/2023
|
It's Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows
- If you're a dividend investor, there is nothing more attractive than dividend aristocrats, those S&P 500 companies that have increased their annual dividend payment for 25 consecutive years or more. A recent article about two dividend stocks trading near 52-week lows got me thinking about the dividend aristocrats and possible opportunities to buy them at or near 52-week lows.
- 11/14/2023
|
Medtronic (MDT) Ascends While Market Falls: Some Facts to Note
- Medtronic (MDT) closed the most recent trading day at $72.08, moving +1.98% from the previous trading session.
- 11/13/2023
|
7 Best Long-Term Stocks Every 30-Year-Old Should Buy and Hold
- Investing in long-term stocks as a 30-year-old is a tricky proposition. On the one hand, you've likely got something close enough to a disposable income that you can afford to sock away extra cash into retirement accounts or a taxable brokerage.
- 11/13/2023
|
3 Evergreen Stocks for Long-term Wealth Generation
- Finding long-term stocks isn't always easy. Avoiding meme stock mania, FOMO, and value traps is difficult in any economy but particularly troublesome today.
- 11/09/2023
|
4 Dividend Aristocrats Signal Buys In November As 6 Await
- "Dividend Aristocrats in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years. "-- Kiplinger.com/Investing. 66 Aristocrats, screened as of November 6, 2023, represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 22.29%-34.44% topped-by O & WBA.
- 11/08/2023
|
Three value stock picks from a veteran manager with a good performance record
- For many years through 2022, it was becoming more difficult for active fund managers to make the case for their services, when broad index funds, with lower fees, were performing so well. But the tech-driven market decline for 2022 might have made some investors think again about different investment styles for the long term.
- 11/08/2023
|
5 Kings And Aristocrats Selling At Decade High Dividend Yields
- The Market believes the Fed may pause rate hikes and soon pivot, leading to increased demand for 10-year Treasury bonds. Long-duration US Treasuries may not be a good investment unless they yield more than 600 basis points over the S&P 500 dividend. Investing in large dividend-paying stocks with yields over 3% may be a better alternative to buying long duration government debt.
- 11/08/2023
|
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
- Medtronic (MDT) concluded the recent trading session at $72.48, signifying a -1.28% move from its prior day's close.
- 11/07/2023
|
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
- Medtronic (MDT) reachead $73.42 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.
- 11/06/2023
|
10 Buffett-Style Dividend Aristocrat Bargains You Don't Want To Miss
- Economists say the recession is canceled; the bond market is 98% sure it's still coming. The bond market is likely right, BUT history is very clear, the time to buy wonderful companies at wonderful prices is now. Warren Buffett-style aristocrat bargains are blue-chip quality aristocrats trading at anti-bubble "fat pitch" valuations.
- 11/04/2023
|
2 Incredibly Cheap Dividend Stocks to Buy Hand Over Fist Ahead of 2024
- Because of their underappreciated value factor, most dividend stocks tend to be top performers over long holding periods. AT&T and Medtronic offer investors high yields and extremely attractive valuations.
- 11/01/2023
|
Medtronic (MDT) Laps the Stock Market: Here's Why
- Medtronic (MDT) closed the most recent trading day at $70.56, moving +0.84% from the previous trading session.
- 10/31/2023
|
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
- Medtronic's diversification and excellent dividend make it a good pick for conservative investors. Alphabet's stock recently took a dive, but the company retains its leadership in multiple industries.
- 10/31/2023
|
Medtronic (MDT) Advances But Underperforms Market: Key Facts
- Medtronic (MDT) closed at $69.97 in the latest trading session, marking a +0.78% move from the prior day.
- 10/30/2023
|
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
- As I type this, equity investors can relate to the statement “nowhere to run, nowhere to hide.” The tech-heavy NASDAQ index is down over 4% in the five days ending Oct. 26.
- 10/29/2023
|
Medtronic Stock Is Simply Too Cheap To Ignore
- Medtronic is a global medical technology company specializing in various medical devices. The company's revenues are well distributed among different segments, with cardiovascular being the largest segment. Medtronic expects further growth in its cardiovascular and neuroscience segments, driven by product launches and the adoption of integrated solutions.
- 10/29/2023
|
Use This Bear Market As A Passive Income Accelerator
- The current bear market presents excellent buying opportunities for high-quality dividend stocks. Many stocks, especially dividend stocks, have dropped due to fear and uncertainty, creating attractive discounts and higher dividend yields. Investors should take advantage of the current market conditions to buy dividend stocks at higher yields and benefit from future dividend growth.
- 10/28/2023
|
2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years
- Medtronic and PayPal are two stocks whose valuations have nosedived since 2021. Medtronic's exposure to China is a concern, but its earnings and cash flow remain resilient.
- 10/24/2023
|
The Value Deepens for Medtech Stocks: Reversal Imminent
- Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units.
- 10/23/2023
|
3 Healthcare Stocks to Invest in for a Big Shot of Gains
- With a few exceptions, healthcare stocks have had a rough go of it in 2023. The Standards and Practices (S&P) 500 Healthcare Index is down 5% year to date, versus a 13% increase in the benchmark S&P 500 index.
- 10/23/2023
|
7 Healthcare Stocks to invest in for a Healthy Future
- One of my favorite sectors will always be the healthcare sector. It is practically a basic need for all human beings and is always in constant development and growth.
- 10/20/2023
|
Michael Farr says investors should look at 'beaten up' stocks like Disney and Medtronic
- UBS' Jason Draho and Hightower's Michael Farr, join 'Power Lunch' to discuss how investors should position in a volatile bond market.
- 10/17/2023
|
7 Resilient Stocks Poised to Prosper in Any Market Condition
- Investors are worried that the stock market's first-half performance in 2023 is reversing. It's unclear what part of the business cycle we are currently in.
- 10/13/2023
|
What other industries could weight loss drugs disrupt?
- Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
- 10/11/2023
|
Final Trades: WST, BIIB, SPY & MDT
- The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
- 10/11/2023
|
The 3 Widest Competitive Moats on Wall Street
- Competitive moats symbolize a company's sustainable advantage, protecting it from competitors and external threats. Three standout examples illustrate this principle vividly.
- 10/11/2023
|
You Can't Control Spin-Offs, but You Can Control What You Do About Them
- Spin-offs are almost always pitched as a way to create value for shareholders, but that's not always what happens. Kellogg recently broke into two companies, Kellanova and WK Kellogg.
- 10/11/2023
|
2 Healthcare Dividend Stocks You'd Regret Not Buying on the Dip
- Medtronic offers impressive innovation, a strong position in healthcare, and an outstanding dividend history. Viatris is undergoing important changes that should lead to stronger financial results in the medium term.
- 10/08/2023
|
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
- Medtronic (MDT) concluded the recent trading session at $76.12, signifying a -0.04% move from its prior day's close.
- 10/06/2023
|
7 Value Stocks Getting Ready to Vault Higher
- If you're searching for the best value stocks to buy now, look no further. Value stocks are back in the spotlight.
- 10/05/2023
|
3 Ways AI Can Help Healthcare Companies Grow
- The healthcare industry is full of manual processes that could benefit from AI. AI can help improve outcomes for patients while also growing revenue for businesses.
- 10/05/2023
|
7 Top Healthcare Stocks That Pay Dividends
- Facing an uncertain market environment, investors ought to consider the top healthcare stocks that pay dividends. Sure, the Federal Reserve may be in a position to facilitate a soft landing for the economy, per bullish analysts.
- 10/04/2023
|
Medtronic (MDT) to Launch Academic R&D Grants With New Pact
- Medtronic's (MDT) partnership will enable teachers to improve their skill set, boosting student opportunities to pursue STEM careers in corporate America.
- 10/04/2023
|
7 ‘Smart Money' Stocks Set to Explode Higher
- In the dynamic world of investing, there's always a buzz surrounding “smart money” stocks. This excitement isn't just about fleeting market trends; it's rooted in the savvy market decisions made by individuals with incredible financial acumen.
- 09/30/2023
|
Opportunities Abound In These Dividend Stalwarts
- Market timers come out in force when stocks are soaring or plummeting, but often miss out on long-term investment opportunities by waiting to make sure stocks have definitively bottomed. I like to keep it simple by buying high-quality dividend growth companies at discounted prices during bear markets. If they get cheaper, I buy more. I highlight a handful of high-quality, investment grade-rated dividend growth stalwarts to consider for your portfolio.
- 09/29/2023
|
My Best Dividend Aristocrats For October 2023
- The ProShares S&P 500 Dividend Aristocrat ETF fell by 2.34% in August and is down 6.25% in September bringing its year-to-date return down to -0.70%. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 26 months of tracking these strategies, only 1 strategy is beating NOBL but all 3 continue to outperform SPY.
- 09/29/2023
|
Here's Why You Should Retain Medtronic (MDT) Stock for Now
- Investors are optimistic about Medtronic (MDT) on strong global expansion.
- 09/28/2023
|
Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
- Dividend aristocrats underperforming the S&P 500 by more than 10 percentage points in 2023. Medtronic, a major aristocrat, has a low P/E ratio, high yield, and potential earnings growth. Positive signs of top-line growth and outperformance suggest recent stock price decline may be overdone.
- 09/27/2023
|
Don't Miss the Boom: 7 Dividend Stocks Set to Explode Higher
- The economic outlook is increasingly uncertain. Between inflation, high-interest rates, and an aggressive Federal Reserve, there is plenty that could hamper the market's returns over the next year.
- 09/26/2023
|
7 Buffett-Style A-Rated Dividend Aristocrat Bargains
- The stock market suffered the worst week in 7 months due to the Fed bursting the dreams of rapid rate cuts. Higher for longer rates is a major threat to big tech, trading at 36X forward earnings, a 31% historical premium. But A-rated dividend aristocrat bargains represent world-beater, Buffett-style "wonderful companies at wonderful prices".
- 09/26/2023
|
Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM
- Medtronic's (MDT) next-generation sensor Simplera receives CE Mark approval.
- 09/22/2023
|
Why Is Medtronic (MDT) Down 2.6% Since Last Earnings Report?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 09/21/2023
|
3 Things About Medtronic That Smart Investors Know
- Medtronic's shares have outpaced the healthcare sector this year. The company has increased revenue by 83% over the past decade.
- 09/21/2023
|
Why the market is excited about these two growth stocks?
- The artificial intelligence (AI) boom has taken the technology world by storm. However, this can benefit every sector and industry.
- 09/19/2023
|
2 Beaten-Down Dividend Growth Stocks That Look Like Bargains Now
- Income-seeking investors with time before retirement should look for dividend stocks that can rapidly raise their payouts. Medtronic's dividend has risen 38% over the past five years, but its stock price has been beaten down.
- 09/19/2023
|
3 Top Healthcare Stocks Defying the Bear Market
- Medtronic delivers a solid dividend as well as strong returns. CRISPR Therapeutics could soon have its first approved therapy on the market.
- 09/15/2023
|
Energy is improving, but there are better opportunities in other sectors, says Matrix's David Katz
- David Katz, Matrix Asset Advisors CIO, joins 'The Exchange' to discuss investing in strong fundamentals with reasonable multiples, the 12-month time horizon bull case for PayPal, and more.
- 09/14/2023
|
Better Bull Market Buy: CRISPR vs. Medtronic Stock
- Medical device giant Medtronic recently lifted its annual earnings guidance. CRISPR Therapeutics is heading for a major milestone: a regulatory decision on what may become its first product.
- 09/14/2023
|
The 3 Most Undervalued Healthcare Stocks to Buy in September 2023
- Healthcare is a sector that has underperformed the broader stock market this year. The S&P 500 Health Care Sector Index is down over 2.50% year-to-date versus a 17% gain in the benchmark S&P 500 index.
- 09/13/2023
|
7 No-Brainer Stocks to Buy With $1000 Right Now
- Finding the best stocks to buy can be tricky. In the stock market, this year has been a beacon for those with a glass-half-full perspective.
- 09/12/2023
|
Top Wall Street analysts select these dividend stocks to enhance returns
- TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Dell and Verizon.
- 09/10/2023
|
3 Dividend Stocks for September 2023
- #Morningstar #PfizerStock #DividendStocks Dividend investors: Put these cheap stocks on your buy list. 00:00 Introduction 00:28 Pfizer PFE 01:03 Medtronic MDT 01:34 Gilead Sciences GILD Susan Dziubinski: Hi.
- 09/09/2023
|
This High-Yield Stock Is Cutting Its Dividend -- Here Is a Company That Won't
- Medical Properties Trust recently cut its dividend due to its financial problems. Medtronic's business is strong enough to handle economic issues, making its dividend secure.
- 09/09/2023
|
Medtronic plc (MDT) Wells Fargo 2023 Healthcare Conference (Transcript)
- Medtronic plc (NYSE:MDT ) Wells Fargo 2023 Healthcare Conference August 6, 2023 12:00 PM ET Company Participants Geoff Martha - CEO Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen All right. Good afternoon, everyone.
- 09/06/2023
|
These 5 Dividend Aristocrats are Quality Stocks for AI Investing
- AI investing is hot and not contained in the tech world. While names like NVIDIA NASDAQ: NVDA garner much attention, numerous blue-chip names are already leaning into the AI action.
- 09/06/2023
|
7 Stocks Hedge Funds Are Loading Up On
- Emulating the moves of hedge fund stock pickers, and some of the most successful hedge funds can produce sizable profits for retail investors. In fact, here are seven of the top institutional stock picks you may want to consider as we near the last few months of 2023.
- 09/03/2023
|
2 Underappreciated Dividend Stocks to Buy in September and Hold Forever
- Shares of Medtronic and CVS Health offer above-average dividend yields after falling significantly in recent weeks. One of CVS Health's integrated healthcare businesses recently experienced a setback, but its overall future still looks bright.
- 09/03/2023
|
Market Crash Coming? 3 Healthcare Stocks to Buy for a Soft Landing.
- Healthcare stocks often make good long-term investments. After all, the U.S. healthcare industry is worth more than $700 billion annually and growing at a brisk clip, especially with an aging population and global health events such as the COVID-19 pandemic.
- 08/31/2023
|
Is Medtronic Stock a Buy for Income Investors?
- Medtronic's revenue and profits advanced in its fiscal Q1. The company pays a dividend that is double that of the S&P 500 index.
- 08/31/2023
|
A Significant Reversal is in Sight for These 5 Med Tech Companies
- Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normalized.
- 08/30/2023
|
Market Crash Coming? 3 Stocks to Buy for a Soft Landing
- Federal Reserve Chair of the United States Jerome Powell continues to sound a hawkish tone, saying that inflation remains “too high” and warning markets that “we are prepared to raise rates further.” Powell reiterated that the Fed remains focused solely on lowering the U.S. inflation rate back down to its 2% annualized target.
- 08/28/2023
|
Medtronic's (MDT) Inceptiv Spinal Cord Stimulator Gets CE Mark
- Medtronic's (MDT) Inceptiv SCS System is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals.
- 08/28/2023
|
Is Medtronic Stock a Buy Now?
- Medtronic's revenue and earnings both grew significantly in the first quarter. It has implemented an "aggressive transformation" strategy to accelerate growth.
- 08/25/2023
|
Should You Buy Medtronic Stock After A Q1 Beat?
- Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.
- 08/25/2023
|
Why Medtronic Stock Dropped Today
- Medtronic shares are down today after the company announced mixed voting results from the U.S. FDA's Circulatory System Devices Panel on its Symplicity Spyral renal denervation system. Wall Street analysts are torn over whether the device will ultimately receive FDA approval.
- 08/24/2023
|
Medtronic Q1 2024 Earnings Review: Management Placates The Market
- Medtronic's Q1 2024 earnings show 6% annual growth in revenues and EPS, marking a third consecutive quarter of mid-single-digit growth. The company's use of AI-driven tools and services, as well as innovative products, has contributed to growth across all divisions. Issues in Russia and China slowed growth slightly. Medtronic's diabetes division faces competition from new weight loss drugs, but the launch of its latest MiniMed device may help gain market share from rivals.
- 08/24/2023
|
Medtronic shares fall after FDA advisors' lukewarm vote on blood-pressure treatment device
- Medtronic PLC shares MDT, -0.05% were down 1.3% premarket on Thursday after advisors to the U.S. Food and Drug Administration had a mixed reaction to the company's investigational renal denervation system, used to treat high blood pressure. In a close vote, the advisory committee said the benefits of the system, Symplicity Spyral, did not outweigh the risks, although the panel voted favorably on the system's safety and effectiveness.
- 08/24/2023
|
US FDA panel votes against use of Medtronic's blood pressure treatment device
- The U.S. Food and Drug Administration's independent experts on Wednesday narrowly voted against recommending the approval of Medtronic's blood pressure treatment device, saying risks tied to using it do not outweigh the benefits.
- 08/23/2023
|
MDT or PODD: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Medtronic (MDT) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck right now?
- 08/23/2023
|
Here are 13 stocks Jim Cramer is watching, including a big retailer earnings winner
- Here are some of the tickers on my radar for Wednesday, Aug. 23, taken directly from my reporter's notebook.
- 08/23/2023
|
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Up (Revised)
- Strength across businesses and geographies, driven by execution, innovation, and improved underlying fundamentals contributes to Medtronic (MDT) Q1 revenues.
- 08/23/2023
|
Medtronic to participate in upcoming investor conferences
- DUBLIN , Aug. 22, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences: 2023 Wells Fargo Healthcare Conference Wednesday, September 6, 2023, at 12:00 p.m. EDT (11:00 a.m.
- 08/22/2023
|
Why Medtronic Stock Was a Winner Today
- The medical device maker unveiled its results for the first quarter of fiscal 2024. It topped analyst estimates for both revenue and adjusted profitability.
- 08/22/2023
|
Medtronic CEO: Our biggest driver is our diabetes business where we doubled growth
- Geoffrey Martha, Medtronic Chairman and CEO, joins 'Squawk on the Street' to discuss the company's quarterly earnings results, the key drivers in the quarter and Medtronic's business in China.
- 08/22/2023
|
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
- Strength across businesses and geographies, driven by execution, innovation and improved underlying fundamentals, contributes to Medtronic's (MDT) Q1 revenues.
- 08/22/2023
|
Medtronic (MDT) Reports Q1 Earnings: What Key Metrics Have to Say
- While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended July 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 08/22/2023
|
Medtronic (MDT) Surpasses Q1 Earnings and Revenue Estimates
- Medtronic (MDT) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.13 per share a year ago.
- 08/22/2023
|
Will Medtronic (MDT) Beat Estimates Again in Its Next Earnings Report?
- Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 08/21/2023
|
US FDA staff raise no concerns about Otsuka, Medtronic blood pressure devices
- The U.S. Food and Drug Administration (FDA) staff reviewers said on Friday they found no safety and effectiveness issues with devices made by Otsuka Holdings and rival Medtronic Plc for use in a blood pressure treatment surgery.
- 08/18/2023
|
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
- Strength across all businesses is likely to drive Medtronic's (MDT) first-quarter performance.
- 08/18/2023
|
7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now
- There's a reasonable argument to be made that investors should load up on blue-chip stocks regularly. After all, large and well-established firms with long track records of success are likely to continue to be successful.
- 08/14/2023
|
3 Dividend Aristocrat Buys For August And 6 To Watch
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. " - Kiplinger.com/Investing. 66 Aristocrats, screened as of August 9, 2023, represented all eleven Morningstar Sectors. Broker estimated-top-ten net gains ranged 15.54%-31.28% topped by TGT and NEE. By yield, WBA topped-all Aristocrats. Top-ten Yields from ESS, ABBV, FRT, BEN, TROW, IBM, AMCR, O, MMM, & WBA, averaged 4.78%.
- 08/11/2023
|
Medtronic (MDT) Rides on Strong Global Growth, New Launches
- Medtronic (MDT) is gaining from positive sales momentum with the rollout of its differentiated Hugo robotic system in many international markets.
- 08/10/2023
|
7 Companies Leading the Way in Advanced AI and Robotics
- Many attribute the recent stock surge to AI stock popularity. At the same time, it's crucial to note that numerous companies are working silently beneath the radar.
- 08/08/2023
|
Here's Why You Should Invest in Medtronic (MDT) Stock Now
- Investors are optimistic about Medtronic (MDT) on strong growth prospects within the Neurosurgery portfolio and upbeat 2024 guidance.
- 08/08/2023
|
3 ‘Strong Buy' Blue-Chip Stocks You Should Be Loading Up On Now
- After five consecutive months of gains in the S&P 500 and Nasdaq Composite, the market might be due for a pullback. One way to protect portfolio gains is to hide in defensive stocks as we enter a seasonally weak period.
- 08/07/2023
|
3 Reliable Dividend Stocks With Yields Above 3% to Buy in August
- CVS Health's dividend yield is more than double the average stock in the benchmark S&P 500. American Tower is the telecommunications industry's favorite real estate investment trust.
- 08/04/2023
|
Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points
- As a prolific cog in the economic machine, the healthcare industry has been a roller coaster ride over the past few years. With the global pandemic, economic slowdown and industry-wide disruptions in play, healthcare stocks took a major hit but are now demonstrating signs of recovery.
- 08/02/2023
|
The Top Healthcare Stocks to Buy With $100
- Medtronic's financial results should improve as the economy revives. Sanofi is making progress on several fronts, and there is more on the way.
- 07/30/2023
|
Better Medtech Buy: J&J vs. Medtronic
- Johnson & Johnson and Medtronic are leaders in the medical device industry and both delivered growth in the most recent quarter. One of these stocks looks like a better buy right now.
- 07/27/2023
|
You Don't Have to Pick a Winner in Dividend Stocks -- Here's Why
- If you consider "winners" as stocks that go up, then you may be looking in the wrong place for good dividend stocks to buy. If owning stocks is a bit too much for you, you can always buy a dividend-focused mutual fund.
- 07/25/2023
|
3 Ultrareliable Dividend Stocks to Buy and Hold for Decades
- Now that Johnson & Johnson no longer sells consumer goods, it's poised to grow, along with sales of pharmaceuticals and medical technology. Medtronic's dominance in the medical device industry has allowed it to raise its dividend payout for 46 consecutive years.
- 07/24/2023
|
Our Dividend Growth Portfolio Continues To Outpace The S&P 500
- In 2015, I purchased 15 of the largest cap U.S. dividend achievers, which have continued to outpace the S&P 500. The portfolio was designed to provide greater protection during recessions and severe bear markets, and began to pull away from the S&P 500 after the world changed in 2020. The portfolio is 55% U.S. stocks and 45% Canadian stocks, with modest allocations to bonds, cash, gold and bitcoin, and a few thematic plays in the electric vehicle and battery space.
- 07/19/2023
|
Tech Bulls Continue Their Rally For These AI Stock Picks
- Advancement in AI has helped give tech stocks their best-performing first half of the year since 1983. Big-tech executives continue to remain bullish over the ongoing demand for AI. Wall Street analysts are now touting tech stocks in different market segments.
- 07/19/2023
|
3 Healthcare Stocks Using AI to Deliver You Healthy Profits
- Artificial intelligence ( AI ) is aiming to revolutionize the healthcare sector, forging a new era of medical innovation. As we dive into the realm of the top AI healthcare stocks, it's imperative to understand the game-changing potential of this technology.
- 07/18/2023
|
1 Green Flag and 1 Red Flag For Medtronic
- Medtronic shares sank last year as the general economic environment weighed on performance. The company also has struggled with growth -- but it's focusing on turning things around.
- 07/18/2023
|
Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
- Medtronic plc exceeded Q4 FY2023 expectations with revenues of $8.5 billion, and plans to acquire insulin patch maker EOFlow, expanding its diabetes management portfolio. Despite a high debt level, Medtronic maintains a payout ratio of over 50% and continues to buy back shares, offering a dividend yield of over 3%. The company's long-term growth, strong free cash flow margins, and market position make it a valuable addition to a healthcare-focused portfolio.
- 07/15/2023
|
Undervalued And Unsexy: 6 Bargain Stocks In Industrials And Healthcare
- Tech companies like Apple and Meta are crushing it on Wall Street. But the next wave of strong returns may come from stocks like Deere and Cigna.
- 07/13/2023
|
2 Top Healthcare Stocks to Buy Right Now
- UnitedHealth Group and Medtronic are respective leaders in the managed care and medical devices industries. Each company offers a market-beating dividend.
- 07/13/2023
|
Whistleblower alleges Medtronic engaged in bribery scheme at veterans hospital
- A recently unsealed lawsuit alleges sales reps from Medtronic, the world's largest medical equipment company, operated a bribery scheme at a veteran hospital.
- 07/12/2023
|
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts - CVS Health (NYSE:CVS), AstraZeneca (NASDAQ:AZN)
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 07/12/2023
|
Wide Moat Stocks Look Appealing on Valuation
- With the right methodology, it's possible for advisors and investors to efficiently locate baskets of stocks with the wide moat designation without the burden of paying up on valuation. Enter the VanEck Morningstar Wide Moat ETF (MOAT) and the VanEck Morningstar SMID Moat ETF (CBOE: SMOT).
- 07/07/2023
|
3 Top Healthcare Stocks to Buy for July
- Patterson Companies and Medtronic have above-average dividends. Merit Medical Systems and Medtronic have been active in growing revenue through acquisitions.
- 07/07/2023
|
Better Buy: Medtronic vs. Intuitive Surgical
- Medtronic is going through an "aggressive transformation" to accelerate growth. In the robotic surgery market, Intuitive Surgical has a hugely dominant position.
- 07/06/2023
|
3 Elite Dividend Stocks Yielding 3%-Plus to Buy Without Hesitation in July
- Chevron has plenty of fuel to continue increasing its dividend. Coca-Cola has grown its payout for more than 60 straight years.
- 07/06/2023
|
3 Dividend Growth Stocks to Buy in July and Never Sell
- UnitedHealth Group might seem like a boring insurance stock, but it has achieved thrilling dividend growth rates in recent years. Steadily reliance on healthcare makes Medtronic's medical device business one that income investors want in their portfolios.
- 07/05/2023
|
Will Medtronic Stock Rebound To Its Pre-Inflation Shock Highs?
- June 2022, just before the Fed started increasing rates, and is now 3% below that level, underperforming the broader markets, with the S&P 500 rising 16% over this per
- 07/03/2023
|
The 3 Most Undervalued Retirement Stocks to Buy Now: June 2023
- Undervalued retirement stocks steal the spotlight when it comes to constructing a robust retirement portfolio. These stocks present opportunities for capital growth and offer a steady income stream through dividend payments.
- 06/29/2023
|
My Best Dividend Aristocrats For July 2023
- My Best Dividend Aristocrats For July 2023
- 06/28/2023
|
3 Dividend Stocks With Massive Payout Ratios
- Dividend stocks and income investing are back on everyone's radar in 2023. Safe mainstays like short-term Treasury Bills and high-yield savings accounting generate decent returns for the first in years.
- 06/28/2023
|
Medtronic plc (MDT) Analyst and Investor Briefing Conference - (Transcript)
- Medtronic plc (NYSE:MDT ) Analyst and Investor Briefing Conference Call June 25, 2023 4:00 PM ET Company Participants Ryan Weispfenning - Vice President, Head of Investor Relations Geoff Martha - Chairman and Chief Executive Officer Que Dallara - Executive Vice President and President, Diabetes Ali Dianaty - Senior Vice President, Product Innovation and Operations, Diabetes Conference Call Participants Matt Miksic - Barclays Robert Marcus - JPMorgan Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer Joanne Wuensch - Citibank Chris Pasquale - Nephron Jayson Bedford - Raymond James Matt Taylor - Jefferies Danielle Antalffy - UBS Matt O'Brien - Piper Sandler Travis Steed - Bank of America Anthony Petrone - Mizuho Jeff Johnson - Baird Marie Thibault - BTIG Ryan Weispfenning Okay. Good afternoon, everyone.
- 06/26/2023
|
Medtronic's (MDT) MiniMed 780G System Favored by New Data
- Medtronic (MDT) presents the clinical and real-world data on the MiniMed 780G system at ADA Scientific Sessions in San Diego.
- 06/26/2023
|
Top Health Care Stocks To Buy Today? 2 To Know
- Health care stocks to check out in the stock market today.
- 06/23/2023
|
Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend
- The healthcare industry is facing pent-up demand for surgeries. Health insurers may struggle with some additional costs as a result.
- 06/22/2023
|
AI May Transform Healthcare: 2 Top Stocks to Buy Now
- The global AI-in-healthcare market is on track to top $100 billion later this decade. Companies that invest in the area now could reap the rewards down the road.
- 06/22/2023
|
2 Promising Stocks That Are Screaming Buys in June
- Over the last few decades, medical device company Medtronic has made long-term investors rich. Cannabis company Cresco Labs is working hard to reduce costs and turn a profit.
- 06/19/2023
|
3 Growth Stocks You Can Buy Right Now for Under $100
- E-commerce outfit PDD Holdings is in the right place at the right time. Medtronic's recent history -- and the stock's recent performance -- are forgettable, but that's on the verge of changing.
- 06/16/2023
|
Medtronic weighs appeal after losing patent case regarding catheter technology
- Medtronic is weighing its next steps after losing another round in a long-running patent dispute with med-tech competitor Teleflex Inc.
- 06/16/2023
|
4 Upcoming Dividend Increases
- All these stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 7.3% and a median increase of 4.0%. There are four increases for next week, down from fifteen last week.
- 06/15/2023
|
Why Medical Device Stocks Like Medtronic Were So Healthy Today
- A recent trend in the U.S. healthcare system could strongly benefit the medical device segment. The health care system is now addressing pent-up demand for procedures that were postponed during the hotter periods of the pandemic.
- 06/14/2023
|
3 Long-term Healthcare Stocks to Add to Your Portfolio
- One of the greatest changes in the American landscape going forward will be demographics. The Baby Boomers make up the largest generation in the country's history.
- 06/14/2023
|
2 Healthcare Stocks That Could Make You Richer
- Medtronic is getting a makeover as it increasingly focuses on high-growth opportunities. Merck is developing additional medicines to decrease reliance on its crown jewel.
- 06/14/2023
|
Is Medtronic's Dividend In A Good Place?
- MDT, a member of the S&P Dividend Aristocrats index, recently provided weak guidance which dampens its low-dividend cover even more. We still appreciate some of the other dividend sub-plots. We shed some insight into the technical and valuation developments.
- 06/14/2023
|
3 Top AI Stocks to Buy Hand Over Fist
- AI stocks don't necessarily have to be technology companies. Some e-commerce and healthcare companies are investing in AI -- this can benefit their businesses and investors over time.
- 06/12/2023
|
Could AI Boost Growth at Medtronic?
- Medtronic has struggled to grow in recent times, but it's put a transformation plan into action. At the same time, it's focusing on one of its strengths: the use of artificial intelligence in its medical devices.
- 06/03/2023
|
High Yield Stock Watchlist: June 2023
- There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. An equally weighted portfolio of these stocks underperformed the Vanguard High Yield Dividend ETF by about 1.5% during the month of May.
- 06/02/2023
|
3 Stocks to Buy for the Coming AI-Powered Bull Market
- The Nasdaq, propelled partially by optimism about artificial intelligence (AI), is already in a bull market, as the index had soared 25% so far this year. The S&P 500, which is on the verge of a bull market as well, has also benefitted from investor enthusiasm related to the technology.
- 06/02/2023
|
Should Income Investors Buy This Soon-to-Be Dividend King?
- Medtronic's revenue and profits rose in the fourth quarter. The company's market-topping payout has room to grow.
- 06/01/2023
|
3 Reliable Dividend Growth Stocks to Buy Hand Over Fist in June
- Now that Johnson & Johnson has spun off its slow-moving consumer health division, its pharmaceutical and medical technology segments are expected to drive growth at a faster pace than usual. Medtronic is purely a medical device company with a slate of new product launches that could drive dividend growth in the years to come.
- 06/01/2023
|
My Best Dividend Aristocrats For June 2023
- Dividend aristocrats are struggling in 2023, with the ProShares S&P 500 Dividend Aristocrats ETF down 4.71% in May. Three strategies for identifying winning aristocrats include focusing on undervalued stocks, fastest expected growth, and a blend of the two. Despite recent underperformance, long-term investors can find value in dividend aristocrats, as they have historically outperformed the S&P 500 index.
- 05/31/2023
|
Final Trades: Medtronic, Merck, The Williams Cos. & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 05/31/2023
|
Here's Why You Should Retain Medtronic (MDT) Stock for Now
- Investors continue to be optimistic about Medtronic (MDT) on the robust performances of the Neurosurgery and Cardiovascular portfolios.
- 05/31/2023
|
What's Next For Medtronic Stock After A 9% Fall In A Week?
- Although the company posted upbeat Q1 results last week, the stock has declined due to lower-than-expected guidance for fiscal 2024.
- 05/31/2023
|
2 Healthcare AI Stocks to Buy on the Dip
- Moderna is working with IBM technology to potentially discover new mRNA medicines. Medtronic is using AI in various specialties and says it could be the key to personalized medicine.
- 05/31/2023
|
Is It Too Late to Buy Medtronic's Stock?
- Medtronic's revenue and earnings are steadily increasing. For the past 46 years, the company consistently increased its dividend.
- 05/31/2023
|
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
- DUBLIN , May 30, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare conference on Monday, June 12, 2023. Geoff Martha, Medtronic chairman and chief executive officer, will answer questions on the company beginning at 10:40 a.m.
- 05/30/2023
|
Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Revised)
- Medtronic (MDT) announces that the findings of the EV ICD Pivotal Study reinforce device safety and effectiveness.
- 05/29/2023
|
Why Medtronic Stock Sank Today
- Some analysts became more bearish on the medical tech specialist's prospects after it published its latest earnings release. That said, there are still pundits who are positive or neutral on the stock.
- 05/26/2023
|
Medtronic (MDT) to Expand Diabetes Care With New Buyout
- Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.
- 05/26/2023
|
A Reversal Is Brewing For Medtronic: Buying The Dip
- A reversal has been brewing for Medtronic NYSE: MDT and healthcare device makers all year. Increasing procedure volume, supply chain normalization, and innovation drive results and underpinning growth.
- 05/26/2023
|
Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
- Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
- 05/25/2023
|
Best Retirement Stocks to Buy Now
- The best retirement stocks ideally have high dividend yields that can be sustained. This can lead to steady income and long-term value for retirees.
- 05/25/2023
|
Why Medtronic Stock Is Sinking Today
- Medtronic announced its 2023 fiscal year fourth-quarter results today. As part of this announcement, the company also unveiled its 2024 financial outlook.
- 05/25/2023
|
Medtronic CFO Explains Outlook Below Expectations
- The company laid out guidance for its next fiscal year that fell well short of analyst expectations.
- 05/25/2023
|
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
- The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended April 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/25/2023
|
MDT Stock Alert: What to Know as Medtronic Acquires EOFlow
- Medtronic (NYSE: MDT ) stock is in the news Thursday after the American medical device company announced its planned acquisition of EOFlow . Medtronic is acquiring EOFlow for its EOPatch device.
- 05/25/2023
|
Medtronic (MDT) Beats Q4 Earnings and Revenue Estimates
- Medtronic (MDT) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.52 per share a year ago.
- 05/25/2023
|
Medtronic Slumps On Light Earnings Outlook; Announces $738 Million Buyout
- Medtronic beat fiscal fourth-quarter expectations Thursday and announced a buyout, but MDT stock dipped in premarket action. The post Medtronic Slumps On Light Earnings Outlook; Announces $738 Million Buyout appeared first on Investor's Business Daily.
- 05/25/2023
|
Medtronic beats profit forecast and stock rises
- Medtronic Plc stock MDT, +0.41% rose 0.9% in premarket trades after the medical device company's fourth-quarter adjusted profit and revenue beat analyst expectations. Medtronic said its fourth-quarter profit fell to $1.18 billion, or 88 cents a share, from $1.49 billion, or $1.10 a share, in the year-ago quarter.
- 05/25/2023
|
Medtronic beats quarterly profit estimates on heart, diabetes devices strength
- Medtronic Plc beat Wall Street estimates for quarterly profit on Thursday, helped by a recovery in non-urgent surgical procedures that were delayed during the pandemic as well as strong demand for its heart and diabetes devices.
- 05/25/2023
|
Medical technology is a good space for cover in recession times, says Mizuho's Anthony Petrone
- Anthony Petrone, senior medical devices analyst at Mizuho, joins 'The Exchange' to discuss medical technology gaining share, the bull case for Medtronic, and how medication advancements could impact the medtech sector.
- 05/24/2023
|
What To Expect From Medtronic's Q4?
- We expect Medtronic stock to trade sideways post-Q4 results announcement, with its revenues and earnings expected to align with the street estimates.
- 05/24/2023
|
Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome
- Medtronic (MDT) announces that the findings of the EV ICD Pivotal Study reinforce device safety and effectiveness.
- 05/24/2023
|
Medtronic Stock: Bull vs. Bear
- Medtronic could have great growth prospects in AI and offers an attractive dividend. However, the stock may not be the best choice for growth or passive income right now.
- 05/24/2023
|
Better Buy: Medtronic vs. Johnson & Johnson
- Medtronic is going through an “aggressive transformation” to boost growth. J&J is spinning off its consumer health business to focus on its higher-growth businesses.
- 05/24/2023
|
The 3 Best Income Stocks to Buy in a Rising-Interest-Rate Scenario
- Rising rates mean many risk-averse investors are flocking to short-term Treasuries, but for traders who prefer a little more action with greater upside potential, income stocks are having their moment in the spotlight. Dividend and stable, high-yield stocks offer reasonably predictable income without sacrificing market excitement or capital return opportunity.
- 05/23/2023
|
What's in the Cards for Medtronic (MDT) in Q4 Earnings?
- Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results.
- 05/19/2023
|
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
- Both stocks have outpaced the S&P 500 so far this year. Vertex is a long-time leader in the treatment of cystic fibrosis.
- 05/19/2023
|
Medtronic's (MDT) Global Market Share Strong, FX Headwind Stays
- Within cardiac rhythm management, Medtronic's (MDT) pacing business continues to outperform the market, banking on strong global growth of its Micra leadless pacemaker family.
- 05/18/2023
|
Why Medtronic Could Have 25% Upside From Today's Levels
- Medtronic has faced hurdles of its own making over the last three years. The company's pipeline, however, has recently delivered some wins.
- 05/14/2023
|
Lowe's, Medtronic Among 10 Companies To Boost Dividends In Late May
- The first half of May brought dividend boosts from several popular companies, including Apple and Cardinal Health. The big increases came from Chesapeake Utilities, Pool Corporation, and Tetra Tech.
- 05/14/2023
|
Which Is the Safer Dividend Stock: Stryker or Medtronic?
- Stryker and Medtronic are two of the biggest names in the medical device industry. Stryker is growing steadily, and its recent headwinds are clearing up.
- 05/12/2023
|
3 Things About Medtronic That Smart Investors Know
- Medtronic is trying to increase its efficiency with an internal overhaul. At the same time, it's planning on buying a bunch of smaller companies.
- 05/11/2023
|
Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
- DUBLIN , May 11, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2023 on Thursday, May 25, 2023. A news release will be issued at approximately 5:45 a.m.
- 05/11/2023
|
2 Outstanding Stocks That Are Screaming Buys in May
- This healthcare company has a promising future as both a growth and income stock. This cannabis company has the potential to thrive in a fiercely competitive market.
- 05/11/2023
|
Medtronic's Fortunes May Be Changing
- Medtronic is one of the largest medical device companies in the world and it is a market leader. The stock is yielding 3%+, almost at a decade high with a dividend growth rate of about 8% annually.
- 05/11/2023
|
This Could Be the Biggest Mistake Investors Make This Year
- Stocks have been taking a beating over the past year and a half, and there are some potential bargains out there right now. According to some of the smartest investors in the world, a bear market is no reason to panic.
- 05/11/2023
|
Is Medtronic Stock a Buy Now?
- Medtronic has delivered a track record of earnings growth -- and recently beat earnings expectations even in a difficult economy. Still, the company may continue to face some headwinds in the coming months.
- 05/07/2023
|
3 HealthTech Stocks to Watch as Digital Health Transforms the Industry
- Increasingly, technologies other than drugs are working to improve patient health. From diagnostic systems like MRIs and CAT scans to high-tech glucose monitoring systems to devices that destroy tumors, medicine makes use of many such technologies.
- 05/04/2023
|
Medtronic Has a Strong Dividend History, but Is That Now in Danger?
- Medtronic has been a very reliable payer of dividends for more than four decades. Management claims the dividend remains a priority for its capital allocation.
- 05/02/2023
|
Is Medtronic Stock a Buy Now?
- Medtronic got some excellent news for its diabetes business. Inflation and currency exchange rates are hurting cash flow.
- 05/02/2023
|
Bert's March 2023 Dividend Income Summary
- I invest in dividend stocks to grow my passive income with dividend income. We received $743.05 in April dividend income.
- 05/02/2023
|
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
- Medtronic has raised its dividend for 45 consecutive years. Edwards Lifesciences had a strong first quarter and upgraded 2023 guidance.
- 05/01/2023
|
7 Dividend Stocks to Buy and Hold for the Next Decade
- Passive investing is a great way to create long-term returns. It can be as simple as identifying dividend stocks to buy and hold for the next decade or more.
- 04/26/2023
|
Medtronic (MDT) Flat As Market Sinks: What You Should Know
- Medtronic (MDT) closed at $89.69 in the latest trading session, marking no change from the prior day.
- 04/25/2023
|
Q1 Earnings Scorecard and Fresh Analyst Reports for Bristol-Myers, Medtronic & Altria Group
- Q1 Earnings Season Scorecard is included in today's Research Daily in addition to new research reports on Bristol-Myers (BMY), Medtronic(MDT) and Altria Group (MO).
- 04/25/2023
|
Medtronic Is Partnering With Nvidia to Create Potentially Game-Changing Tech. Is the Stock a Buy?
- Medtronic will use Nvidia AI technology to detect precancerous tissue earlier -- and improve patient outcomes. The medical device giant sees AI as the key to personalized medicine.
- 04/25/2023
|
Why Medtronic Stock Edged Higher Today
- An analyst at Wells Fargo upgraded Medtronic's stock today. In response, the medtech giant's shares edged higher.
- 04/24/2023
|
Medtronic: Reversal In-Play For This High-Yield Stock
- The med-tech companies have gotten a lot of attention lately, and Medtronic (NYSE: MDT) is included. The rebound in procedures and healthcare services following the pandemic drives a rebound in the industry amplified by innovation.
- 04/24/2023
|
Medtronic Stock Has Room to Rise as 'Major Milestone' Is Reached
- Wells Fargo analysts raised their price target for shares of the medical-technology company to $100 from $77.
- 04/24/2023
|
SDOG: ETF With A Simple And Sensible Strategy, But Average Result
- SDOG: ETF With A Simple And Sensible Strategy, But Average Result.
- 04/24/2023
|
Got $5,000? 2 Unstoppable Stocks to Buy and Hold Forever
- Novo Nordisk boasts a strong expertise in diabetes and other critical areas of medicine. Medtronic offers a rich and growing portfolio of products as well as a solid dividend.
- 04/20/2023
|
Why Medtronic Stock Soared More Than 4% Higher Today
- Good financial results from two peers lifted sentiment on the medical-device maker. Medtronic has also been doing well lately, and those companies' performances indicate more growth could be coming.
- 04/19/2023
|
3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth
- As the population of our country continues to age, treatments and disease detection will continue to increase in demand. Additionally, improvements in imaging, robotics, and AI technology continue to give scientists new tools to make better medical devices.
- 04/10/2023
|
2 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
- Johnson & Johnson is undergoing significant changes, but its solid foundation makes it an excellent buy. Medtronic's long-term prospects are bright, thanks to the burgeoning medical device industry.
- 04/07/2023
|
Dividend Growth Investing Like Peter Lynch
- Although Peter Lynch wasn't explicitly a dividend growth investor, his principles and advice are highly applicable to a dividend growth strategy. Certain categories and sectors of stocks work better for dividend growth investors than others.
- 04/07/2023
|
2 Top Healthcare Stocks to Buy Right Now
- Medtronic and Cigna are dominant businesses in the medical devices and health insurance industries, respectively. Both companies should have promising dividend growth prospects.
- 04/07/2023
|
4 Dividend Aristocrat Buys For April + 2 To Watch
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 67 Aristocrats, screened as of April 5, 2023, represented all eleven Morningstar Sectors. Broker estimated top ten net gains ranged from 14.14%-42.97% topped by SWK & VFC.
- 04/07/2023
|
These 10 Most Undervalued Stocks Are Unstoppable, Morningstar Says
- The S&P 500 is "significantly undervalued," says Morningstar, but making money with stocks will still be a "rough road." The post These 10 Most Undervalued Stocks Are Unstoppable, Morningstar Says appeared first on Investor's Business Daily.
- 04/06/2023
|
New Investor? Buy These 2 Growth Stocks
- Companies with the ability to grow their businesses over time can be a great foundation for a portfolio. Texas Instruments makes chips that help to transform analog into digital.
- 04/06/2023
|
The 7 Most Undervalued Dividend Stocks to Buy in April 2023
- In these tumultuous times, with markets facing substantial headwinds from yet another financial crisis, savvy investors are on the lookout for safe havens. Perhaps the best refuge is in undervalued dividend stocks, particularly those trading at significant discounts compared to their sector peers.
- 04/03/2023
|
High Yield Stock Watchlist: April 2023
- There are 19 stocks on my high-yield watchlist for April 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
- 04/03/2023
|
Medtronic (MDT) Launches New Venture to Treat Kidney Failure
- Medtronic's (MDT) new venture is dedicated to reshaping kidney health and driving patient-centered technology solutions.
- 04/03/2023
|
3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now
- Shares of CVS Health have been beaten down in response to lower COVID-related revenue, but this is only a temporary setback. Medtronic shares offer an above-average dividend yield, and its payout has risen for 45 consecutive years.
- 04/03/2023
|
My Best Dividend Aristocrats For April 2023
- NOBL gave up a big chunk of its January gains in February, finishing the month down 2.36%. March has seen the ETF tumble some more as it's down 1.88% through 3/29. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.
- 03/30/2023
|
2 Dividend Growth Stalwarts With Impressive Streaks Going and Yield Twice That of the S&P 500
- Medtronic and ExxonMobil are two top dividend stocks that have been raising their payouts for 40-plus years. Medtronic's business should pick up this year now that China has abandoned its restrictive COVID lockdowns.
- 03/30/2023
|
UBS double downgrades Medtronic
- The "Halftime Report" traders debate the biggest analyst calls of the day
- 03/29/2023
|
Medtronic Stock Slammed With UBS Downgrade
- UBS hit Medtronic PLC (NYSE:MDT) with a downgrade to "sell" from "buy," with a steep price-target cut to $79 from $127.
- 03/29/2023
|
Will the Big Shifts at Medtronic Boost Revenue, Rating?
- Gastroenterology AI biotech Medtronic (NYSE: MDT) has maintained a HOLD rating since Sept 1, 2022, but a focused strategy could change that very soon. The company has recently revealed a plan to trim some personnel that should, first of all, cut some expenses.
- 03/28/2023
|
3 Tech Stocks to Buy for the Fourth Industrial Revolution
- The Fourth Industrial Revolution refers to the use of multiple advanced technologies, including “artificial intelligence (AI), robotics, [and] the Internet of Things (IoT).” Also in the mix are “faster computer processing,” “biotechnology,” and “Energy capture, storage, and transmission,” Salesforce reported.
- 03/25/2023
|
MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare
- MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.
- 03/24/2023
|
Recessions Don't Have to Be Scary for Your Portfolio. Here's Why.
- Economies are complex, but a simple surety is that recessions happen with some regularity. It can be tough to stay invested when everything around you looks like it is falling apart.
- 03/24/2023
|
Medtronic (MDT) to Enhance AI Innovation With New Platform
- Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.
- 03/23/2023
|
Why Is Medtronic (MDT) Down 6.1% Since Last Earnings Report?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 03/23/2023
|
Medtronic's (MDT) Affera Ablation System Gets CE Mark
- Medtronic's (MDT) Affera Mapping and Ablation System is intended to treat atrial arrhythmias.
- 03/17/2023
|
5 Stocks Gurus Are Trying Their Luck With for St. Patrick's Day
- Ahead of St. Patrick's Day, when everyone is Irish for a day, investors may be interested in trying their luck with companies headquartered on the Emerald Isle.
- 03/16/2023
|
7 Blue-Chip Stocks to Buy and Hold for Decades
- High uncertainty may continue to loom over the stock market, but that doesn't mean you need to stay on the sidelines. Instead, keep your eyes on the long-term, with solid additions to your portfolio, such as the best blue-chip stocks to buy and hold.
- 03/15/2023
|
2 High-Yield Sleep-At-Night Stocks To Buy And Forget About
- Medtronic (NYSE: MDT) and Verizon (NYSE: VZ) are 2 high-yielding stocks that investors who like to sleep at night should consider. They offer yield and value, and they also have robust upside potential.
- 03/15/2023
|
7 Undervalued Dividend Stocks for Your Must-Buy List
- With markets getting dragged down by another financial crisis, investors should seek safety. In fact, one of the best places for that is in undervalued dividend stocks.
- 03/14/2023
|
Healthcare Stocks With at Least 30 Years of Dividend Increases
- While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
- 03/14/2023
|
Here's My Top Growth Stock to Buy Now
- I usually buy stocks with long histories of annual dividend increases when they are trading with historically high yields. I own two stocks that fit this bill recently and I added to them both, with one being more "growthy" than the other.
- 03/13/2023
|
7 Blue-Chip Stocks to Buy at an All-Time Low
- Although the biggest and most-established enterprises generally outperform smaller firms during troubled times, this concept doesn't always ring true, meaning that speculators can target beaten-down blue-chip stocks to buy. To be sure, a few advantages exist in targeting this sector over a lesser-capitalized fare.
- 03/12/2023
|
The 4 Dividend Aristocrat Buys For March
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." --Kiplinger.com/Investing. 67 Aristocrats screened as of March 8, 2023, represented all eleven Morningstar Sectors. Broker estimated top ten net gains ranged 16.32%-32.64% topped by WBA & VFC.
- 03/10/2023
|
Medtronic: A Smart Dividend Gem To Buy On The Cheap
- Medtronic is seeing a decent rebound to its topline, as the healthcare segment recovers. Management is transforming the company through cost reductions and investments in high growth and synergistic areas.
- 03/10/2023
|
Medtronic: Slow Growth Makes Me Hesitate To Buy
- Medtronic seems to be a blue-chip company that's committed to increasing its dividend. Its financial position is stable, and its payout ratio is sustainable.
- 03/10/2023
|
If I Could Only Buy 1 Stock Right Now, This Would Be It
- I prefer to buy long-term dividend payers when they are out of favor. That is exactly the situation Medtronic finds itself in today.
- 03/09/2023
|
High Yield Stock Watchlist: March 2023
- There are 17 stocks on my high-yield watchlist for March 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
- 03/07/2023
|
Is This Dividend Growth Stock a Buy Right Now?
- This medical technology-oriented business is a proven innovator.
- 03/02/2023
|
Is Medtronic Stock a Buy Now?
- This healthcare company is both a growth and an income stock with a bright future.
- 03/02/2023
|
Is Medtronic Still a Great Dividend Stock?
- Innovation and consistent dividend increases attract investors.
- 03/01/2023
|
Medtronic's (MDT) MiniMed 780G System Shows Favorable Results
- Medtronic's (MDT) MiniMed 780G system was designed to forecast real-life requirements where carbohydrate counts aren't always exact and meal doses are often missed.
- 02/27/2023
|
Dividend Stocks To Buy Now? 3 For Your Watchlist
- Dividend stocks to watch this week.
- 02/27/2023
|
These 11 stocks will be Dividend Kings in 5 years or less.
- But today, we are serving up the main course with these 11 stocks well on their way to becoming dividend kings. We have ordered this list by how many consecutive years these companies have grown their dividends.
- 02/27/2023
|
My Best Dividend Aristocrats For March 2023
- NOBL started the year off with a gain of 3.23% in January; it is thus far not faring as well in February, but the ETF is still positive year-to-date. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.
- 02/25/2023
|
Will Medtronic Stock See Higher Levels After An Upbeat Q3?
- Medtronic recently reported its Q3FY23 results, with revenue and earnings falling above our estimates.
- 02/23/2023
|
Medtronic Isn't Out of the Woods Yet
- Medical-device maker Medtronic's financial results were positive, but the company has more to do to convince investors of its growth path.
- 02/21/2023
|
Medtronic (MDT) Q3 Earnings Beat Estimates, Margins Down
- Medtronic's (MDT) CGM business banks on strong sales of the MiniMed 780G system and the associated increase in CGM attachment rates on the strength of the Guardian 4 sensor in Q3.
- 02/21/2023
|
Medtronic plc (MDT) Q3 2023 Earnings Call Transcript
- Medtronic plc (NYSE:MDT ) Q3 2023 Earnings Conference Call February 21, 2023 8:00 AM ET Company Participants Ryan Weispfenning - Investor Relations Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Chief Financial Officer Bob White - Executive Vice President and President, Medical Surgical Portfolio Brett Wall - Executive Vice President and President, Neuroscience Portfolio Que Dallara - Executive Vice President and President, Diabetes Operating Unit Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Joanne Wuensch - Citi Matt Miksic - Barclays Cecilia Furlong - Morgan Stanley Shagun Singh - RBC Travis Steed - BofA Rick Wise - Stifel Nicolaus Ryan Weispfenning Good morning. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
- 02/21/2023
|
Medtronic Stock, A Bottom Is In Play
- Hum-drum Medtronic (NYSE: MDT) has seen its shares fall dramatically over the past year due to a massive downdraft in the analysts' sentiment. The downdraft was caused by the peaking of COVID-19 and the tailwind it provided to businesses.
- 02/21/2023
|
Medtronic (MDT) Receives CE Mark Approval For Aurora System
- Medtronic (MDT) Aurora EV-ICD system indicated for patients at risk of life-threatening arrhythmias.
- 02/21/2023
|
Medtronic stock rises on Q3 earnings as company tightens outlook
- Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the rise in stock for Medtronic following third-quarter earnings.
- 02/21/2023
|
Medtronic (MDT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended January 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/21/2023
|
Medtronic (MDT) Surpasses Q3 Earnings and Revenue Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 3.17% and 2.76%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
- 02/21/2023
|
Medtronic Beats Quarterly Expectations, Tightens 2023 Earnings Outlook
- Medtronic raised the low end of its earnings outlook on Tuesday after beating quarterly expectations, but MDT stock sank a fraction. The post Medtronic Beats Quarterly Expectations, Tightens 2023 Earnings Outlook appeared first on Investor's Business Daily.
- 02/21/2023
|
Medtronic Beat Earnings Expectations. The Stock Is Rising.
- "We returned to mid-single digit organic growth as we execute our strategy," CEO Geoff Martha said in a statement.
- 02/21/2023
|
Medtronic tops third-quarter estimates as revenue boosted by strong cardiovascular and neuroscience portfolios
- Medtronic Plc stock MDT, +0.71% rose in premarket trade Tuesday, after the medical device maker beat fiscal third-quarter consensus estimates. The Dublin-based medical device maker posted net income of $1.222 billion, or 92 cents a share, for the quarter to Jan. 27, down from $1.480 billion, or $1.10 a share, in the year-earlier period.
- 02/21/2023
|
Got $5,000? Buy and Hold These 3 Market-Beating Stocks
- It's best to buy into good companies when their stocks are down.
- 02/20/2023
|
5 Stocks In The Dividend Growth Sweet Spot
- Finding companies with a high initial yield and rapid dividend growth is difficult. I present my criteria for finding such companies. At present, there are 16 companies meeting my initial screening requirements. Using additional metrics, these are reduced to five.
- 02/15/2023
|
Medtronic to announce financial results for its third quarter of fiscal year 2023
- DUBLIN , Feb. 14, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2023 on Tuesday, February 21, 2023. A news release will be issued at approximately 5:45 a.m.
- 02/14/2023
|
Should Medtronic's Recent Colibri Patent Controversy Concern You?
- In early February 2023, Medtronic PLC (NYSE: MDT) was found guilty of patent infringement regarding Colibri Heart Valve LLC transcatheter aortic valve replacement system (TAVR). While this is certainly troubling for one of the biggest medical technology manufacturers in the world, it may not significantly derail any momentum they have.
- 02/13/2023
|
Here's What To Expect From Medtronic's Q3
- We expect Medtronic stock to trade higher post Q3, with its revenues and earnings likely falling above the street estimates.
- 02/10/2023
|
High Yield Stock Watchlist - February 2023
- There are 12 stocks on my high-yield watchlist for February 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
- 02/10/2023
|
My Dividend Stock Portfolio: New January Record - 100 Holdings With 26 Buys
- Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federal Reserve and a solid earnings season.
- 02/09/2023
|
3 MedTech Stocks Likely to Beat Estimates This Earnings Season
- MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EXAS, MDT and IART are poised ahead of their earnings releases.
- 02/08/2023
|
4 Dividend Aristocrat Buys For February
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. By yield, VFC topped all Aristocrats. Top-ten yields from TROW, ESS, FRT, AMCR, ABBV, O, IBM, MMM, WBA, & VFC, averaged 4.38%.
- 02/08/2023
|
What's in the Cards for Medtronic (MDT) in Q3 Earnings?
- Severe currency headwinds are expected to have affected Medtronic's (MDT) profitability in fiscal Q3.
- 02/07/2023
|
Medtronic: A Turnaround In 4 Steps
- Medtronic has underperformed the market considerably over the last seven years. The company realized that it's not working and initiated a turnaround strategy.
- 02/07/2023
|
Bert's January 2023 Dividend Income Summary
- We received $736.32 in January dividend income! This represents an 18.46% dividend increase compared to last year. The strong dividend income growth is great! That is exactly how you want to start the year off. Our dividend income grew nearly $115 from January 2022.
- 02/07/2023
|
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023
- You can bet the farm on these companies' dividends.
- 02/04/2023
|
Buying The Medtronic Turnaround Story
- Medtronic is working through top-line headwinds. The company actually stands to benefit from incremental top-line and EPS growth over the long term.
- 02/02/2023
|
My Top 10 High Yield Dividend Stocks For February 2023
- I present my top 10 High Yield dividend stocks that are poised to offer strong future returns. The annualized rate of return for this watchlist is 16.31% over the past 27 months.
- 02/02/2023
|
Barron's And Bloomberg 2023 Ideal Dividend Stocks Of The Year
- Two Barron's Annual Roundtable, plus one Bloomberg Intelligence articles published late-January listed 99 intriguing stocks for 2023; 77 were unduplicated US publicly-listed companies, of which, 56 paid-dividends. Barron's two roundtable discussions January 20 and 27 split 49 picks from 9 panelists in half, whereas Bloomberg detailed all 50 in their January 16 BusinessWeek edition.
- 01/31/2023
|
The 4% DGI Core Portfolio: 2022 Year-End Review
- We present the 2022 year-end review of our eight-year-old Passive DGI-Core Portfolio. We consider this portfolio and strategy as the foundation of our overall portfolio. We will provide updates on changes, additional investments, dividends collected, and an overall 2022 performance.
- 01/28/2023
|
My Best Dividend Aristocrats For February 2023
- NOBL fell 4.12% in December, which brings the Fund's return for the year to a loss of 6.5%. Thus far this month, through January 25th, the dividend aristocrat ETF is up 1.92% and starting the year on a bright note.
- 01/28/2023
|
Capital Wealth Planning's Kevin Simpson offers his five star stock picks
- Kevin Simpson, Capital Wealth Planning, joins 'Closing Bell: Overtime' to offer his five star stock picks,
- 01/27/2023
|
Dividend Growth Checkup - 2022
- Analyzing my real-life portfolio's dividend growth for 2022. Dividend growth pulled back some compared to 2021; however, it was still a strong year of dividend growth.
- 01/25/2023
|
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 01/25/2023
|
3 Outstanding Dividend Stocks You Can Buy Now and Hold Forever
- For years, these businesses have impressed investors with their ability to raise quarterly dividend payouts.
- 01/24/2023
|
Ranking The Diversified Healthcare Giants
- The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
- 01/22/2023
|
I'll Avoid These Sectors In 2023
- I wrote an article about which sectors I intend to focus on for this year, with a number of example picks for each sector. In this article, it's the opposite. I will show you what sectors I will try to avoid, given volatility or negative potential for these sectors.
- 01/15/2023
|
High Yield Stock Watchlist - January 2023
- There are 15 stocks on my high yield watchlist for January 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
- 01/13/2023
|
3 Cheap Dividend Stocks With More Than 10% Upside
- These 3 dividend stocks all pay stable and growing dividends
- 01/12/2023
|
3 Stocks to Buy Before the Bull Market
- The bear market isn't going to last forever. Buying these stocks could set you up for some great long-term returns.
- 01/11/2023
|
Is Medtronic Stock Ready to Revive?
- The world's largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out.
- 01/10/2023
|
Most therapeutic areas back to pre-pandemic levels, says Medtronic CEO
- Geoffrey Martha, Medtronic CEO, joins 'TechCheck' to discuss future of the company and his outlook for 2023.
- 01/10/2023
|
Medtronic plc (MDT) J.P. Morgan 41st Annual Healthcare Conference
- Medtronic plc (NYSE:MDT ) J.P. Morgan 41st Annual Healthcare Conference January 9, 2023 11:15 AM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Chief Financial Officer Que Dallara - Executive Vice President and President, Diabetes Operating Unit Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Conference Call Participants Robbie Marcus - J.P.
- 01/09/2023
|
3 Reliable Dividend Stocks You Can Buy With $600
- With products and services that many of us can't live without, these businesses are poised to deliver steadily rising dividend payouts.
- 01/09/2023
|
Medtronic Is A Strong Buy, Well-Positioned For The Future
- Medtronic plc is a well-established medical devices company with a diverse range of products and a strong track record of financial performance. Medtronic operates in business segments that are well-positioned for the future.
- 01/06/2023
|
Medtronic: Destruction Is Nearly Over
- Medtronic investors have suffered a massive battering as MDT moves closer to its COVID lows. The company's headwinds are likely still manifesting, worsened by macroeconomic challenges.
- 01/06/2023
|
This Robotic Products Company Is A Better Pick Over Medtronic Stock
- We believe Intuitive Surgical stock (NASDAQ: ISRG) is currently a better pick than Medtronic stock (NYSE: MDT), given its better prospects.
- 01/06/2023
|
The 7 Best Dividend Stocks for Passive Income in 2023
- Dividend stocks are getting hot again so it makes sense to look for the best dividend stocks for passive income. The new year is here, and many investors are switching up their strategies.
- 01/05/2023
|
Medtronic: Can This Medical Device Maker Turn Itself Around?
- Medtronic PLC ( MDT , Financial) once again ranked as the number one medical device company in the world in terms of revenue in 2022, according to a study by Proclinical. Moreover, Proclinical estimates that the medical device industry was worth $488.98 billion in 2021 and projects that it could reach a value of $718.92 billion by 2029, representing a significant runway for growth.
- 01/05/2023
|
5 Dividend Aristocrat Buys For January
- "Dividend Aristocrats. in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 65 Aristocrats screened as of January 3, 2022 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 13.23%-26.61% topped by VFC & TGT.
- 01/05/2023
|
3 Healthcare Stocks With Attractive Dividends
- During periods of market weakness, such as in 2022, healthcare stocks tend to outperform the broader market. This is owed to the group's relative stability when it comes to revenue and earnings, which also translates to their ability to pay dividends irrespective of economic conditions.
- 01/05/2023
|
My Top 10 High Yield Dividend Stocks For January 2023
- I present my top 10 High Yield dividend stocks that are poised to offer strong future returns. The annualized rate of return for this watchlist is 12.67% over the past 26 months.
- 01/02/2023
|
Shares of This Medical Device Maker—and Dividend Aristocrat—Look Attractive
- Medtronic is dividend aristocrat, with 45 straight years of payout increases. But shares in the company, a top maker of medical devices, haven't been regal performers.
- 01/02/2023
|
Wall Street Thinks This Obscure Growth Stock Could Soar 92% in 2023
- As COVID-19 headwinds fade, AngioDynamics' business could rebound.
- 12/30/2022
|
My 5 Favorite, Undervalued Investments For Year-End 2022
- The time has come to take a look at my portfolio and see where to cut, and where to invest. The market is ripe for investing, and there are opportunities. There are opportunities in almost every sector out there. In this article, I'll show you some of my current favorite ones.
- 12/30/2022
|
2 Dividend Stocks That Can Help You Retire Early
- These are the types of investments long-term investors can buy and forget about.
- 12/28/2022
|
My Best Dividend Aristocrats For January 2023
- NOBL gained 7.12% in November, which brings the Fund's return for the year to a loss of 2.14%. Thus far this month, through December 23rd, the dividend aristocrat ETF is down 3.47%, bringing its year-to-date return to -5.86%.
- 12/26/2022
|
3 Medical Dividend Stocks That Hit the Sweet Spot
- These three offer high dividend yields and consistent revenue growth.
- 12/26/2022
|
This Powerful Dividend-Paying Stock Hit Its 52-Week Low. Should You Buy Before 2022 Ends?
- This medtech company is among the most dominant in the world.
- 12/24/2022
|
Why Is Medtronic (MDT) Down 2.4% Since Last Earnings Report?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 12/22/2022
|
Here's Why This Great Dividend Stock Is a Buy
- This medical technology-focused stock offers income investors a 3.6% dividend yield.
- 12/22/2022
|
5 Stocking Stuffer Stocks for Christmas 2022
- The end of the year is often a time for investors to buy and sell stocks and clean up their portfolios. Some investors allocate excess cash to new investments or add to existing holdings.
- 12/21/2022
|
Pick Either Abbott Stock Or Its Industry Peer – Both Are Likely To Offer Similar Returns
- We believe that Abbott stock and Medtronic stock in the medical devices industry will likely give similar returns over the next three years. Although Abbott is trading at a higher valuation of 4.2x trailing revenues, compared to 3.
- 12/21/2022
|
Medtronic (MDT) Enrolls 1st Patient Trial for Hugo RAS System
- Medtronic's Hugo RAS system is designed to be used in Expand URO U.S. clinical trial study for urologic surgical procedures.
- 12/16/2022
|
Siemens Healthineers, GE Healthcare eye Medtronic units - Bloomberg News
- Siemens Healthineers AG and General Electric Co's healthcare business are weighing a potential acquisition of two units being spun off by Medtronic Plc, Bloomberg news reported on Thursday, citing people familiar with the matter.
- 12/15/2022
|
2 Stocks to Buy if There Is a Recession Next Year
- It pays to be prepared, and these stocks could help you.
- 12/13/2022
|
2 Dividend Aristocrats to Buy and Hold Until You Retire
- Both of these stocks have characteristics that make for stable, long-term investments.
- 12/12/2022
|
Medtronic: Income Investor's Delight Available at a Discount
- Medtronic PLC ( MDT , Financial) is an attractive stock for investors looking for solid and profitable options. The broad portfolio of medical devices, medications and services has been the driving force of the company's success.
- 12/09/2022
|
Medtronic: Buy The Dip And Start The DRIP
- Medtronic is a durable healthcare products company with a longstanding history of success and a sound business model. Market sentiment has been highly negative around the stock based on what I see as being temporary headwinds.
- 12/07/2022
|
Medtronic Is A Compelling 3.6% Dividend Grower
- 3.6% Dividend Yield. Dividend increased 8% last fiscal year. High 80% cash flow conversion with 50% Free Cash Flow (FCF) shareholder return target.
- 12/06/2022
|
2 Urgent Dividend Sells And 2 Blue Chip Replacements To Increase Your Income
- As the SPX has risen to 4,000, some stocks have become outrageously expensive. Others, in the same sector, are still very cheap.
- 12/02/2022
|
My Top 10 High Yield Dividend Stocks For December 2022
- I present my top 10 High Yield dividend stocks that are poised to offer strong future returns. The annualized rate of return for this watchlist is 16.68% over the past 25 months.
- 12/02/2022
|
7 Excellent Dividend Stocks to Buy for the Holiday Season
- With the holiday season upon us, investors may want to focus largely on dividend stocks to buy. While growth-oriented names provide the most excitement, market participants must acknowledge reality.
- 11/30/2022
|
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
- The lowest yield on this list is 2.7%.
- 11/30/2022
|
Medtronic plc (MDT) 5th Annual Evercore ISI HealthCONx Conference (Transcript)
- Medtronic plc (NYSE:MDT ) 5th Annual Evercore ISI HealthCONx Conference Call November 29, 2022 5:10 PM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Okay. Thanks, everyone for joining us.
- 11/29/2022
|
12 Potent Picks Are December's Ideal Dividend Buys
- A February 2, 2022, Kiplinger Today special report headlined, "Potent Picks to Profit in 2022,” featured 97 dividend-fetching stocks from 118 in that article. Here is YCharts 11/25/22 update. Article titles were: '65 Best Dividends', '15 Value Stocks', '15 Best Mid-Caps', '10 European Plays', '9 High Yields', '6 Sturdy Defensive Stocks.'
- 11/29/2022
|
Should You Buy Medtronic Stock At $80?
- The recent fall can be attributed to the Q2FY23 results the company reported yesterday, with revenue falling below and earnings above our estimates.
- 11/25/2022
|
My Best Dividend Aristocrats For December 2022
- NOBL gained 10.31% in October, which brings the Fund's return for the year to a loss of 8.96%. Thus far this month, through November 22nd, the dividend aristocrat ETF is up 6.52%, bringing its year-to-date return to -3.03%.
- 11/24/2022
|
Medtronic Stock Falls After Medical-Device Maker Posts Lower Earnings
- Supply-chain and demand challenges pressure the Dublin-based company's latest quarterly results.
- 11/22/2022
|
These 2 Stocks Just Made Surprising Moves
- Markets had a strong day.
- 11/22/2022
|
Medtronic (MDT) Q2 Earnings Beat Estimates, Margins Down
- Medtronic's (MDT) Q2 organic revenues reflect slower supply recovery and lower-than-anticipated underlying market procedure volumes in certain businesses.
- 11/22/2022
|
Medtronic plc (MDT) Q2 2023 Earnings Call Transcript
- Medtronic plc (NYSE:MDT ) Q2 2023 Earnings Conference Call November 22, 2022 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head, Investor Relations Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Chief Financial Officer Brad Welnick - Investor Relations Que Dallara - Executive Vice President and President, Diabetes Operating Unit Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Brett Wall - Executive Vice President and President, Neuroscience Portfolio Bob White - Executive Vice President and President, Medical Surgical Portfolio Conference Call Participants Robbie Marcus - JPMorgan Travis Steed - Bank of America Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Matt O'Brien - Piper Sandler Josh Jennings - Cowen & Company Matt O'Brien - Piper Sandler Matt Taylor - Jefferies Pito Chickering - Deutsche Bank Joanne Wuensch - Citi Ryan Weispfenning Good morning. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and welcome to snowing Minneapolis.
- 11/22/2022
|
Medtronic (MDT) Q2 Earnings Surpass Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 1.56% and 1.72%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/22/2022
|
Medical Behemoth Medtronic Crumbles After Missing Its Own Guidance
- Medtronic reported mixed earnings and lighter-than-expected organic sales growth, leading MDT stock to tumble. The post Medical Behemoth Medtronic Crumbles After Missing Its Own Guidance appeared first on Investor's Business Daily.
- 11/22/2022
|
Medtronic Lowers Earnings Guidance, Citing Slower Procedure and Supply Recovery
- The medical device maker misses fiscal second-quarter sales expectations and lowers its earnings guidance for the year.
- 11/22/2022
|
Medtronic stock falls after profit beats expectations but revenue misses, and outlook is downbeat
- Shares of Medtronic PLC MDT, +1.22% dropped 2.4% in premarket trading Tuesday, after the medical devices maker reported fiscal second-quarter profit that topped expectations but revenue that missed and provided a downbeat full-year outlook, citing weakness in procedure volumes in certain businesses and the pricing impact of procurement in China. Net income for the quarter to Oct. 28 fell to $427 million, or 32 cents a share, from $1.31 billion, or 97 cents a share, in the year-ago period.
- 11/22/2022
|
4 No-Brainer Dividend Stocks for the End of 2022
- The end of the year is usually an excellent time to look for deals. In 2022, a bear market caused by rising interest rates in response to the highest inflation in four decades punished stock prices.
- 11/21/2022
|
Bob Iger ‘has the right touch' at Disney, former Medtronic CEO says
- Former Medtronic CEO Bill George joins Yahoo Finance Live to discuss the state of leadership for Disney following the mass media company's decision to replace Bob Chapek with former CEO Bob Iger, investor complexities, innovating the franchise, and the outlook for Twitter under Elon Musk's leadership.
- 11/21/2022
|
3 Unstoppable Growth Stocks to Buy and Hold for the Next Decade
- These impressive businesses seem to have plenty of room for further growth.
- 11/20/2022
|
Medtronic CEO Geoff Martha on Q3 EPS beat, pipeline and more
- Medtronic reported a quarterly profit above Wall Street estimates, helped in part by stronger demand for ventilators amid the pandemic. Medtronic CEO Geoff Martha joined Tuesday "Squawk on the Street" to discuss the company's results.
- 11/19/2022
|
Medtronic CEO Geoffrey Martha on fourth-quarter earnings beat and guidance
- Geoffrey Martha, Medtronic chairman and CEO, joined "Squawk on the Street" to discuss the company's fourth-quarter earnings beat and outlook.
- 11/19/2022
|
What's in the Cards for Medtronic (MDT) in Q2 Earnings?
- Medtronic's (MDT) Evolut PRO+ launch in Europe and Evolut PRO launch in China are expected to have contributed to the company's fiscal Q3 top line.
- 11/18/2022
|
Will Medtronic Stock See Higher Levels Post Q2 Results?
- Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 second-quarter results on Tuesday, November 22. We expect Medtronic to post revenues and earnings in line with the street estimates.
- 11/17/2022
|
Cloud DX welcomes former Medtronic Canada president Neil Fraser to its board
- Cloud DX (TSX-V:CDX, OTCQB:CDXFF) Inc announced it has appointed Neil Fraser to its board as an independent director. Formerly president of Medtronic Canada, Fraser is currently a board member of Sona Nanotech (CSE:SONA) Inc and a member of various health-related councils including the CD Howe Institute and the International Working Group on Global Research, Development & Innovation with the BRG Institute.
- 11/15/2022
|
Medtronic to announce financial results for its second quarter of fiscal year 2023
- DUBLIN , Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2023 on Tuesday, November 22, 2022. A news release will be issued at approximately 5:45 a.m.
- 11/15/2022
|
Walgreens Named November Aristocrats Top Dog
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 65 Aristocrats screened as of November 8, 2022 represented all eleven Morningstar sectors. Broker-estimated top-ten net gains ranged 11.21%-36.63%, topped by MDT & ESS.
- 11/10/2022
|
Medtronic: Buy This 'A' Quality Gem On The Cheap
- Medtronic is a premium quality enterprise that trades at a significant discount to its historical valuations. It has a long runway of growth with exposure to popular health categories.
- 11/07/2022
|
This Dividend Stock Is Breaking Up, but Income Investors Shouldn't Worry
- Medtronic is getting ready to spin off a division, but it has made it very clear that dividend investors don't need to worry.
- 11/03/2022
|
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
- Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 11/02/2022
|
Does an Upcoming Spinoff Makes This Dividend-Paying Stock a Smart Buy Now?
- An upcoming buy-one-get-one-free deal could do wonders for your passive-income stream.
- 10/30/2022
|
My Best Dividend Aristocrats For November 2022
- NOBL fell 9.15% in September, which brings the Funds return for the year to a loss of 17.47%. Thus far this month, through October 24th, the dividend aristocrat ETF is up 6.04%, bringing its year-to-date return to -12.49%.
- 10/26/2022
|
Medtronic: 45 Years Of Dividend Increases, All-Time High Yield
- Elective and deferred surgeries booming during the Covid reopening fell short of projections. This has weighed down the healthcare equipment space. While many names in the space now have reasonable valuations, Medtronic is the most enticing for yield.
- 10/25/2022
|
Medtronic to separate its patient monitoring and respiratory interventions businesses
- Medtronic Plc MDT, +0.98% said Monday it's planning to separate its patient monitoring and respiratory interventions businesses in a move aimed at better positioning both the NewCo and Medtronic for long-term success. The Dublin-based medical device company said the business had about $2.2 billion in revenue in fiscal 2022.
- 10/24/2022
|
2 Stocks to Buy and Forget in This Bear Market
- Both have lagged the market in the past year.
- 10/23/2022
|
Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know
- Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
- 10/21/2022
|
Bear Market Bargains: 2 Stocks Near Multi-Year Lows That Are Red-Hot Buys
- These stocks may not stay this cheap for long.
- 10/19/2022
|
Medtronic to webcast renal denervation investor & analyst briefing on November 7
- DUBLIN , Oct. 14, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its Medtronic Coronary and Renal Denervation business during the American Heart Association annual scientific sessions (AHA 2022) on Monday, November 7, 2022, at 5 p.m. CST. The webcast will feature remarks from Medtronic Coronary and Renal Denervation management, including comments on the 6-month results from the SPYRAL HTN-ON MED Randomized Trial (ON MED).
- 10/14/2022
|
Down Nearly 50%, Is This Growth Stock Still a Buy?
- Intuitive Surgical enjoys a wide moat in the robotic-assisted-surgery space.
- 10/12/2022
|
Income Plus Low Volatility Makes This Fund A Safe Haven
- Are you looking for a relatively safe mutual fund haven amid current market carnage? Check out Madison Covered Call & Equity Income Fund (MENYX).
- 10/12/2022
|
3 Diabetes Care Stocks That Could Help Set You Up for Life
- These companies are three of the leading manufacturers of continuous glucose monitoring systems.
- 10/09/2022
|
Here is What to Know Beyond Why Medtronic PLC (MDT) is a Trending Stock
- Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 10/05/2022
|
Medtronic: Upgrading To Buy
- Medtronic struggled to fill orders over the past year due to supply issues. As a result, the enterprise value of the company is near five-year lows.
- 10/05/2022
|
BlackRock's DeSpirito: Brace For Stubborn Inflation
- Inflation is easing, says a top thinker for BlackRock, the world's largest asset manager. But it's not falling to what Americans have grown used to.
- 09/30/2022
|
Medtronic Stock Is A Better Pick Over This Pharmaceuticals Bellwether
- We believe Medtronic stock (NYSE: MDT) is currently a better pick than Johnson & Johnson stock (NYSE: JNJ), given its better prospects.
- 09/28/2022
|
7 Large-Cap Sleeper Stocks to Buy Before Wall Street Wakes Up
- Today, I want to consider some large-cap sleeper stocks to buy. If you were able to travel back in time one year ago, the current market environment might feel like a bad dream.
- 09/27/2022
|
My Best Dividend Aristocrats For October 2022
- NOBL fell 2.78% in August which brings the Funds return for the year to a loss of 9.16%. Thus far, through September 23rd, the dividend aristocrat ETF is down 6.71%, bringing its year-to-date return to -15.25%.
- 09/26/2022
|
Two-minute drill: PSA, MDT & WTW
- Jeremy Bryan, Gradient Investments portfolio manager, joins 'Closing Bell: Overtime' to discuss his favorite stock picks including; Public Storage, Medtronic and Willis Towers Watson.
- 09/26/2022
|
Medtronic: Prefer U.S. Treasury Bonds
- Medtronic entered a bear market and has fallen more than the S&P 500 since the last quarter of 2021. Since I see few strong growth catalysts, I compare investing in Medtronic to investing in a 10-year US Treasury bond.
- 09/25/2022
|
Medtronic Is Now Mind-Numbingly Cheap
- Medtronic is well-positioned to benefit from global demographic trends. The market appears to be overly rotated on short-term supply side concerns.
- 09/23/2022
|
Medtronic (MDT) Gets FDA's 510(k) Nod for Pediatric ICM
- This latest approval broadens Medtronic's scope within its Cardiovascular Diagnostics and Services wing within broader Cardiovascular business.
- 09/22/2022
|
Medtronic (MDT) Down 4% Since Last Earnings Report: Can It Rebound?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 09/22/2022
|
Is Trending Stock Medtronic PLC (MDT) a Buy Now?
- Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
- 09/22/2022
|
Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2022 (Transcript)
- Medtronic plc (NYSE:MDT ) Bank of America Global Healthcare Conference 2022 September 15, 2022 9:10 AM ET Company Participants Rob ten Hoedt - Executive Vice President & President EMEA & APAC Conference Call Participants Travis Steed - Bank of America Rob ten Hoedt [Call Starts Abruptly] That is the de novo patients plus the deferred patients should all be treated, then we're going to get this increase in productivity. That happened in Spain and Italy but it didn't in France, in the UK and in Germany.
- 09/15/2022
|
3 Cheap Dividend Stocks To Consider
- Dividend stocks have performed better this year than the broader market, but that is mostly because of the difference in sector allocation between dividend payers and nonpayers. Whether buying socks or stocks, to paraphrase Warren Buffett, it's usually a good idea to buy quality items on discount.
- 09/13/2022
|
Medtronic plc (MDT) CEO Geoffrey Martha Presents at Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)
- Medtronic plc (NYSE:MDT ) Morgan Stanley 20th Annual Global Healthcare Conference September 12, 2022 12:30 PM ET Company Participants Cecilia Furlong - VP, Medical Technology Equity Research Conference Call Participants Geoffrey Martha - Chairman and CEO Cecilia Furlong Good afternoon. Welcome to the first day of the Morgan Stanley Healthcare Conference.
- 09/12/2022
|
Your Portfolio Could Be Missing This Stock With Monster Potential
- When a leading healthcare technology stock falls during a bear market it means one thing -- opportunity
- 09/12/2022
|
4 S&P 500 Dividend Aristocrat Dogs To Buy, 1 To Watch
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 65 Aristocrats screened as of September 8, 2022 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 16.54%-36.34% topped by VFC & SWK.
- 09/11/2022
|
Is Most-Watched Stock Medtronic PLC (MDT) Worth Betting on Now?
- Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 09/08/2022
|
Medtronic to appear at September investor conferences
- DUBLIN , Sept. 7, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following September 2022 investor conferences: Wells Fargo 2022 Healthcare Conference Wednesday, September 7, 2022, at 11:35am EDT (10:35am CDT) Karen Parkhill, executive vice president & chief financial officer, IT & enterprise excellence answered questions about the company.
- 09/07/2022
|
Medtronic plc (MDT) 2022 Wells Fargo Healthcare Conference Call Transcript
- Medtronic plc (NYSE:MDT ) 2022 Wells Fargo Healthcare Conference Call September 7, 2022 11:35 AM ET Company Participants Karen Parkhill - Executive Vice President and Chief Financial Officer Gregory Hertz - Senior Director of Investor Relations Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities, LLC Lawrence Biegelsen All right. Good morning.
- 09/07/2022
|
Is Medtronic a Buy?
- The company reported earnings last week.
- 09/02/2022
|
Should Income Investors Buy This Dividend Aristocrat?
- Medtronic's dividend yield tops 3%, approximately double the S&P 500 index's yield.
- 09/02/2022
|
Medtronic (MDT) Obtains U.S. Distribution Rights for BioButton
- Medtronic's (MDT) new deal with BioIntelliSense will ensure accessibility to BioButton for continuous vital sign measurements of general care patients in the United States.
- 09/01/2022
|
Companies are undergoing a ‘massive change in leadership,' former Medtronic CEO says
- Former Medtronic CEO Bill George joins Yahoo Finance Live anchors Brian Sozzi and Brad Smith to discuss corporate leadership, where Meta CEO Mark Zuckerberg went wrong, the generational shift from Baby Boomers to Gen X and Millennials, and challenges CEOs face today.
- 08/30/2022
|
Cloud DX to Present on Teladoc Partnership and More at Emerging Growth Conference
- Individual and institutional investors, advisors, and analysts are invited to attend Cloud DX's interactive presentation at the Emerging Growth Conference Cloud DX and Teladoc Health announced a new partnership to deliver integrated remote patient monitoring (RPM) solutions to providers across Canada CEO Robert Kaul will present on the implications of the Agreement and update investors on other Cloud DX initiatives including the partnership with Medtronic KITCHENER, ON / ACCESSWIRE / August 30, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), is pleased to announce that it has been invited to present at the Emerging Growth Conference on August 31, 2022. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the company's Founder & CEO, Robert Kaul.
- 08/30/2022
|
Three Reasons Why Medtronic Stock can be a Recession Winner
- Despite short-term headwinds, there are reasons for investors with a long-term outlook to consider Medtronic as a stock to manage through this recession.
- 08/29/2022
|
Should You Buy Medtronic Stock Around $90?
- Medtronic's revenue (Q1) of $7.4 billion was down 8%, while its EPS of $1.13 was down 17% y-o-y, compared to our estimates of $7.3 billion and $1.15, respectively.
- 08/26/2022
|
Analyst: Medtronic Stock's Future Growth is Doubtful
- Raymond James is losing confidence in the growth potential for Medtronic PLC (NYSE:MDT), according to a bear note the firm issued earlier today.
- 08/24/2022
|
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever
- These companies won't give you headaches.
- 08/24/2022
|
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
- Medtronic (MDT) posts better-than-expected results for the fiscal first quarter and maintains earnings and sales outlook for the full year.
- 08/23/2022
|
Medtronic plc (MDT) CEO Geoff Martha on Q1 2023 Results - Earnings Call Transcript
- Medtronic plc (NYSE:MDT ) Q1 2023 Results Conference Call August 23, 2022 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head, IR Geoff Martha - Chairman and CEO Karen Parkhill - CFO Sean Salmon - EVP and President, Cardiovascular Portfolio Bob White - EVP and President, Medical Surgical Portfolio Brett Wall - EVP and President, Neuroscience Portfolio Que Dallara - EVP and President, Diabetes Operating Unit Conference Call Participants Robbie Marcus - JPMorgan Vijay Kumar - Evercore ISI Travis Steed - Bank of America Global Research Cecilia Furlong - Morgan Stanley Larry Biegelsen - Wells Fargo Securities Joanne Wuensch - Citi Jayson Bedford - Raymond James Steve Lichtman - Oppenheimer & Co. Rich Newitter - Truist Securities Rick Wise - Stifel, Nicolaus & Company Ryan Weispfenning Good morning, and welcome to Medtronic's Fiscal Year 2023 First Quarter Earnings Broadcast. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
- 08/23/2022
|
Medtronic (MDT) Q1 Earnings and Revenues Surpass Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 0.89% and 2.34%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/23/2022
|
Medtronic Narrowly Beats Earnings Forecasts, Though Declines Continue
- Medtronic beat fiscal first-quarter expectations Tuesday, but sales and adjusted profit both declined. MDT stock was flat, in response.
- 08/23/2022
|
Medtronic earnings rise 22%, while revenue and adjusted profit beat estimates
- Medtronic Plc MDT, -2.01% said Tuesday its first-quarter net income increased by 22% to $929 million, or 70 cents a share, from $769 million, or 56 cents a share, in the year-ago quarter. Adjusted profit totaled $1.13 a share.
- 08/23/2022
|
Medtronic: An Undervalued Dividend Aristocrat
- Medtronic, like many medical device makers, has seen poor share price action lately. I see considerable value with shares near the bottom of their 5-year trading range.
- 08/22/2022
|
3 Quality Blue-Chip Stocks With Safe Dividends
- When it comes to investing in dividend stocks, there are many ways to find high-quality companies to buy. We like to focus on those companies that have long track records of dividend increases, as such companies have already passed the test when it comes to sustainable, growing income for shareholders.
- 08/22/2022
|
Medtronic: Bottomed In July, Buy This Rally Back Up
- Medtronic heads into its FQ1'23 earnings release on August 23. We posit MDT has likely bottomed out at its July lows after falling more than 36% from its September highs. The company is also confident of lapping much easier comps from FY23, as its supply chain situation is expected to improve further. The company also remains committed to its guidance.
- 08/22/2022
|
The 7 Best Bargain Stocks to Buy Now
- Given the unique circumstances associated with the Covid-19 pandemic, investors may want to take a step back from the crowd and consider the best bargain stocks to buy now. To be sure, several equity-based opportunities printed much red ink this year, presenting cheap prospects to consider.
- 08/22/2022
|
What To Expect From Medtronic's Q1?
- High inflation, the Covid-19-induced lockdowns in China, and supply chain disruptions likely weighed on the company's overall performance.
- 08/22/2022
|
Earnings Previews: JD.com, KE Holdings, Macy's, Medtronic
- The three major U.S. equity indexes closed higher on Thursday. The Dow Jones industrials added 0.06%, while the S&P 500 rose by 0.23%, and the Nasdaq closed up 0.21%.
- 08/19/2022
|
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
- Going by the industry-wide macro trend, we expect Medtronic (MDT) to once again report an adverse effect related to the global supply chain issues in fiscal Q1.
- 08/18/2022
|
Buy 6 August 40+ Year Dividend Growers
- DRIP Investing lists over 800 stocks that have annually increased dividends for 5 years or more. As of July, 62 stocks have hiked their dividends annually 40 years or more. Parsed from 129 Champions, utilizing YCharts data as of 8/15/22, those 62 select-dividend stocks ranged 0.87% to 5.95% in annual yield, and ranged -17.74% to 31.143% in analyst 1-yr price.
- 08/17/2022
|
Stock Market Sell-Off: How I'm Continuing to Make Passive Income
- I love my dividend stocks, and since I'm still not retired, market downturns let me buy more of what I own as I reinvest my dividends.
- 08/14/2022
|
Undervalued Medtronic Sports Solid Dividend Growth Prospects
- Medtronic is a global leader in medical technology. The company functions in four operating segments: Cardiac & Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. It is a stellar free cash flow generator with a strong Dividend Cushion ratio, though the outlook for the company's margin expansion opportunities has been diminished somewhat.
- 08/12/2022
|
Medtronic to announce financial results for its first quarter of fiscal year 2023
- DUBLIN , Aug. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its first quarter of fiscal year 2023 on Tuesday, August 23, 2022. A news release will be issued at approximately 5:45 a.m.
- 08/10/2022
|
Are Medtronic And Intuitive Surgical Poised For Big Growth?
- Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
- 08/09/2022
|
Buy 4 S&P 500 August Dog Days Dividend Aristocrats
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 65 Aristocrats screened as of August 4, 2022 represented all eleven Morningstar Sectors. Broker estimated top-ten net gains ranged 14.54%-40.69% topped by XOM & SWK.
- 08/08/2022
|
7 Blue-Chip Stocks to Buy Before the Bull Market Returns
- The bear market is firmly in place so long as the economy worsens. The incoming recession is a necessary headwind.
- 07/29/2022
|
Medtronic Stock Keeps Ticking Forward
- Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year.
- 07/27/2022
|
It'll take a few years for Medtronic to receive U.S.-made chips from the CHIPS Act, says CEO
- Geoff Martha, Medtronic chairman and CEO, joins 'Closing Bell' to discuss what's at stake for Medtronic in the CHIPS Act, where the chips Medtronic uses come from and how quickly the company would be impacted by the passage of the CHIPS Act.
- 07/26/2022
|
Investors May Want to Follow Progress of VC-Backed Medtechs
- At least one group is bullish about the outlook for the medtech industry: venture capitalists.
- 07/25/2022
|
How Medtronic Is Strengthening Its Robotics Portfolio
- Advanced technology in spinal surgery is helping the company build its case in a fast-growing market.
- 07/24/2022
|
Medtronic: Flashing Robust Buy Signals, Buy Hand Over Fist (Technical Analysis)
- Medtronic stock has been battered over the past year over several headwinds, including considerable supply chain challenges. However, we believe it has formed a significant long-term bottom. MDT has a robust long-term uptrend. It has rewarded long-term investors who bought on significant dips over time. Our analysis is flashing those robust buy signals.
- 07/22/2022
|
Don't Buy Medtronic For Its Diabetes Franchise
- Medtronic is the world's largest pure-play medical device company. It is a dividend aristocrat, conservatively financed and well diversified. It seems like a great long-term investment. The company piqued my interest because of its diabetes portfolio, however, I found that managerial missteps left Medtronic in a weak position compared to Abbott and Boston Scientific.
- 07/22/2022
|
These 3 Stocks Are Timely Buys Amid the Market Sell-off
- With the market off its peak, these three stocks are worth a close look while they are on the sale rack.
- 07/21/2022
|
11 High-Yield Dividend Aristocrats Perfect For The Coming Recession
- Fears of a recession are mounting, with BAC and Deutsche Bank now forecasting a mild downturn in 2023. A recession could even begin by December 2022. Even without a recession Morgan Stanley is confident stocks have 10% lower to fall. If we get a mild recession, stocks could fall 25% more and in a severe recession, 35%.
- 07/20/2022
|
At Its 52-Week Low, Medtronic Is A Buy
- Shares of Medtronic have reached their 52-week low this week. Medtronic's dividend yield is almost 3%, making it an attractive dividend growth prospect.
- 07/17/2022
|
7 Stocks Trading at a 52-Week Low Worth Buying Now
- Looking for a bargain? Bottom-fishing investors may want to check out these stocks trading at a 52-week lows, or within 5% of that floor.
- 07/14/2022
|
3 Stocks the World's Best Investors Are Buying Now
- Following these legendary investors could help your portfolio weather any storm.
- 07/12/2022
|
2 Safe Stocks That Can Survive Any Downturn
- These stocks are worth buying whether or not a recession is coming.
- 07/02/2022
|
Is This Beaten-Down Dividend Aristocrat a Buy?
- This leading medical device company just announced that it would be sending more cash to its shareholders each quarter.
- 07/02/2022
|
3 Dividend Stocks With Elevated Yields I'd Buy Right Now Without Hesitation
- I don't buy stocks very often, but I recently jumped in to buy this trio paying their highest yields ever. Here's why.
- 06/30/2022
|
My Best Dividend Aristocrats For July 2022
- NOBL gains 0.31% in May but is down 5.99% in 2022 after the first 5 months. Thus far, through June 28th, the dividend aristocrat ETF is down 6.22%, inclusive of its dividend payment this month.
- 06/29/2022
|
6 Jeff Auxier Stocks Approaching 52-Week Lows
- As we approach the halfway point of 2022, several of Jeff Auxier (Trades, Portfolio)'s stocks are trading close to their 52-week lows.
- 06/28/2022
|
7 Dividend Stocks to Buy and Hold Forever
- Despite rising interest rates, investors continue to like dividend-paying stocks. Here are seven dividend stocks to buy and hold forever.
- 06/27/2022
|
3 Stocks That Could Create Lasting Generational Wealth
- If you are looking for stocks that you can own for your entire life and leave to your kids, this trio should be on your list.
- 06/22/2022
|
Medtronic Forecasted to Retain Top Medtech Market Share
- Movin' on up. That's the expectation for Medtronic PLC ( MDT , Financial), which is forecasted to boost its share of a worldwide medtech market that is pegged to grow 5% a year, reaching three-quarters of a trillion dollars by 2028.
- 06/21/2022
|
The Best Stocks to Invest $1,000 in Right Now
- It's hard to hit the buy button in a bear market, but these two passive-income machines are worth the emotional pressure.
- 06/20/2022
|
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
- This bear market is the 2nd worst start to the year in US stock market history. And cracks are beginning to form in credit markets that could potentially send stocks falling even lower in the coming months.
- 06/18/2022
|
5 Stocks the World's Top Investors Are Loading Up on Right Now
- It's not smart to just copy what big investors are buying, but it can be profitable to look at their purchases for promising investment ideas.
- 06/17/2022
|
Medtronic plc (MDT) CEO Geoff Martha on Goldman Sachs Global Healthcare Conference (Transcript)
- Medtronic plc (NYSE:MDT ) Goldman Sachs Global Healthcare Conference Call June 14, 2022 11:00 AM ET Company Participants Geoff Martha - Chairman & Chief Executive Officer Conference Call Participants Amit Hazan - Goldman Sachs Amit Hazan Okay. All right.
- 06/14/2022
|
Medtronic: Stable Growth Ahead
- Medtronic has been a stable growth company for several decades. Leadership position in cardiovascular, neuroscience, and spine markets will persist into the future.
- 06/12/2022
|
2 Top Healthcare Stocks to Buy Right Now
- These stocks are major players in different areas of the healthcare sector.
- 06/11/2022
|
Medtronic: Buy The Dip And Start The DRIP
- Medtronic has seen material share price weakness recently, bringing the shares to value territory. While headwinds remain, new product launches could offset these challenges.
- 06/11/2022
|
Will Medtronic Stock See Higher Levels?
- Medtronic's revenue of $8.1 billion was down 1% y-o-y and fell short of the $8.4 billion consensus estimate.
- 06/10/2022
|
Medtronic: A Quality Medical Device Company Facing Pressures
- Medtronic ( MDT , Financial) is one of the world's largest medical device companies. The company develops and manufactures therapeutic medical devices for chronic diseases such as pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy and surgical tools.
- 06/08/2022
|
Why Medtronic Is a Long-Term Winner
- Shares of medical device company Medtronic PLC ( MDT , Financial) have fallen 8% year to date, but are down 23% over the last year.
- 06/07/2022
|
7 Safe Retirement Stocks to Buy So You Can Sleep at Night
- Recent market volatility has exposed risks at many former high-fliers. But these safe retirement stocks are resistant to the current troubles.
- 06/07/2022
|
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions
- Look for consistency in dividend payments when choosing dividend stocks.
- 06/04/2022
|
3 Guru Favorites Trading Near 52-Week Lows
- With the S&P 500 down 13.95% year to date, value investors are wondering whether it is time to go bargain-hunting.
- 06/02/2022
|
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
- DUBLIN , May 31, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual Goldman Sachs global healthcare conference on Tuesday, June 14, 2022. Geoff Martha, Medtronic chairman and chief executive officer, will answer questions on the company beginning at 8:00 a.m.
- 05/31/2022
|
Should Medtronic Make the Cut For Your Recovery Watchlist?
- Medtronic stock is down 6% since the medical device company reported earnings on May 26, 2022. In this article, we'll take a look at MDT stock so you can decide if it deserves a place on your recovery watchlist
- 05/31/2022
|
Should I buy Medtronic shares in June 2022?
- Medtronic plc (NYSE: MDT) shares have weakened more than 4% after the company reported weaker than expected fourth-quarter results. The company missed estimates with Q4 EPS and Q4 revenue, and the research company Needham downgraded Medtronic from buy to hold.
- 05/30/2022
|
2 Blue Chip Stocks That Missed Thursday's Big Rally
- Some companies failed to join in on gains of as much as 3% for major indexes.
- 05/26/2022
|
Medtronic plc (MDT) CEO Geoff Martha on Q4 2022 Results - Earnings Call Transcript
- Medtronic plc (NYSE:MDT ) Q4 2022 Earnings Conference Call May 26, 2022 8:00 AM ET Company Participants Ryan Weispfenning - Head of IR Geoff Martha - CEO Karen Parkhill - CFO Brad Lerman - SVP, General Counsel, Corporate Secretary Bob White - EVP and President of the Medical Surgical Portfolio Sean Salmon - EVP and President of the Cardiovascular Portfolio and former Head of the Diabetes Operating Unit Conference Call Participants Vijay Kumar - Evercore ISI Travis Steed - Bank of America Merrill Lynch Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Josh Jennings - Cowen Joanne Wuensch - Citi Pito Chickering - Deutsche Bank Ryan Weispfenning Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
- 05/26/2022
|
Medtronic's (MDT) Q4 Earnings and Revenues Lag Estimates
- On a positive note, Medtronic (MDT) registers organic growth in the Cardiovascular and Neuroscience segments.
- 05/26/2022
|
Medtronic, DaVita To Jointly Form Kidney Health-Focused Company
- Medtronic plc (NYSE: MDT) and DaVita Inc (NYSE: DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products.
- 05/26/2022
|
Medtronic (MDT) Q4 Earnings and Revenues Lag Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of -2.56% and 3.85%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/26/2022
|
Why Are Medtronic Shares Plunging Today?
- Medtronic Plc's (NYSE: MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%.
- 05/26/2022
|
Medtronic stock falls after earnings miss and downbeat outlook, but dividend boosted
- Shares of Medtronic PLC PLC, -0.31% dropped 3.2% in premarket trading Thursday, after the medical technology company missed fiscal fourth-quarter profit and sales expectations and provided a downbeat earnings outlook, citing pressure from inflation, supply chain constraints and COVID-19 controls in China. Net income rose to $1.49 billion, or $1.10 a share, from $1.36 billion, or $1.00 a share, in the year-ago period.
- 05/26/2022
|
Will Medtronic Stock See Higher Levels Following Its Q4 Results?
- Medtronic (NYSE: MDT) is scheduled to report its fiscal fourth-quarter results on Thursday, May 26.
- 05/25/2022
|
Best 3 defensive stocks to buy as the S&P nears a bear market
- American stocks are not doing well. On Friday, the S&P 500 moved close to a bear market and analysts believe that this will happen in the near term.
- 05/24/2022
|
5 Analyst Favorite Blue Chip Stocks to Buy With Dividend Hikes Likely This Week
- After years of a low interest rate environment, which now is trending higher, many investors have turned to equities, not only for the growth potential but also for the solid and dependable dividends that help to provide an income stream.
- 05/23/2022
|
2 Safe Stocks to Buy in a Bear Market
- These two leading companies have survived market downturns before.
- 05/21/2022
|
Medtronic (MDT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/19/2022
|
Medtronic to announce financial results for its fourth quarter and full fiscal year 2022
- DUBLIN , May 19, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2022 on Thursday, May 26, 2022. A news release will be issued at approximately 5:45 a.m.
- 05/19/2022
|
Here's What Makes Medtronic Stock A Better Pick Over This Pharmaceuticals Company
- Looking at stock returns, Eli Lilly's 55% growth is much better than Medtronic's -16% change over the last twelve months.
- 05/19/2022
|
Medtronic's (MDT) Onyx Frontier DES Receives FDA Approval
- Medtronic's (MDT) Onyx Frontier DES is utilized to treat patients with CAD.
- 05/16/2022
|
Here's Why Investors Should Retain Medtronic (MDT) Stock
- Investors are optimistic about Medtronic's (MDT) rising market share gains and ongoing business recovery.
- 05/13/2022
|
Medtronic (MDT) Global Business Gains Ground, Volume Woes Stay
- Since the start of fiscal 2022, Medtronic (MDT) has been witnessing a strong recovery and displayed a return to growth.
- 05/06/2022
|
Is Medtronic a Buy?
- The healthcare stock has been outperforming the market.
- 04/28/2022
|
Why Surgical Innovation Should Boost Medtronic's Growth
- Its entry into the booming robotic surgery space may unlock additional revenue.
- 04/28/2022
|
Medtronic: Holding The Stock A Solid Decision Despite Diabetes Woes
- Medtronic is the world's largest medical device company - market cap is ~$145bn, and revenues will likely be >$3.3bn in FY22. The company also pays a dividend yielding 2.3% at the present time and its share price is ~20% discounted to recent highs.
- 04/25/2022
|
Highly Valued Abbot Laboratories Could Move Lower
- Abbott Laboratories (NYSE: ABT) is not in danger of losing its business but we have some concerns its share price could fall. Not only is it a highly-valued stock compared to peers but its current revenue and earnings are based largely on COVID-19.
- 04/20/2022
|
This Medical Devices Company Is Likely To Offer Better Returns Over Medtronic Stock
- We think that Stryker Corp. stock currently is a better pick compared to its industry peer, Medtronic stock, despite it being the more expensive of the two, trading at 5.7x trailing revenues compared to 4.7x for Medtronic. Even if we were to look at the P/EBIT ratio, SYK stock appears to be more.
- 04/11/2022
|
Medtronic (MDT) Innovations Aid Global Growth, Volume Woe Stays
- In the neuroscience portfolio, Medtronic (/MDT) is gaining market share in Cranial and Spinal technologies.
- 04/05/2022
|
Medtronic (MDT) Reports Positive Findings Backing RDN System
- Medtronic's (MDT) Symplicity Spyral RDN system demonstrated durable and clinically significant reductions in blood pressure at the SPYRAL HTN-ON MED trial.
- 04/05/2022
|
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
- With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. The post 7 Medical Device Stocks to Buy as Covid-19 Fears Fade appeared first on InvestorPlace.
- 04/05/2022
|
3 Best Telemedicine Stocks for Investors
- What's a break in the clouds due to the pandemic? Maybe the ease of meeting with your doctor.
- 04/02/2022
|
Why It's Time to Buy This 1 Dividend Aristocrat
- There are several reasons to consider buying Medtronic aside from its market-topping dividend.
- 03/30/2022
|
Medtronic (MDT) Completes 1st Patient Implant of Implantable TNM
- Medtronic's (MDT) TITAN 2 study will examine the safety and efficacy of the implantable TNM device in people with OAB.
- 03/28/2022
|
Why Medtronic Is Attractive While It's Still Down
- Medtronic is a shareholder-friendly company with a long history of dividend raises.
- 03/28/2022
|
4 S&P 500 Aristocrats Are April's Top Dividend Dogs
- "Dividend Aristocrats. in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing.
- 03/25/2022
|
3 Stocks to Focus on With MedTech M&A Scaling New Heights
- MedTech stocks like Owens & Minor (OMI), Thermo Fisher (TMO) and Medtronic (MDT) are prudent investment choices given their long-term growth potential with recent M&A deals.
- 03/24/2022
|
Is Medtronic (MDT) a Suitable Value Investor Stock Now?
- Let's see if Medtronic (MDT) stock is a good choice for value-oriented investors right now from multiple angles.
- 03/23/2022
|
Healthy Dividends: Bullish On Medtronic's Dividend Aristocrat Status
- Medtronic is one of the leading medical device companies in the world. The company's comprehensive product portfolio has fueled steady revenue and EBITDA growth.
- 03/22/2022
|
Medtronic (MDT) Boosts Surgical Robotics Wing With New Deal
- According to Medtronic (MDT), Touch Surgery Enterprise is the first AI-powered platform of its kind for the operating room (OR). It is compatible with Medtronic's Hugo robotic-assisted surgery (RAS) system.
- 03/18/2022
|
Dividend Aristocrats For "Prudent Speculators"
- We find significant appeal in dividend stocks as relatively low interest rates for developed markets around the globe plague income-oriented investors, while sustained inflation threatens to erode our purchasing power, asserts Jason Clark, editor at The Prudent Speculator.
- 03/18/2022
|
Better Buy: Intuitive Surgical vs. Medtronic
- Both are two exceptional growth stocks -- but which is the better choice for investors now?
- 03/17/2022
|
Here's Why You Should Hold on to Medtronic (MDT) Stock For Now
- Investors are optimistic about Medtronic's (MDT) better-than-expected earnings and strong market share gains.
- 03/15/2022
|
Upcoming Ex-Dividend Dates: March 16-31, 2022
- We provide a summary of upcoming ex-dividend dates in a quick reference table.
- 03/15/2022
|
Medtronic (MDT) Inks Deal to Offer Touch Surgery Enterprise
- Medtronic's (MDT) Touch Surgery Enterprise gives surgical teams a powerful new tool to enhance patient care by simplifying the process to capture and analyze surgical videos.
- 03/10/2022
|
Biden to meet with CEOs of Micron, HP, Medtronic in push for spending on chip manufacturing
- President Joe Biden is slated to meet Wednesday afternoon with executives from big U.S. tech companies, as he continues his push to secure billions of dollars in taxpayer money for semiconductor manufacturing.
- 03/09/2022
|
2 Cheap Dividend Stocks Near Their 52-Week Lows
- Medtronic and Anheuser-Busch will be good investments to hold as economic activity returns to normal.
- 03/09/2022
|
Medtronic plc (MDT) Management Presents at 42nd Annual Cowen Health Care Conference Call Transcript
- Medtronic plc (MDT) Management Presents at 42nd Annual Cowen Health Care Conference Call Transcript
- 03/07/2022
|
Medtronic (MDT) to Gain From New Reimbursement Program for CGM
- Ontario government's new comprehensive reimbursement program for CGM will enhance access to Medtronic's (MDT) integrated CGM technology for type 1 diabetes patients.
- 03/07/2022
|
4 Stocks in Spotlight With AI Making Inroads in MedTech
- MedTech stocks like Medtronic (MDT), Stryker (SYK), Allscripts Healthcare Solutions (MDRX) and Syneos Health (SYNH) are evolving rapidly in the field of AI-driven technologies.
- 03/07/2022
|
IHI: A Standout Performer With Equally Strong Future Growth Prospects
- IHI: A Standout Performer With Equally Strong Future Growth Prospects
- 03/05/2022
|
Medtronic's (MDT) NuVent Balloon to Strengthen ENT Business
- Medtronic's (MDT) Nuvent balloons are one-time use devices featuring a flexible balloon section that allows customized placement based on patient anatomy.
- 03/01/2022
|
My Best Dividend Aristocrats For March 2022
- NOBL starts the year on a sour note losing 4.08% in January.
- 02/24/2022
|
Best Stocks To Invest In Right Now? 5 Health Care Stocks In Focus
- Can these top health care stocks be the way to go amidst all the uncertainty in the stock market now?
- 02/23/2022
|
Medtronic: Market Share To Remain Stable
- We believe Medtronic historically lost market share as the company does not operate in the high-growth IVD market.
- 02/22/2022
|
Medtronic plc (MDT) CEO Geoff Martha on Q3 2022 Results - Earnings Call Transcript
- Medtronic plc (MDT) CEO Geoff Martha on Q3 2022 Results - Earnings Call Transcript
- 02/22/2022
|
Medtronic's (MDT) Q3 Earnings Beat, Revenues Lag Estimates
- Medtronic (MDT) registers organic growth in the Cardiovascular, Neuroscience and Diabetes segments in Q3.
- 02/22/2022
|
Medtronic (MDT) Q3 Earnings Top Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 0.74% and 1.60%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/22/2022
|
Medtronic's (MDT) Cryoablation Catheters Get FDA Expanded Nod
- Medtronic's (MDT) Cardiac Cryoablation is the only ablation catheter approved to treat pediatric AVNRT.
- 02/22/2022
|
Medtronic outlook matches estimates, but Q3 results fall short
- Medtronic MDT, -1.10% said Tuesday it expects procedure volumes in most of its markets to be back to pre-COVID level by the end of the fourth quarter. The medical device maker said its third-quarter net income rose 17% to $1.48 billion, or $1.10 a share, from $1.27 billion, or 94 cents a share, in the year-ago quarter.
- 02/22/2022
|
3 Stocks to Buy as Investors Double Down on Digital Health
- Three digital health stocks are moving the needle for the fast-growing telehealth business. Let's have a look at TDOC, MDT and BFLY.
- 02/22/2022
|
Riding The Stock Waves: Update On The Medical Devices Sector
- Riding The Stock Waves: Update On The Medical Devices Sector
- 02/21/2022
|
Medtronic's heart device unit may ease earnings pressure from Omicron
- Steady sales of pacemakers and heart stents may have likely helped Medtronic Plc offset weak demand for its other medical devices, in a quarter that saw an Omicron-led surge in COVID-19 cases and staffing crisis at most U.S. hospitals.
- 02/18/2022
|
2 Crushed Dividend Champions Worth Saving
- 2 Crushed Dividend Champions Worth Saving
- 02/18/2022
|
What To Expect From Medtronic's Q3?
- Medtronic stock is scheduled to report its fiscal third-quarter results on Tuesday, Feb 22. We expect Medtronic to post revenues and earnings above the consensus estimates.
- 02/18/2022
|
Medtronic (MDT) Gains But Lags Market: What You Should Know
- In the latest trading session, Medtronic (MDT) closed at $103.91, marking a +1.56% move from the previous day.
- 02/15/2022
|
2 Top Healthcare Stocks to Buy Right Now
- Medtronic and AstraZeneca are trading at appealing valuations for the long run.
- 02/12/2022
|
Medtronic Is That 'Boring' And Reliable Stock Your Portfolio Needs
- Medtronic Is That 'Boring' And Reliable Stock Your Portfolio Needs
- 02/12/2022
|
Stifel healthcare analyst Rick Wise explains why he remains bullish on Medtronic
- Rick Wise, Stifel healthcare analyst, joins 'The Exchange' to discuss his analysis on Medtronic.
- 02/09/2022
|
Medtronic to announce financial results for its third quarter of fiscal year 2022
- DUBLIN, Feb. 8, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2022 on Tuesday, February 22, 2022. A news release will be issued at approximately 5:45 a.m.
- 02/08/2022
|
Medtronic Issues Voluntary Recall For TurboHawk Plus Directional Atherectomy System
- Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional Atherectomy System. Recently, Medtronic issued a recall for the HawkOne Atherectomy system due to tip damage risk, used during procedures intended to remove a blockage from peripheral arteries and improve blood flow.
- 02/07/2022
|
Medtronic (MDT) Reports First Procedure in Europe With Hugo RAS
- Medtronic's (MDT) Hugo RAS system was utilized to perform robotic prostatectomy at OLV Hospital in Aalst, Belgium.
- 02/07/2022
|
Medtronic (MDT) Gains But Lags Market: What You Should Know
- Medtronic (MDT) closed the most recent trading day at $103.49, moving +0.35% from the previous trading session.
- 01/31/2022
|
10 Dividend Growth Stocks For January 2022
- I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To pick candidates, I use different screens every month that focus on various aspects of dividend growth investing such as valuation, yield, and growth.
- 01/30/2022
|
Eaton Vance Worldwide Health Sciences Fund Dumps Medtronic, Boosts Abbott Labs
- The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the fourth quarter of 2021 earlier this week.
- 01/28/2022
|
Opportunity In The Early 2022 Sell-Off
- The stock market sell-off in early 2022 has led to selective opportunities in quality dividend growth stocks. Three stocks are outlined that have faced near-term challenges but have long-term growth prospects.
- 01/26/2022
|
Medtronic (MDT) Undertakes Investment to Advance STEM Education
- The Medtronic Foundation, solely funded by Medtronic plc (MDT), entered into 13 new partnerships to bridge the inequity in STEM education among underrepresented and underserved communities.
- 01/24/2022
|
Medtronic Recalls HawkOne Atherectomy System Due To Tip Damage Risk
- Medtronic Inc (NYSE: MDT) is recalling HawkOne Directional Atherectomy System due to the risk of the guidewire within the catheter moving downward or prolapsing when force is applied during use. FDA has identified this as a Class I recall, the most serious type of recall.
- 01/21/2022
|
7 Comeback Stocks Set to Make a Stellar Return in 2022
- These robust comeback stocks have come under pressure and could generate significant wealth over time. Here are seven possible picks.
- 01/18/2022
|
7 Dividend Growth Stocks For 2022
- Companies with growing dividends can give you a buffer that prevents you from selling stocks in bad times.
- 01/18/2022
|
Medtronic's (MDT) DTM SCS Endurance Therapy Study Data Positive
- Medtronic's (MDT) DTM SCS endurance therapy offers meaningful clinical benefits by reducing pain, improving quality of life and offering meaningful device longevity for patients.
- 01/17/2022
|
Medtronic's Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief
- Medtronic plc (NYSE: MDT) announced three-month results from an on-label, prospective, multi-center study of Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) pain therapy. The data showed meaningful pain relief using DTM SCS endurance therapy for chronic overall, back, or leg pain.
- 01/14/2022
|
1 Green Flag for Medtronic in 2022, and 1 Red Flag
- When the stock price follows the action of the FDA, investors hope the news is good.
- 01/14/2022
|
Medtronic (MDT) Gets MHLW Approval for Micra AV Sale in Japan
- The Micra AV approval is likely to boost Medtronic's (MDT) Cardiac Rhythm Management business while delivering the benefits of leadless pacing in Japan.
- 01/12/2022
|
3 Reasons Medtronic Is A Buy
- 3 Reasons Medtronic Is A Buy
- 01/11/2022
|
Medtronic (MDT) to Buy Affera, Expand in Electrophysiology
- Affera's full suite of solutions and technologies will complement Medtronic's (MDT) existing atrial and ventricular arrhythmia disease management portfolio.
- 01/11/2022
|
Medtronic: Short-Term Pain, Long-Term Gain
- In the short term, Medtronic is likely to miss its revised forecast; however, company performance is likely to exceed historical values long term, and the stock is a Hold.
- 01/11/2022
|
Medtronic's Leadless Micra AV Pacing System Scores Approval In Japan
- Japan's Ministry of Health, Labor, and Welfare has approved Medtronic plc's (NYSE: MDT) Micra AV Transcatheter Pacing System (TPS). The Company will launch the product this month.
- 01/11/2022
|
Medtronic plc (MDT) CEO Geoff Martha at 40th Annual J.P. Morgan Healthcare Conference (Transcript)
- Medtronic plc (MDT) CEO Geoff Martha at 40th Annual J.P. Morgan Healthcare Conference (Transcript)
- 01/10/2022
|
Medtronic's Evolut Pro TAVR Approved In China, Acquires Cardiac Arrhythmia Treatment Developer Affera
- Medtronic Plc's (NYSE: MDT) CoreValve Evolut Pro TAVR system has received National Medical Products Administration approval in China. The approval marks the first Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis at high or extreme risk for open-heart surgery.
- 01/10/2022
|
3 Unstoppable Growth Stocks to Buy in 2022 and Beyond
- Diversification is key in investing!
- 01/09/2022
|
What's Happening With Medtronic Stock?
- The stock price of Medtronic has seen a fall of 4% over the last month, underperforming the broader indices, with the S&P 500 rising 2% over the same period. This underperformance can largely be attributed to the U.S. FDA's warning letter to Medtronic for its Northridge facility in California.
- 01/07/2022
|
2 Stocks That Could Set You Up for Life
- Both of these stocks have lagged the market in the past year, but don't let that scare you away.
- 01/05/2022
|
Medtronic (MDT) Gains As Market Dips: What You Should Know
- Medtronic (MDT) closed the most recent trading day at $106.39, moving +0.27% from the previous trading session.
- 01/04/2022
|
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
- Medtronic (MDT) closed the most recent trading day at $103.95, moving -0.55% from the previous trading session.
- 12/29/2021
|
Should You Buy This Beaten-Down Blue-Chip Stock?
- Medtronic's stock has significantly lagged the S&P 500 this year for a variety of reasons.
- 12/28/2021
|
IMF December Buys: The 12 Stocks Added To My Fund
- I added 12 stocks to the portfolio this month.
- 12/27/2021
|
7 Stock Bargains Worth a Look After the Most Recent Pullback
- Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors. The post 7 Stock Bargains Worth a Look After the Most Recent Pullback appeared first on InvestorPlace.
- 12/27/2021
|
Top Dividend Aristocrats Tag 4 To Buy For January
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger. The 65 Aristocrats screened as of December 23, 2021, represented all eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 14.59%-32.89% topped by MDT and LEG.
- 12/26/2021
|
Medtronic Is The Prescription For Easing Your Portfolio Fears
- MDT is an Irish company for tax purposes (15% dividend tax withholding if you don't file with your broker). MDT has fallen 25% in a matter of weeks. MDT might be just what your diversified and prudently risk-managed portfolio is looking for right now.
- 12/24/2021
|
Medtronic (MDT) to Gain From Expanded Medicare Coverage for CGM
- CMS' expanded Medicare coverage includes continuous glucose monitors that can be integrated with Medtronic's (MDT) insulin pumps.
- 12/23/2021
|
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 12/23/2021
|
4 Internet of Medical Things (IoMT) Stocks to Buy for 2022
- Stocks like Boston Scientific (BSX), Medtronic (MDT), DexCom (DXCM) and Syneos Health (SYNH) are evolving rapidly in the field of IoMT.
- 12/23/2021
|
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now
- Investors are optimistic about Medtronic's (MDT) better-than-expected earnings in the fiscal second quarter and robust performance of the Diabetes arm.
- 12/22/2021
|
Medtronic's (MDT) INVOS System Gets FDA 510 (k) Clearance
- Medtronic's (MDT) INVOS 7100 system can deliver key signals to pediatric clinicians for making time-sensitive decisions
- 12/20/2021
|
3 Healthcare Stocks That Could Help Make You a Fortune
- These three stocks are leaders in their respective fields within the vast healthcare industry.
- 12/20/2021
|
Why Medtronic Sank by 6% Today
- The company revealed it had received a warning letter from the FDA about one of its California facilities.
- 12/15/2021
|
Medtronic Shares Fall After FDA Warning Letter To Its Diabetes Business
- Medtronic Plc (NYSE: MDT) received a warning letter from the FDA highlighting certain concerns related to medical device quality requirements at the Company's diabetes business headquarters. The Company said that the letter focused on inadequacies in risk assessment, complaint handling, and device recalls at Medtronic's facility in Northridge, California.
- 12/15/2021
|
Medtronic warned by FDA about manufacturing facility for insulin pumps
- Shares of Medtronic MDT, -1.04% gained 0.3% in premarket trading on Wednesday after the company said it received a warning letter from the Food and Drug Administration following an inspection at a factory that makes its MiniMed 600 series insulin infusion pump and a remote-controller device for MiniMe 508 and Paradigm pumps. The company said it will make corrections to quality system requirements.
- 12/15/2021
|
Upcoming Ex-Dividend Dates: December 15-27, 2021
- We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
- 12/14/2021
|
3 Healthcare Stocks for Long-Term Dividend Growth
- When selecting dividend stocks to buy, investors are faced with a variety of choices. However, we like healthcare stocks for many reasons, particularly given inherent recession resilience and long-term earnings growth.
- 12/10/2021
|
My Dividend Growth Portfolio November Update: 27 Holdings, 7 Buys, 4 Sells
- The portfolio generated $1,067 in dividends during the month, an improvement over August. YTD, I've received $12,700. I closed out my positions in REM, DIS, MLPA, and SPYD.
- 12/09/2021
|
Here's Why Medtronic Stock Dipped 11% in November
- Medical device companies are struggling with difficult economic conditions and a COVID-19 resurgence.
- 12/08/2021
|
Medtronic (MDT) Gets Health Canada License for Hugo RAS System
- The receipt of the Health Canada license for Medtronic's (MDT) Hugo RAS System is likely to enhance accessibility to robotic-assisted surgery in Canada.
- 12/08/2021
|
Canada Approves Medtronic's Hugo Robotic-Assisted Surgery Platform
- Medtronic plc (NYSE: MDT) has received a Health Canada license to use the Hugo robotic-assisted surgery system. According to a news release, those procedures make up about half of all robotic surgery procedures performed today.
- 12/07/2021
|
Medtronic CEO on partnering with Elon Musk at the height of COVID-19
- Medtronic CEO Geoff Martha joins 'Influencers with Andy Serwer' to discuss his experience working with Elon Musk to build ventilators at the height of the pandemic. Don't Miss: Valley of Hype: The Culture That Built Elizabeth Holmes WATCH HERE: https://youtu.be/Sb179GLPNYE Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 12/04/2021
|
'Inflationary costs are real': Medtronic CEO
- Medtronic CEO Geoff Martha joins 'Influencers with Andy Serwer' to discuss inflation and its impact on the U.S. economy. Don't Miss: Valley of Hype: The Culture That Built Elizabeth Holmes WATCH HERE: https://youtu.be/Sb179GLPNYE Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 12/02/2021
|
Medtronic (MDT) Gets Health Canada License for GI Genius Module
- Medtronic Canada ULC, a subsidiary of Medtronic (MDT), receives Health Canada license for the GI Genius module that aids in colorectal cancer screening.
- 12/01/2021
|
Cloud DX partners with Medtronic Canada ULC to provide virtual healthcare to patients across Canada
- Cloud DX (TSX-V:CDX, OTCQB:CDXFF) said that it has been selected by Medtronic Canada ULC—a subsidiary of Medtronic PLC (NYSE:MDT)—for providing virtual healthcare to patients across Canada. The Brampton, Ontario-based company said that the partnership advances Medtronic's commitment to improving patient outcomes and lowering overall costs along the care continuum.
- 12/01/2021
|
5 Health Care Dividend Aristocrats to Buy for 2022 as Yields Plunge Once Again
- Just when you thought it was starting to look safer, yet another COVID-19 variant comes around.
- 12/01/2021
|
What's Next For Medtronic Stock After A Mixed Q2?
- Medtronic recently reported its Q2 FY22 results, which were mixed with revenue slightly below, and earnings above our estimates. The company reported sales of around $7.8 billion (up 3% y-o-y), compared to our estimate of $8.0 billion.
- 11/29/2021
|
5 Dividend Aristocrat Bargains Near 52-week Lows
- As people kick off Black Friday shopping across the U.S., five dividend aristocrat stocks with high guru ownership that are trading near 52-week lows are Cardinal Health Inc. ( CAH , Financial), AT&T Inc. ( T , Financial), Medtronic PLC ( MDT , Financial), International Business Machines Corp ( IBM , Financial) and Leggett & Platt Inc. ( LEG , Financial), according to the All-in-one Screener, a Premium feature of GuruFocus.
- 11/26/2021
|
Medtronic Is Poised For A Rebound
- Medtronic has suffered from COVID's impact on elective surgeries and staff shortages. The Wall Street consensus outlook is for a major rebound over the next 12 months.
- 11/24/2021
|
Medtronic plc (MDT) CEO Geoffrey Martha on Q2 2022 Results - Earnings Call Transcript
- Medtronic plc (MDT) CEO Geoffrey Martha on Q2 2022 Results - Earnings Call Transcript
- 11/23/2021
|
7 Top Tech Stocks to Buy Despite Recent Tapering Concerns
- Here are seven top tech stocks worth considering for investors taking a truly long-term view of the growth sector relative to the market. The post 7 Top Tech Stocks to Buy Despite Recent Tapering Concerns appeared first on InvestorPlace.
- 11/23/2021
|
Medtronic's (MDT) Q2 Earnings Beat, Revenues Lag Estimates
- Medtronic (MDT) cuts revenue growth guidance for the full year on the projection of a severe pandemic impact to continue through the rest of the year.
- 11/23/2021
|
Medtronic (MDT) Q2 Earnings Surpass Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 2.33% and 1.18%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/23/2021
|
Medtronic Q2 Sales Hit By By Labor Shortage, COVID-19; Expects Lower Sales Growth Rate For FY22
- Medtronic Plc's (NYSE: MDT) Q2 FY22 sales of $7.85 billion increased 3% Y/Y as reported and 2% on an organic basis, missing the consensus of $7.96 billion. Q2 adjusted EPS of $1.32 increased 30% from $1.02 a year ago, surpassing the analyst consensus of $1.29.
- 11/23/2021
|
Medtronic Misses on Sales and Cuts Outlook—It Isn't All Bad News
- The maker of medical devices beat expectations for earnings, but slashed its outlook for sales growth for the remainder of this fiscal year.
- 11/23/2021
|
What To Expect From Medtronic's Q2?
- Medtronic stock is scheduled to report its fiscal second-quarter results on Tuesday, Nov 23. We expect Medtronic to likely post revenues and earnings largely in-line with the consensus estimates.
- 11/22/2021
|
Final Trades: Medtronic, Zoom & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 11/19/2021
|
Medtronic (MDT) Earnings Expected to Grow: Should You Buy?
- Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 11/16/2021
|
Medtronic's (MDT) PillCam SB3 System Gets 510 (k) Clearance
- Medtronic's (MDT) PillCam SB3 System provides a convenient option for a contactless procedure and helps ensure that patients can access care promptly.
- 11/16/2021
|
2 Dividend Stocks to Buy on the Dip
- These income stocks also make for good recovery plays.
- 11/11/2021
|
Medtronic (MDT) Dips More Than Broader Markets: What You Should Know
- In the latest trading session, Medtronic (MDT) closed at $122.29, marking a -0.59% move from the previous day.
- 11/09/2021
|
Medtronic to announce financial results for its second quarter of fiscal year 2022
- DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2022 on Tuesday, November 23, 2021. A news release will be issued at approximately 5:45 a.m.
- 11/09/2021
|
Medtronic's Intrepid Valve Eliminates Mitral Regurgitation At 30 Days, Study Shows
- Medtronic plc (NYSE: MDT) announced early data for its self-expanding Intrepid transcatheter mitral valve replacement (TMVR) system for mitral valve regurgitation (MR) utilizing the transfemoral access route. Data from the first 15 patients enrolled in an Early Feasibility Study of the Intrepid Transfemoral System showed 100% survival and no stroke, a median procedure time of 46 minutes, and none/trace MR in all implanted patients at 30 days.
- 11/08/2021
|
Is This Under-the-Radar Medical Devices Stock a Buy?
- The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?
- 11/03/2021
|
This Stock Is Likely To Outperform Medtronic
- We think that Intuitive Surgical stock is currently is a better pick compared to Medtronic stock, despite Intuitive Surgical being the more expensive of the two. ISRG trades at about 23x trailing revenues, compared to just 5x for Medtronic.
- 10/29/2021
|
Medtronic Warns On Percept PC Implantable Neurostimulators In Europe
- Medtronic Plc (NYSE: MDT) has issued an urgent field safety notice in Europe to warn of its Percept PC Implantable Neurostimulator (INS) issues. The notice's purpose is to inform customers of the potential failure with the Model B35200 Percept PC INS following a cardioversion procedure.
- 10/20/2021
|
Why Medtronic Fell by Almost 6% on Monday
- An important clinical trial will last longer than some expected.
- 10/18/2021
|
Medtronic CEO discusses the company's advancements on deep brain stimulation therapies
- CNBC's Jim Cramer interviewed Medtronic chairman and CEO Geoff Martha on Tuesday's episode of "Mad Money."
- 10/12/2021
|
Medtronic's Hugo Surgical Robot Wins Regulatory Nod In Europe
- Medtronic plc (NYSE: MDT) has secured European approval for its Hugo surgical robot. Hugo performed its first human procedure in June this year, a minimally invasive prostatectomy in Chile.
- 10/11/2021
|
Medtronic Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval
- Multiple Hospitals Across Europe Set to be the First to Install Hugo™ RAS System and Expand the Benefits of Robotic-Assisted Surgery to Their Patients DUBLIN, Oct. 11, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the Hugo™ robotic-assisted surgery (RAS) system, authorizing the sale of the system in Europe. CE Mark approval is for urologic and gynecologic procedures, which make up about half of all robotic procedures performed today.
- 10/11/2021
|
Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps
- The FDA has announced that Medtronic Plc (NYSE: MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic is offering to replace all MiniMed 600 series insulin pumps that have a clear retainer ring.
- 10/06/2021
|
7 Healthcare Stocks to Add to Your Portfolio
- Healthcare stocks could take over from energy stocks as top dog during this defensive cycle as yields move higher and tech stocks lose value. The post 7 Healthcare Stocks to Add to Your Portfolio appeared first on InvestorPlace.
- 10/06/2021
|
BofA Securities Is Out With Its Top 10 Stock Picks for Q4
- As incredible as it may seem, 2021 is down to the final 90 days of the year. Halloween and the other holidays will soon be upon us, and many investors and traders across Wall Street are a touch anxious over what could be a volatile quarter, especially following September, which was the worst month for stocks since 2020.
- 10/05/2021
|
Medtronic plc (MDT) Management Presents at General Manager Call Series Conference (Transcript)
- Medtronic plc (MDT) Management Presents at General Manager Call Series Conference (Transcript)
- 10/04/2021
|
SVP General Counsel And Corporate Sec Of Medtronic Trades $10M In Company Stock
- Bradley Lerman, SVP General Counsel And Corporate Sec at Medtronic (NYSE:MDT), made a large buy and sell of company shares on September 30, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Bradley Lerman exercised options to purchase 49,147 Medtronic shares at a price of $78.00 per share for a total of $3,833,466 on September 30.
- 10/04/2021
|
Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke
- DUBLIN, Oct. 4, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the publication of a study demonstrating, through the use of a Medtronic continuous rhythm monitoring device, that atrial fibrillation (AF) is directly and transiently associated with ischemic stroke. The findings were published online on September 29 in JAMA Cardiology.
- 10/04/2021
|
MedTech Thrives on M&A Frenzy: 3 Stocks to Focus on
- MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.
- 09/30/2021
|
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
- DUBLIN, Sept. 30, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics, navigation, robotics, and AI-powered data to surgeons and patients.
- 09/30/2021
|
Medtronic (MDT) Gets CE Mark for Radial Artery Access Portfolio
- Medtronic's (MDT) Rist Radial Access Catheters are indicated for the introduction of interventional devices into the peripheral, coronary and neuro vasculature.
- 09/29/2021
|
Here's Why You Should Retain Medtronic (MDT) Stock for Now
- Investors are optimistic about Medtronic (MDT) owing to new product flow and strong market share gain across the company's businesses.
- 09/28/2021
|
Medtronic (MDT) Hugo RAS System Used for 1st Clinical Procedure
- Medtronic's (MDT) Hugo RAS system is a modular, multi-quadrant platform intended for a broad range of soft-tissue procedures.
- 09/28/2021
|
Medtronic's Radial Artery Access Portfolio Approved In Europe
- Medtronic plc (NYSE: MDT) has received CE Mark approval for its radial artery access portfolio, including the Rist 079 Radial Access Guide Catheter and Rist Radial Access Selective Catheter. The Rist 079 Radial Access Guide Catheter is designed to access the neuro vasculature through the radial artery versus the transfemoral artery.
- 09/28/2021
|
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
- DUBLIN, Sept. 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE Mark approval for its radial artery access portfolio, which includes the Rist™ 079 Radial Access Guide Catheter and Rist™ Radial Access Selective Catheter.
- 09/28/2021
|
Going One Better Than The Dividend Aristocrats
- The Dividend Aristocrats have historically beat the market with less volatility. Can you improve your odds by paying attention to certain metrics such as quality or safety?
- 09/27/2021
|
First Procedure in Asia-Pacific Performed with Medtronic Hugo™ Robotic-Assisted Surgery System
- The Robotic Prostatectomy Took Place at Apollo Hospitals, Greams Road, Chennai, India DUBLIN and CHENNAI, India, Sept. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with the Hugo™ robotic-assisted surgery (RAS) system.
- 09/27/2021
|
4 Stocks to Watch as Demand for Surgical Robots Ready to Rise
- Watch out for the likes of Asensus Surgical (ASXC), Stryker (SYK), Medtronic (MDT) and Intuitive Surgical (ISRG) as demand for surgical robots is set to rise, owing to the conveniences they offer.
- 09/24/2021
|
Why Is Medtronic (MDT) Down 4.2% Since Last Earnings Report?
- Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
- 09/23/2021
|
Medtronic (MDT) Starts Pediatric Trial for Scoliosis Treatment
- Medtronic's (MDT) BRAIVE IDE study will assess the safety and efficacy of growth modulation system in correcting the spine's curve in patients with juvenile or adolescent idiopathic scoliosis.
- 09/23/2021
|
U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics Challenges
- DUBLIN, Sept. 22, 2021 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed an additional three patents in a dispute with Axonics over intellectual property for its sacral neuromodulation (SNM) device family, the InterStim™ systems.
- 09/22/2021
|
Medtronic Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis
- As First Patient Is Enrolled in the Clinical Trial of Braive™ Growth Modulation System, Study Reaffirms Medtronic's Commitment to Pediatric Spine Innovation DUBLIN, Sept. 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has enrolled its first patient and completed the first surgical procedure in its BRAIVE™ IDE study, which will evaluate the safety and effectiveness of the Braive™ growth modulation system for treatment of progressive Adolescent Idiopathic Scoliosis (AIS).
- 09/22/2021
|
Medtronic Recalls Pipeline Flex Embolization: What You Need To Know
- Medtronic Plc (NYSE: MDT) is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology stents due to a risk of the devices' wires and tubes fracturing and breaking off. The devices are used for brain aneurysms that bulge or balloon out the sides of the blood vessel (wide-neck and fusiform).
- 09/20/2021
|
Upcoming Ex-Dividend Dates: September 21-October 4, 2021
- We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
- 09/19/2021
|
Medtronic plc (MDT) Presents at Bank of America 2021 Global Healthcare Conference (Transcript)
- Medtronic plc (MDT) Presents at Bank of America 2021 Global Healthcare Conference (Transcript)
- 09/17/2021
|
Medtronic's (MDT) Pilot Plan to Address SCA Care Disparities
- Medtronic's (MDT) pilot program offers an advanced and scalable method to use real-world clinical data which enable quicker and appropriate care for patients at-risk of SCA.
- 09/15/2021
|
Medtronic plc (MDT) CEO Geoffrey Martha Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
- Medtronic plc (MDT) CEO Geoffrey Martha Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
- 09/14/2021
|
U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Patents
- DUBLIN, Sept. 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (IP) for its sacral neuromodulation device family, the InterStim™ systems.
- 09/13/2021
|
Medtronic Collaboration with Mpirik to Address Disparities in Care Associated with Sudden Cardiac Arrest
- DUBLIN, Sept. 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced a pilot program with Mpirik to address disparities in care associated with the prevention of sudden cardiac arrest (SCA), a condition in which the heart suddenly and unexpectedly stops beating.
- 09/13/2021
|
Upcoming Ex-Dividend Dates: September 14-27, 2021
- We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
- 09/13/2021
|
Medtronic's (MDT) Emprint Ablation System Study Data Positive
- Medtronic's (MDT) Emprint Ablation Catheter Kit received Breakthrough Device Designation status from the FDA in April 2021 and is currently in development.
- 09/08/2021
|
Medtronic Executives to Speak at Upcoming Investor Conferences
- DUBLIN, Sept. 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences: 2021 Virtual Wells Fargo Healthcare Conference Thursday, September 9, 2021, at 10:40 am EDT Bob White, executive vice president & president, Medical Surgical Portfolio, will answer questions about the company.
- 09/07/2021
|
Why Medtronic's Latest Quarterly Results Weren't as Good as They Might Seem
- The healthcare giant posted strong growth. But there's more to the story.
- 09/04/2021
|
7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In
- Covid-19 showed us how rapid advances in medicine and technology could create significant growth opportunities for healthcare stocks. The post 7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In appeared first on InvestorPlace.
- 09/02/2021
|
Is This Medical-Device-Making Dividend Aristocrat a Buy?
- Medtronic met analysts' consensus revenue estimate and exceeded earnings forecasts in the first quarter of its fiscal 2022.
- 09/02/2021
|
4 Blue Chip Bargains In The Biopharma Space
- 4 Blue Chip Bargains In The Biopharma Space
- 09/01/2021
|
Medtronic's (MDT) Micra TPS CED Study Outcome Favorable
- Medtronic's (MDT) Micra TPS new study data supports the relationship of a lower risk of complications with leadless pacing.
- 08/30/2021
|
Medtronic Shares Real-World Data For Micra Leadless Pacemaker
- Medtronic Plc (NYSE: MDT) touted data demonstrating reductions in reinterventions and complications with its Micra pacemaker. Medtronic's Micra Coverage with Evidence Development (CED) study showed that the Micra transcatheter pacing system (TPS) was associated with a 38% reduction in reinterventions and a 31% reduction in chronic complications at two years when compared with traditional transvenous pacemakers.
- 08/27/2021
|
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless Pacemaker
- Results Presented at ESC 2021 Show Micra TPS Compares Favorably to Traditional Pacemakers DUBLIN, Aug. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new data from the Micra Coverage with Evidence Development (CED) Study, the largest evaluation of leadless pacemakers to date, which showed the Micra™ Transcatheter Pacing System (TPS) was associated with a 38% reduction in reinterventions and a 31% reduction in chronic complications at 2-years compared with traditional transvenous (TV-VVI) pacemakers. The data were presented virtually today in a late-breaking trials presentation at the European Society of Cardiology (ESC) Congress 2021.
- 08/27/2021
|
Is There More Room For Growth In Medtronic Stock?
- Medtronic recently reported its fiscal Q1 2022 results, which were better than our estimates. The company reported revenues of $8.0 billion, slightly above ours and the consensus estimate of $7.9 billion.
- 08/26/2021
|
Wednesday Afternoon Analyst Upgrades and Downgrades: Applied Materials, Best Buy, Intuit, Medtronic, Toll Brothers and More
- The markets were higher across the board near midday, after a strong two-day rally opened the trading week.
- 08/25/2021
|
Medtronic (MDT) Receives FDA Nod for Evolut FX TAVR System
- Medtronic's (MDT) Evolut FX TAVR system offers hemodynamic and durability benefits of the Evolut platform with new product and procedure enhancements.
- 08/25/2021
|
Why Medtronic Stock Popped Today
- Medtronic "beat earnings" in Q1 -- and plans to keep on doing that all year long.
- 08/24/2021
|
Medtronic Wins FDA Approval Of Next-Gen TAVR System For Aortic Stenosis
- The FDA has approved Medtronic plc's (NYSE: MDT) Evolut FX TAVR system, a self-expanding transcatheter aortic valve replacement (TAVR) system. The Evolut FX system incorporates the same supra-annular valve design with hemodynamic performance superior to surgical aortic valve replacement (SAVR) across large-scale, randomized clinical trials.
- 08/24/2021
|
Medtronic plc (MDT) CEO Geoffrey Martha on Q2 2021 Results - Earnings Call Transcript
- Medtronic plc (MDT) CEO Geoffrey Martha on Q2 2021 Results - Earnings Call Transcript
- 08/24/2021
|
The Delta variant will be ‘short lived,' Medtronic CEO says
- Karen Parkhill, Medtronic CFO, joins Yahoo Finance Live to discuss the company's strong first-quarter financial results and break down how the company continues to advance their cardiac monitoring and AI technology post-COVID. Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 08/24/2021
|
Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Up
- Medtronic's (MDT) fiscal first-quarter results reflect a strong recovery from the impact of the COVID-19 pandemic on elective procedures that the company experienced in 2020.
- 08/24/2021
|
Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
- DUBLIN, Aug. 24, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system. Designed to enhance ease-of-use and provide greater precision and control throughout the procedure, the Evolut FX system maintains the industry-leading hemodynamic (blood flow) and durability benefits of the Evolut platform, while bringing product and procedure innovation for patients with symptomatic severe aortic stenosis.
- 08/24/2021
|
Medtronic (MDT) Beats Q1 Earnings and Revenue Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 6.82% and 1.57%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/24/2021
|
Medtronic Q1 Earnings Double As Elective Procedures Recover
- Medtronic Plc's (NYSE: MDT) Q1 FY22 sales of $7.9 billion increased 23% Y/Y as reported and 19% on an organic basis, beating the consensus estimate of $7.86 billion. Q1 adjusted EPS of $1.41 more than doubled from $0.62 a year ago, surpassing the analyst consensus of $1.32.
- 08/24/2021
|
Medtronic: Q1 Earnings Insights
- Shares of Medtronic (NYSE:MDT) moved higher by 0.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 127.42% over the past year to $1.41, which beat the estimate of $1.32.
- 08/24/2021
|
Medtronic stock gains after profit and sales beats, outlook for earnings nudged up
- Shares of Medtronic PLC MDT, -1.09% tacked on 0.6% in premarket trading Tuesday, after the medical device maker reported fiscal first-quarter profit and sales that beat expectations, and nudged up its full-year earnings outlook, citing a strong recovery from the impact of the COVID-19 pandemic on elective procedures. Net income for the quarter to July 30 rose to $763 million, or 56 cents a share, from $487 million, or 36 cents a share, in the year-ago period.
- 08/24/2021
|
Medtronic Reports First Quarter Fiscal 2022 Financial Results
- DUBLIN, Aug. 24, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2022, which ended July 30, 2021. Key Highlights Revenue of $8.0 Billion Increased 23% Reported and 19% Organic GAAP Diluted EPS of $0.56; Non-GAAP Diluted EPS of $1.41 Company Reiterates FY22 Revenue Guidance; Raises Lower End of FY22 EPS Guidance by 5 cents "FY22 is off to a strong start - Q1 reflects solid execution & continued procedure recovery" Chairman & CEO Geoff Martha The company reported first quarter worldwide revenue of $7.987 billion, an increase of 23% as reported and 19% on an organic basis, which excludes the $245 million benefit of foreign currency translation.
- 08/24/2021
|
Is a Surprise Coming for Medtronic (MDT) This Earnings Season?
- Medtronic (MDT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 08/23/2021
|
What To Expect From Medtronic's Q1?
- Medtronic stock (NYSE: MDT) is scheduled to report its fiscal first-quarter results on Tuesday, Aug 24. We expect Medtronic to likely post revenues and earnings largely in-line with the consensus estimates.
- 08/23/2021
|
Why Medtronic Is A Med-Tech Powerhouse Worth Buying
- Medtronic is one of the world's leading medical technology companies, posting more than $30 billion in revenue in fiscal year 2021.
- 08/23/2021
|
Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2022
- DUBLIN, Aug. 23, 2021 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Friday, August 20, 2021, approved the fiscal year 2022 second quarter cash dividend of $0.63 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2021.
- 08/23/2021
|
Will Medtronic (MDT) Beat Estimates Again in Its Next Earnings Report?
- Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 08/19/2021
|
Medtronic (MDT) Q1 Earnings to Benefit From Market Share Gains
- Robust performances of Micra leadless pacemaker, Cobalt, and Crome High Power devices are likely to have boosted Medtronic's (MDT) CRM business in Q1.
- 08/19/2021
|
Medtronic (MDT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/17/2021
|
This Revolutionary Medical Device Company Goes to 11
- To stand tall against a competitive market, NuVasive depends on a strong spinal platform.
- 08/13/2021
|
Medtronic (MDT) to Expand Neuroscience Line With XENT Buyout
- Medtronic's (MDT) acquisition of Intersect ENT is intended to offer a wide-ranging variety of solutions to help surgeons treat CRS patients.
- 08/11/2021
|
Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2022
- DUBLIN, Aug. 10, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2022 on Tuesday, August 24, 2021. A news release will be issued at approximately 5:45 a.m.
- 08/10/2021
|
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.
- NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Intersect ENT, Inc. (NASDAQ: XENT) and its board of directors concerning the proposed acquisition of the company by Medtronic plc (NYSE: MDT). Stockholders will receive $28.25 for each share of Intersect ENT stock that they hold.
- 08/09/2021
|
Medtronic: A Fully Valued Dividend Champion
- Medtronic is a Dividend Champion with 44 consecutive years of dividend growth. Shares currently offer a yield of 1.96%. Medtronic is a leader in the medtech space with ample cash to spend on R&D and tuck-in M&A.
- 08/08/2021
|
3 Big Dividends, Paying Monthly, For Your Retirement Basea
- A monthly income stream provides a lot of flexibility for the income investor. Monthly dividends makes DCA work even better.
- 08/08/2021
|
Why Medtronic (MDT) Is Buying Intersect ENT For $1.1 Billion
- Medtronic plc (NYSE:MDT) announced it entered into a definitive agreement with Intersect ENT (NASDAQ: XENT) for $1.1 billion. The post Why Medtronic (MDT) Is Buying Intersect ENT For $1.1 Billion appeared first on Pulse 2.0.
- 08/07/2021
|
SHAREHOLDER ALERT: WeissLaw LLP Investigates Intersect ENT, Inc.
- NEW YORK, Aug. 6, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intersect ENT, Inc. ("Intersect" or the "Company") (NASDAQ: XENT) in connection with the proposed acquisition of the Company by Medtronic plc ("Medtronic") (NYSE:MDT). Under the terms of the merger agreement, the Company's shareholders will receive $28.25 per share in cash for each share of Intersect common stock that they hold.
- 08/06/2021
|
Medtronic Expands Its ENT Portfolio With Intersect ENT Acquisition For $28.25/Share
- Medtronic plc (NYSE:MDT) has agreed to acquire Intersect ENT Inc (NASDAQ:XENT) for $28.25 per share in an all-cash transaction implying an enterprise value of approximately $1.1 billion. Medtronic's acquisition of Intersect ENT expands the company's portfolio of products used during ear, nose, and throat procedures.
- 08/06/2021
|
dorsaVi extends data capture and analysis agreement with Medtronic
- dorsaVi has extended its agreement with Medtronic for a further 6 months, worth an additional US$171,000 following the continued success of their partnership. The agreement extension, on top of a US$330,000 master service agreement (MSA) signed in March 2021, is aimed at optimising the technology and build on insights from the ongoing agreement.
- 08/05/2021
|
The Highest Quality Dividend Growth Stocks
- This article updates one published by David Van Knapp in June 2020.
- 08/03/2021
|
Medtronic's AI Algorithms For Cardiac Monitoring Scores FDA Approval
- The FDA has cleared Medtronic Plc's (NYSE: MDT) two AccuRhythm AI algorithms for use with the Linq II ICM. AccuRhythm AI applies artificial intelligence to heart rhythm event data collected by the Linq II insertable cardiac monitor (ICM) to improve the information provided to physicians for better diagnoses and treatments for abnormal heart rhythms.
- 07/28/2021
|
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
- AI Algorithms Enhance LINQ II™ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients DUBLIN, July 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM). AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.
- 07/28/2021
|
Could Medtronic's Surgical Robotics Business Be a Growth Catalyst?
- The medical device company's Hugo robotic-assisted surgery (RAS) system may end up playing a significant role in its growth.
- 07/28/2021
|
Medtronic (MDT) Introduces New Drug Coated Balloon Catheter
- Medtronic's (MDT) newly-launched Prevail DCB demonstrates impressive safety and drug deliverability, utilizing a rapid absorption drug to treat patients with coronary artery disease.
- 07/27/2021
|
Medtronic's Antibacterial Envelope Effective In Reducing Infections In Cardiac Device Patients With Hematomas
- Medtronic plc (NYSE: MDT) has announced new data from the WRAP-IT study published in Heart Rhythm. The study evaluated Tyrx absorbable antibacterial envelope, an absorbable, single-use device that holds a cardiac implantable electronic device or implanted neurostimulator.
- 07/26/2021
|
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
- Medtronic Prevail DCB™ Designed to Treat Complex Lesions with Superior Deliverability, Rapid Absorption of Paclitaxel DUBLIN, July 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of the Prevail™ drug coated balloon (DCB) Catheter in Europe following CE (Conformité Européene) mark. The newest coronary DCB on the market, the Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).
- 07/26/2021
|
Medtronic's (MDT) Hugo RAS System Now Available at UC CHRISTUS
- Recent integration of Medtronic's (MDT) Hugo RAS System at UC CHRISTUS is intended to support the teaching institution's new robotic surgery program.
- 07/22/2021
|
Barron's 42 Mid 2021 RoundTable Picks Show 21 With Dividends And 4 With Ideal Returns
- Barron's 42 Mid 2021 RoundTable Picks Show 21 With Dividends And 4 With Ideal Returns
- 07/21/2021
|
Medtronic Hugo™ Robotic-Assisted Surgery System Cornerstone of New Robotics Program in Latin America
- Advanced Technology at UC CHRISTUS Expands Access to Minimally Invasive Surgery for More Patients DUBLIN, July 20, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the integration of the Hugo™ robotic-assisted surgery (RAS) system at Hospital Clinico de la Red de Salud UC CHRISTUS in Santiago, Chile, to support the teaching institution's new robotic surgery program. UC CHRISTUS is the latest institution to join Medtronic's Partners in Possibility Program, a group of pioneering hospitals that will be among the first in the world to use the Hugo RAS system in support of the Hugo system patient registry.
- 07/20/2021
|
Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery
- GALWAY, Ireland--(BUSINESS WIRE)--Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery
- 07/15/2021
|
Is This Surgical Robotics Company a Cheap Buy Now?
- After Asensus Surgical joined the Russell 2000 index last month, the stock climbed higher but has since fallen back to earth.
- 07/15/2021
|
Our U.S. Stock Portfolio, First Half Of 2021 Review
- U.S. stocks moved to new all-time highs in the first half of 2021 as we eye the other side of the pandemic.
- 07/14/2021
|
This Ultra-Safe Dividend Stock Looks Like a Solid Buy After a 9% Boost
- The healthcare behemoth's payout increase was in line with investor expectations, but can it afford the increased dividend cost?
- 07/08/2021
|
Medtronic's (MDT) DEFINE AFib Study to Assess AF Burden
- Medtronic (MDT) begins first app-based study to understand atrial fibrillation burden in patients, utilizing data collected from the LINQ range of insertable cardiac monitors.
- 07/07/2021
|
Medtronic (MDT) Diabetes Arm Grows With Favorable InPen Data
- Medtronic's (MDT) InPen is a FDA as well as CE Mark-cleared smart insulin pen available for patients who require multiple daily injections.
- 06/29/2021
|
Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes
- DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies DUBLIN, June 29, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company's first app-based research study. Using data collected from the LINQ family of insertable cardiac monitors (ICMs), the study aims to address unanswered questions around atrial fibrillation (AF) burden and its impact on patient outcomes, quality of life, and healthcare utilization.
- 06/29/2021
|
Medtronic InPen™ Real-World Data and Extended Infusion Set* Pivotal Trial Results Demonstrate Strong Clinical Outcomes and Positive User Experience
- Data Were Presented at the American Diabetes Association 81st Scientific Sessions DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The presentations illustrated increases in Time in Range when using an InPen™ smart insulin pen, safety of an extended-wear infusion set that lasts up to 7 days, and patient satisfaction with the longer-wear infusion set.
- 06/28/2021
|
Palliare Completes $8m Series A Funding Round
- GALWAY, Ireland--(BUSINESS WIRE)--Palliare Closes $8M Series A Funding Round
- 06/28/2021
|
Diabetes Space Thrives on CGM Devices in 2021: 3 Stocks in Focus
- CGM device stocks Medtronic (MDT), Dexcom (DXCM) and Tandem Diabetes (TNDM) are expected to continue their run over the next few months.
- 06/25/2021
|
Medtronic (MDT) Reports First Surgery With Hugo RAS System (Revised)
- Medtronic (MDT) to begin patient registry for the Hugo RAS system following first successful patient procedure at Clinica Santa Maria in Chile.
- 06/25/2021
|
Medtronic (MDT) Reports First Surgery With Hugo RAS System
- Medtronic (MDT) to begin patient registry for the Hugo RAS system following first successful patient procedure at Clinica Santa Maria in Chile.
- 06/24/2021
|
5 BofA Securities US 1 List Stocks to Buy Now That Also Pay Very Dependable Dividends
- Despite ongoing inflation chatter, after spiking last week during the worst week for the markets since last October, interest rates have fallen back, and once again growth and income investors are looking for ideas.
- 06/24/2021
|
Medtronic Announces Real-World Data on InPen™ and Extended Infusion Set* Pivotal Trial Data at the American Diabetes Association 81st Scientific Sessions
- DUBLIN, June 23, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June 25-29, 2021. Medtronic will be participating in this year's ADA virtual sessions with seven data presentations, a product theater, two on-demand learning sessions, and a virtual exhibit.
- 06/23/2021
|
Medtronic (MDT) Gets Expanded FDA Nod for Cryoablation Catheters
- Medtronic's (MDT) Cardiac Cryoablation Catheters offer safe and effective substitute to antiarrhythmic drug therapy for the prevention of atrial arrythmia recurrence.
- 06/23/2021
|
First Procedure in the World with Medtronic Hugo™ Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile
- The Robotic Prostatectomy Marked the Start of the Hugo™ RAS System Global Patient Registry DUBLIN, June 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient procedure with the Hugo™ robotic-assisted surgery (RAS) system. The robotic prostatectomy was performed June 19 by urological surgeon Ruben Olivares, M.D.
- 06/22/2021
|
Medtronic Scores FDA Expanded Approval For Cardiac Cryoablation Catheters For Paroxysmal Atrial Fibrillation
- The FDA has granted expanded approval for Medtronic plc's (NYSE: MDT) cardiac cryoablation catheters for atrial fibrillation. The approval comes for Arctic Front Family of Cardiac Cryoablation Catheters to treat recurrent symptomatic paroxysmal atrial fibrillation (episodes that last less than seven continuous days) as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy.
- 06/21/2021
|
Medtronic Receives FDA Expanded Approval for Arctic Front™ Family of Cardiac Cryoablation Catheters for Initial Use for Recurrent Symptomatic Paroxysmal Atrial Fibrillation
- - First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy - Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia Recurrence DUBLIN, June 21, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it received U.S. Food and Drug Administration (FDA) expanded approval for the Arctic Front™ Family of Cardiac Cryoablation Catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (episodes that last less than seven continuous days) as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. The expanded indication is based on results from STOP AF First, a prospective, multicenter randomized study that demonstrated superior efficacy of the Medtronic cryoablation procedure for preventing atrial arrhythmia recurrence compared to the use of AAD therapy.
- 06/21/2021
|
Upcoming Ex-Dividend Dates: June 22-July 5, 2021
- We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
- 06/21/2021
|
Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on
- These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.
- 06/18/2021
|
3 Upcoming Dividend Increases Including Medtronic
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List.
- 06/17/2021
|
Your question, your trade #AskHalftime
- The traders answer viewer questions in #AskHalftime.
- 06/16/2021
|
Medtronic (MDT) Progresses in SCS With FDA Nod for Vanta
- Vanta utilizes Medtronic's (MDT) proprietary AdaptiveStim technology for personalized pain relief.
- 06/14/2021
|
Upcoming Ex-Dividend Dates: June 15-28, 2021
- This article series presents upcoming ex-dividend dates. We provide a summary table with relevant data and key statistics, including the next payout and pay date.
- 06/14/2021
|
Here's My Top Stock to Buy in June
- This stock is in a league of its own.
- 06/13/2021
|
5 Probable MedTech Winners Post-COVID on Discounted PEG
- Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.
- 06/11/2021
|
American Airlines, Biogen, Dow and More Thursday Afternoon Analyst Calls
- With the trading day about halfway over, the markets were moving higher, after being stuck in the doldrums for the first half of the week.
- 06/10/2021
|
3 Dividend Aristocrats Growing Dividends
- The Dividend Aristocrats remain one of my favorite places to invest as these companies have raised dividend payments to shareholders for at least 25 consecutive years. Companies attaining membership in this group have business models that can withstand the impact of a recession as their products or services remain in high demand even in an economic downturn.
- 06/10/2021
|
Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform
- DUBLIN, June 10, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for Vanta™, a high performance recharge-free implantable neurostimulator (INS) with a device life that can be optimized up to 11 years. At comparable settings, the Vanta neurostimulator offers nearly twice the device life than competitive primary cell devices.1,2 It also utilizes Medtronic's proprietary AdaptiveStim™ technology for personalized pain relief that adapts to the patient's movement or body position using a built-in accelerometer.
- 06/10/2021
|
Medtronic's (MDT) STROKE AF Trial Outcome Backs ICM Progress
- STROKE AF trial shows Medtronic's (MDT) Reveal LINQ ICM has a seven-fold advantage in detecting AF compared to traditional standard of care in patients with large vessel or small vessel stroke.
- 06/09/2021
|
Medtronic plc (MDT) CEO Geoff Martha Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
- Medtronic plc (MDT) CEO Geoff Martha Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
- 06/08/2021
|
Medtronic (MDT) Progresses in Neuromodulation on New FDA Nod
- Medtronic's (MDT) SenSight claims to deliver patient-specific DBS therapy for the treatment of symptoms associated with Parkinson's, dystonia and essential tremor and medically refractory epilepsy.
- 06/08/2021
|
Study Shows Medtronic's Cardiac Monitor Tops Standard Care for Atrial Fibrillation Detection
- Medtronic plc (NYSE: MDT) has announced clinical trial results from the STROKE atrial fibrillation (AF) trial assessing its Reveal LINQ Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats compared to standard of care. The findings were published in the Journal of the American Medical Association.
- 06/07/2021
|
Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care
- DUBLIN, June 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal LINQ™ Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care. The findings were published in the June 1, 2021 issue of the Journal of the American Medical Association (JAMA).
- 06/07/2021
|
Medtronic Pulls Plug On Heart Implant Device Amid Growing Concerns Over Patient Safety
- Medtronic PLC (NYSE: MDT) announced Thursday that it is stopping the distribution and sale of the Medtronic HVAD System, an implantable heart pump, after numerous data indicated higher occurrences of adverse events, including stroke and mortality, as compared to other circulatory-support devices. What Happened: On Thursday morning, the company notified physicians to halt new implants of the HVAD System and shift to an alternative form of mechanical circulatory support.
- 06/04/2021
|
Medtronic plc. (MDT) CEO Geoff Martha Presents at Bernstein 37th Annual Strategic Decisions Conference Transcript
- Medtronic plc. (MDT) CEO Geoff Martha Presents at Bernstein 37th Annual Strategic Decisions Conference Transcript
- 06/03/2021
|
Medtronic Halts Sale of Heart Device HVAD System Over Neurological Adverse Events
- Medtronic plc (NYSE: MDT) will stop the distribution and sale of its HVAD System and has notified physicians to cease new implants of the HVAD System and transition to an alternative means of durable mechanical circulatory support. The decision comes after the company's clinical comparisons showed a higher rate of neurological adverse events, including stroke and mortality, with the HVAD System than with other circulatory support devices.
- 06/03/2021
|
Medtronic to Stop Distribution and Sale of HVAD™ System
- - Company Developing Support Program for Current HVAD Patients - Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, is stopping the distribution and sale of the Medtronic HVAD™ System. This morning, the company notified physicians to cease new implants of the HVAD System and transition to an alternative means of durable mechanical circulatory support.
- 06/03/2021
|
Better Buy: Medtronic or Boston Scientific?
- Which one of these medical device makers is better poised for a breakout year?
- 06/03/2021
|
Medtronic plc (MDT) Management Presents at Jefferies Virtual Healthcare Conference (Transcript)
- Medtronic plc (MDT) Management Presents at Jefferies Virtual Healthcare Conference (Transcript)
- 06/02/2021
|
Real-World Data on Over 4,000 Patients Using the Medtronic MiniMed™ 780G System Demonstrate Time in Range Mirroring Pivotal Trial
- Results Demonstrate 76% Time in Range and 94% Time in Advanced Hybrid Closed Loop Mode DUBLIN, June 2, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 4,120 individuals on the MiniMed™ 780G system, a small subset of those on the latest system today across nine countries in Europe. Data showed an average overall Time in Range of 76.2% and an overnight Time in Range of 83%, mirroring results from the pivotal trial.
- 06/02/2021
|
4 Dividend Increases Expected In June 2021
- 4 Dividend Increases Expected In June 2021
- 06/02/2021
|
Medtronic (MDT) Diabetes Arm Secures Two Approvals in Europe
- These two latest innovations are likely to enable Medtronic (MDT) to offer the only pump that adjusts and corrects every five minutes with an infusion set that lasts twice as long.
- 06/01/2021
|
Medtronic Announces Scientific Data Presentations at the 14th International Conference on Advanced Technologies & Treatments for Diabetes
- Data on the Company's Holistic Portfolio Will Include Real-World Data on MiniMed™ 780G System and New Data on Medtronic Continuous Glucose Monitoring Systems and Extended-Wear Infusion Set DUBLIN, June 1, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its virtual participation at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking place June 2-5, 2021. Medtronic will showcase clinically meaningful outcomes associated with the company's comprehensive product portfolio and future technologies, as well as customer-centric support and services provided in a remote environment during the COVID-19 pandemic, including onboarding and training for healthcare providers and patients.
- 06/01/2021
|
Dividend Increases: May 22-28, 2021
- This article series covers dividend changes on a weekly basis. A summary table presents relevant data and key statistics of dividend increases.
- 05/30/2021
|
Medtronic CFO on the coronavirus pandemic: We've come out stronger
- Yahoo Finance's Anjalee Khemlani and Julie Hyman speak with Medtronic CFO Karen Parkhill about the company's latest earnings report, outlook, and much more.
- 05/27/2021
|
Medtronic plc's (MDT) CEO Geoffrey Martha on Q4 2021 Results - Earnings Call Transcript
- Medtronic plc's (MDT) CEO Geoffrey Martha on Q4 2021 Results - Earnings Call Transcript
- 05/27/2021
|
Medtronic Earnings Double On Procedure Recovery; Hikes Dividend By 9%
- Medtronic Plc's (NYSE: MDT) Q4 earnings beat consensus, aided by a recovery in its core business as more people opted for elective procedures that suffered the impact of the COVID-19 pandemic. Q4 adjusted EPS of $1.50 beat the analyst consensus of $1.42, 160% higher than $0.58 from the same period last year.
- 05/27/2021
|
How Medtronic Beat Wall Street Expectations in Its Fiscal Q4
- The company appeared to turn the corner on COVID-19.
- 05/27/2021
|
Medtronic's (MDT) Q4 Earnings Beat Estimates, Margins Up
- Medtronic's (MDT) fourth-quarter results reflect a strong recovery in terms of elective procedures.
- 05/27/2021
|
Medtronic CEO Geoffrey Martha on fourth-quarter earnings beat and guidance
- Geoffrey Martha, Medtronic chairman and CEO, joined "Squawk on the Street" to discuss the company's fourth-quarter earnings beat and outlook.
- 05/27/2021
|
Earnings Hits and Misses: Best Buy, Medtronic, Nvidia, Pure Storage, Snowflake
- Here's a quick look at some earnings reports that were released after markets closed on Wednesday or before Thursday's opening bell.
- 05/27/2021
|
Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
- Medtronic (MDT) delivered earnings and revenue surprises of 5.63% and 0.55%, respectively, for the quarter ended April 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/27/2021
|
Medtronic beats profit and revenue expectations, boosts dividend
- Shares of Medtronic PLC slipped 0.1% in premarket trading Thursday, after the medical technology and services company reported fiscal fourth-quarter profit and sales that rose above expectations, citing a "strong recovery" in elective procedures, and boosted its dividend by 8.6%, but provided a less than upbeat full-year outlook. Net income for the quarter to April 30 rose to $1.36 billion, or $1.00 a share, from $646 million, or 48 cents a share, in the year-ago period.
- 05/27/2021
|
Recap: Medtronic Q4 Earnings
- Shares of Medtronic (NYSE:MDT) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share were up 158.62% over the past year to $1.50, which beat the estimate of $1.42.
- 05/27/2021
|
Medtronic Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Announces 9% Dividend Increase
- DUBLIN, May 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year 2021, which ended April 30, 2021. The company reported fourth quarter worldwide revenue of $8.188 billion, an increase of 37 percent as reported and 32 percent on an organic basis, which adjusts for the $241 million benefit of foreign currency translation.
- 05/27/2021
|
Earnings Previews: Best Buy, Medtronic, Nvidia, Pure Storage
- With the Memorial Day holiday coming up, the flood of earnings reports will be slowing to a trickle until a couple of weeks after the June quarter closes.
- 05/25/2021
|
Medtronic Executives to Speak at Upcoming Investor Conferences
- DUBLIN, May 25, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences: Jefferies Virtual Healthcare Conference Wednesday, June 2, 2021, at 1:30 pm EDT Sean Salmon, executive vice president & president, cardiovascular portfolio and president, diabetes operating unit, will answer questions about the company. Bernstein 37th Annual Strategic Decisions Conference Thursday, June 3, 2021, at 3:30 pm EDT Geoff Martha, chairman & chief executive officer, will make a presentation and answer questions about the company.
- 05/25/2021
|
Share Gain in Core Markets to Aid Medtronic (MDT) Q4 Earnings
- Growing momentum in capital equipment purchases might have aided Medtronic (MDT) Q4 earnings.
- 05/24/2021
|
3 Stocks to Watch on Rising Demand for Smart Medical Devices
- Rising demand for smart medical devices due to their convenience of providing active monitoring of patients makes it wise to look at names like Apple (AAPL), Garmin (GRMN) and Medtronic (MDT).
- 05/24/2021
|
The Perfect Predictive Power Of Dividends
- Forecasting the income provided from a dividend growth portfolio has proven remarkably accurate, regardless of tweaks to investing philosophy. Long range predictions of an individual stock price is akin to fortune telling, yet in aggregate, the stock market increases with consistency over time.
- 05/23/2021
|
Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
- Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/20/2021
|
Medtronic (MDT) Reveals Promising Results From Evolut Trial
- The Low Risk Trial has demonstrated non-inferiority of Medtronic's (MDT) TAVR system over open heart surgery.
- 05/20/2021
|
Medtronic's Evolut Aortic Valve Replacement Shows Positive Outcomes Even After Two Years
- Medtronic Plc (NYSE: MDT) has announced the complete two-year outcomes from a low-risk trial comparing the Evolut transcatheter aortic valve replacement (TAVR) system to open-heart surgery in characteristically younger, healthier aortic stenosis patients. Data were presented at the EuroPCR 2021 e-Course.
- 05/18/2021
|
Late Breaking Data at EuroPCR Demonstrates Long-Term Benefits of Medtronic Radiofrequency Renal Denervation in Real-World Hypertensive Patients
- Medtronic Launches New GSR-DEFINE Study to Expand Real-World Data to 5,000 Patients DUBLIN, May 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new clinical data from the Global SYMPLICITY Registry (GSR) indicating that renal denervation (RDN) with the Medtronic Symplicity™ Renal Denervation System was associated with clinically significant and sustained blood pressure reductions in a real-world hypertensive patient population through three years. Results from the prospective, single-arm, global, observational study are being presented as a Late-Breaking Clinical Trial session at the 2021 EuroPCR Annual Meeting.
- 05/18/2021
|
Medtronic's (MDT) Coronary Market Share Grows Amid Pandemic
- In Gastrointestinal, Medtronic (MDT) is witnessing some modest share gains, driven in part by its partnership with the NHS in England.
- 05/17/2021
|
How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre
- The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on how to trade healthcare trends.
- 05/14/2021
|
New Survey Identifies Opportunity to Improve Shared Decision Making Between Cardiologists and Heart Valve Disease Patients
- DUBLIN, May 14, 2021 /PRNewswire/ -- New findings from an American College of Cardiology's (ACC) survey revealed more than half of cardiologists (57%) believe patient preparation may lead to better quality discussions around treatment options for heart valve disease (HVD). Results from the ACC CardioSurve panelist survey, sponsored by Medtronic (NYSE: MDT), and conducted by the American College of Cardiology, garnered responses from more than 150 cardiologists around key factors driving treatment choices for patients with symptomatic severe aortic stenosis.
- 05/14/2021
|
Medtronic to Announce Financial Results for its Fourth Quarter and Full Fiscal Year 2021
- DUBLIN, May 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its fourth quarter and full fiscal year 2021 on Thursday, May 27, 2021. A news release will be issued at approximately 5:45 a.m.
- 05/13/2021
|
Medtronic and Medtronic Foundation Partner to Address COVID-19 Surges with Focus on Equity
- DUBLIN and MINNEAPOLIS, May 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and the Medtronic Foundation announced an additional $3M USD for COVID-19 relief efforts – a combination of financial resources, personal protective equipment (PPE) donations, and Medtronic employee engagement – focused on underserved areas of India, Brazil, the United States, and other global regions. This latest COVID-19 response expands Medtronic and Medtronic Foundation's COVID-19 support to $56M USD.
- 05/13/2021
|
MedTech Round Up: Update On Products By Conformis, Medtronic, Orthofix, Neovasc
- The FDA has given 510(k) clearance for Conformis Inc's (NASDAQ: CFMS) Identity Imprint Knee Replacement System, available in both cruciate-retaining (CR) and posterior stabilized (PS) versions. Identity Imprint utilizes a proprietary 3-dimensional "best-fit" algorithm to select the implant that most closely meets the geometric and anatomic requirements of the patient based on the patient's computed tomography scans.
- 05/10/2021
|
Medtronic (MDT) to Enhance Patient Care via Digital Portal
- Medtronic's (MDT) first patient-centric digital health platform is expected to provide better outcome for patients undergoing the company's SCS therapy.
- 05/10/2021
|
Medtronic Launches New Pediatric Monitor That Alerts Clinicians To Potential Airway Obstructions During Ventilation
- DUBLIN, May 10, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of the SonarMed™ airway monitoring system. The first and only device of its kind, the SonarMed airway monitoring system utilizes acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for their smallest patients.
- 05/10/2021
|
6 Dividend Increases Expected In May 2021
- Dividend stocks continue to amaze. If the goal is to produce a passive income stream that will one day cover our expenses, making sure that income stream grows is critical.
- 05/05/2021
|
Medtronic Announces CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
- As TAVI Patient Population Grows, PRO+ TAVI System Launches with Four Valve Sizes and Lowest Delivery Profile DUBLIN, May 3, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark of the Evolut™ PRO+ TAVI System – the newest-generation Medtronic TAVI system that builds off the proven self-expanding, supra-annular Evolut TAVI platform. The Evolut PRO+ TAVI System includes four valve sizes with an external pericardial tissue wrap that provides advanced sealing for the largest annular range (for self-expanding TAVI technology) on the market.
- 05/03/2021
|
Procedure-Related Techniques and Care Pathways from the OPTIMIZE PRO Clinical Study Show Promising Early Outcomes for Patients Implanted with the Medtronic Evolut™ TAVR System
- DUBLIN, April 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 roll-ins) treated in the OPTIMIZE PRO clinical study. The post-market, prospective, multi-center study is evaluating procedural outcomes (including pacemaker rate) associated with procedure-related techniques and post-procedure TAVR care pathways when using the self-expanding, supra-annular Evolut™ PRO and PRO+ TAVR systems in patients with symptomatic severe aortic stenosis.
- 04/28/2021
|
Medtronic Receives FDA Breakthrough Designation for the Emprint™ Ablation Catheter Kit
- Minimally Invasive Option Has Potential to Provide Long-Term Management of Lung Malignancies While Protecting Lung Function DUBLIN, April 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the Emprint™ ablation catheter kit – an investigational device not yet approved or cleared in the United States. The catheter is intended to be used in conjunction with the Emprint™ microwave generator and Medtronic lung navigation platform to provide a minimally invasive, localized treatment of malignant lesions in the lung, and it can be used together with standard of care therapy when indicated.
- 04/27/2021
|
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
- EDEN PRAIRIE, Minn., April 27, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the appointment of Hijaz Haris, as its Vice President of Marketing.
- 04/27/2021
|
Can This Popular Reddit Stock Make You Rich?
- Up over 250% in less than a year, what's behind the rise of this hot stock?
- 04/27/2021
|
Medtronic Partners with Surgical Theater to Provide First Augmented Reality Platform for Use in Real-Time During Complex Cranial Procedures
- DUBLIN and LOS ANGELES, April 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, and Surgical Theater today announced a partnership to interface Surgical Theater's SyncAR™ augmented reality (AR) technology with Medtronic's StealthStation™ S8 surgical navigation system. This collaboration will enable neurosurgeons to use AR technology in real-time to enhance visualization during complex cranial procedures.
- 04/26/2021
|
FDA Approves Medtronic's Embolization Device For Stopping Brain Aneurysms
- The FDA has approved Medtronic plc's (NYSE: MDT) Pipeline Flex Embolization Device with Shield Technology, a chemically bonded, synthetic coating that helps camouflage the metal implant from blood cells and hides it from the body's typical responses to an invading object. The company celebrated the 10th anniversary of the implant when it was first introduced in the U.S, designed to divert blood flow away from a brain aneurysm and prevent its rupture.
- 04/21/2021
|
Medtronic Receives U.S. FDA Approval for Pipeline™ Flex Embolization Device with Shield Technology™
- First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline™ Flex Embolization Device with Shield Technology™. Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.
- 04/21/2021
|
IN.PACT™ AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions
- IN.PACT AV Access Trial 24 Month Results Presented as a Podium First at Charing Cross Symposium DUBLIN and LONDON, April 20, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.1,2 "A patient who receives hemodialysis will often need to have several reinterventions each year to maintain patency and keep critical access sites open and functioning properly," said Andrew Holden, MBChB, FRANZCR, director of interventional radiology at Auckland Hospital and associate professor of radiology at Auckland University.
- 04/20/2021
|
Medtronic plc (MDT) Conversation and Q&A with Medtronic's Cardiac Rhythm Management Business (Transcript)
- Medtronic plc (MDT) Conversation and Q&A with Medtronic's Cardiac Rhythm Management Business (Transcript)
- 04/16/2021
|
Accredited Investors Inc. Buys BTC iShares MSCI EAFE Value ETF, iShares Russell 2000 Value ETF,.
- Edina, MN, based Investment company Accredited Investors Inc. (Current Portfolio) buys BTC iShares MSCI EAFE Value ETF, iShares Russell 2000 Value ETF, iShares MSCI All Country Asia ex Japan Index Fund, iShares S&P Mid-Cap 400 Value ETF, Vanguard Total World Stock ETF, sells WisdomTree Emerging Markets High Dividend Fund, Vanguard FTSE All-World ex-US ETF, iShares Core S&P Mid-Cap ETF, iShares S&P 500 Growth ETF, iShares Core MSCI Emerging Markets ETF during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Accredited Investors Inc.. As of 2021Q1, Accredited Investors Inc. owns 154 stocks with a total value of $731 million.
- 04/16/2021
|
Medtronic partners with cybersecurity startup Sternum to protect its pacemakers from hackers
- If you think cyberattacks are scary, what if those attacks were directed at your cardiac pacemaker? Medtronic, a medical device company, has been in hot water over the last couple of years because its pacemakers were getting hacked through their internet-based software updating systems.
- 04/16/2021
|
Medtronic Is Healing Hearts and Padding Portfolios
- The new Micra AV leadless pacemaker proves that good things come in small packages.
- 04/15/2021
|
Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes
- DUBLIN, April 14, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days. An infusion set is tubing that delivers insulin from the pump to the body and typically requires a set change every few days.
- 04/14/2021
|
3 3D Stocks That Can Advance the World of Healthcare
- These 3D stocks have proven to be instrumental in improving the quality of healthcare outcomes The post 3 3D Stocks That Can Advance the World of Healthcare appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn't matter if you have $500 in savings or $5 million.
- 04/13/2021
|
U.S. FDA Grants De Novo Clearance for First and Only Artificial Intelligence System for Colonoscopy; Medtronic Launches GI Genius™ Intelligent Endoscopy Module
- - The GI Genius™ Module Assists Physicians in Detecting Pre-Cancerous Growths; Potentially Addressing 19 Million Colonoscopies Annually - Transformative AI Colorectal Cancer Prevention Platform Expands Medtronic Capabilities in Medical Technology Data Analytics and Insights DUBLIN, April 12, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) granted de novo clearance for GI Genius™ intelligent endoscopy module in the United States. The GI Genius module is the first and only commercially available computer-aided detection (CADe) system using artificial intelligence (AI) to identify colorectal polyps.
- 04/12/2021
|
Medtronic (MDT) Hits New 52-Week High: What's Driving It?
- Medtronic's (MDT) ventilator sales are robust and prospects of the Diabetes arm remain strong amid the pandemic.
- 04/07/2021
|
Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes
- MINNEAPOLIS, April 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.
- 04/07/2021
|
Final Trades: Hanesbrands, Norwegian Cruise Line, Medtronic & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 04/05/2021
|
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now
- Investors continue to be optimistic about Medtronic (MDT) on its slew of product launches and regulatory approvals.
- 04/05/2021
|
Why Medtronic Is a Retiree's Dream Stock
- This is a stable investment you can buy and forget about.
- 04/01/2021
|
10 Dividend Growth Stocks For March 2021
- This monthly series ranks a selection of dividend growth stocks in Dividend Radar, presenting the 10 top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to get quality scores and sort them in descending order, breaking ties with additional metrics.
- 03/28/2021
|
Medtronic Receives FDA Approval for "Breakthrough" Transcatheter Pulmonary Valve Replacement for Patients with Congenital Heart Disease
- DUBLIN, March 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for its Harmony™ Transcatheter Pulmonary Valve (TPV), the first minimally invasive therapy created to treat patients with a specific type of congenital heart defect of the right ventricle (RV), one of the four chambers of the heart, which makes it difficult for blood to travel from the heart to the lungs. The Harmony TPV, which is placed inside a patient's native anatomy during a catheter-based procedure, was designated as a Breakthrough Therapy under FDA's Breakthrough Device Designation (BDD) program, an approval pathway intended to help patients receive more timely access to certain life-saving technologies.
- 03/26/2021
|
Medtronic (MDT) Directional Lead for DBS System Gets CE Mark
- This SenSight system according to Medtronic (MDT), is set to enhance detection of local field potentials (LFPs).
- 03/23/2021
|
Dividend Champion And Contender Highlights: Week Of March 21
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 03/21/2021
|
This Company Will Fix the Hidden COVID Danger to Come
- There are long-term implications to the coronavirus pandemic that the market is not appreciating.
- 03/21/2021
|
4 Stocks in Focus as Diabetes Sector Grows Amid Pandemic
- Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.
- 03/19/2021
|
5 Analyst Favorite Stocks to Buy for Q2 That Could Be Huge Winners
- Just like that, we are less than two weeks from the end of the first quarter. While it has been a very positive one for investors, the rise in interest rates has brought in much higher volatility and has really pressured technology stocks.
- 03/19/2021
|
Medtronic (MDT) Gets FDA Nod for Revised Neuromodulation Labeling
- This latest development is expected to contribute to Medtronic's (MDT) pain therapy business in the coming months.
- 03/18/2021
|
Here's Why Medtronic Is A Better Pick Over Intuitive Surgical Stock
- We think that Medtronic currently is a better pick compared to Intuitive Surgical. MDT stock trades at about 5.7x trailing revenues, compared to around 18.5x for ISRG.
- 03/18/2021
|
Medtronic Receives Approval for U.S. Labeling of the Intellis™ Platform Showing Superior Back Pain Relief When Using DTM™ Spinal Cord Stimulation
- DUBLIN, March 17, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Intellis™ Platform with Differential Target Multiplexed (DTM™) programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter randomized control trial reflecting superior back pain relief with DTM SCS when compared to conventional SCS.
- 03/17/2021
|
Medtronic plc (MDT) Presents at Oppenheimer 31st Annual Healthcare Conference (Transcript)
- Medtronic plc (MDT) Presents at Oppenheimer 31st Annual Healthcare Conference (Transcript)
- 03/16/2021
|
Upcoming Ex-Dividend Dates: March 16-29, 2021
- In this article series, we provide a summary of upcoming ex-dividend dates.
- 03/15/2021
|
Health Logic Interactive is Pleased to Announce the Appointment of Experienced MedTech Executive as CEO
- NEX: CHIP CALGARY, AB, March 12, 2021 /PRNewswire/ - Health Logic Interactive Inc. ("Health Logic" or the "Company") (NEX: CHIP), is pleased to announce the hiring of Mr. David Barthel, as the Chief Executive Officer for Health Logic.
- 03/12/2021
|
Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2021
- DUBLIN, March 8, 2021 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Friday, March 5, 2021, approved the fiscal year 2021 fourth quarter cash dividend of $0.58 per ordinary share, representing a 7.4 percent increase over the prior year. This quarterly declaration...
- 03/08/2021
|
A Trio of Fast-Growing Revenue Stock Picks
- The S&P 500 stocks saw their aggregate trailing 12-month real revenue per share increase at a compound annual growth rate of nearly 2% over the past five years. The share price of the benchmark index for the U.S. stock market traded at $3,841.94 at close on Friday, up by more than 90% over the past five years through March 5.
- 03/07/2021
|
4 Stocks to Watch as FDA Action Plan Stresses MedTech Digitization
- These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.
- 03/05/2021
|
4 Medical Technology Leaders Have Upcoming Catalysts That Could Be Huge
- When the market is expensive and overbought like the current one is, it is very important to stay with companies that not only have solid earnings potential but also have upcoming catalysts that can help move the shares higher.
- 03/04/2021
|
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now
- Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.
- 03/03/2021
|
Medtronic's (MDT) HVAD Pump Kit Recall Classified as Class I
- The latest back-to-back incidents will, undoubtedly, create a major drag in Medtronic's (MDT) VAD performance.
- 03/03/2021
|
Medtronic PLC (MDT) Presents at Cowen Healthcare Broker Conference Call - (Transcript)
- Medtronic PLC (MDT) Presents at Cowen Healthcare Broker Conference Call - (Transcript)
- 03/02/2021
|
Medtronic To Recall HeartWare Implant Kits After Patient Deaths
- The FDA has classified another recall of Medtronic Plc's (NYSE: MDT) HeartWare HVAD ventricular assist device as a Class I event in light of the potential for serious harm. Medtronic is recalling 157 HVAD pump implant kits from the U.S. after receiving complaints that some devices have failed to start or restart promptly.
- 03/02/2021
|
Medtronic's (MDT) Market Share Grows Amid COVID-19 Woes
- In Coronary, the ongoing issue related to the China drug-eluting stent national tender, Medtronic (MDT) is currently winning share globally.
- 03/01/2021
|
Medtronic plc (MDT) CEO Geoffrey Martha on Q3 2021 Results - Earnings Call Transcript
- Medtronic plc (MDT) CEO Geoffrey Martha on Q3 2021 Results - Earnings Call Transcript
- 02/23/2021
|
Medtronic's (MDT) Q3 Earnings Beat Estimates, Margins Fall
- Medtronic (MDT) procedure volumes hurt by resurgence of COVID-19 cases despite increased demand for related diagnostics and therapies.
- 02/23/2021
|
Medtronic CEO Geoff Martha on Q3 EPS beat, pipeline and more
- Medtronic reported a quarterly profit above Wall Street estimates, helped in part by stronger demand for ventilators amid the pandemic. Medtronic CEO Geoff Martha joined Tuesday "Squawk on the Street" to discuss the company's results.
- 02/23/2021
|
